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ABSTRACT 
This dissertation focuses on the application of urban metabolism metrology (UMM) to 
process streams of the natural and built water environment to gauge public health 
concerning exposure to carcinogenic N-nitrosamines and abuse of narcotics. A survey of 
sources of exposure to N-nitrosamines in the U.S. population identified contaminated 
food products (1,900 ± 380 ng/day) as important drivers of attributable cancer risk 
(Chapter 2). Freshwater sediments in the proximity of U.S. municipal wastewater 
treatment plants were shown for the first time to harbor carcinogenic N-nitrosamine 
congeners, including N-nitrosodibutylamine (0.2-3.3 ng/g dw), N-nitrosodiphenylamine 
(0.2-4.7 ng/g dw), and N-nitrosopyrrolidine (3.4-19.6 ng/g dw) were, with treated 
wastewater discharge representing one potential factor contributing to the observed 
contamination (p=0.42) (Chapter 3). Opioid abuse rates in two small midwestern 
communities were estimated through the application of wastewater-based epidemiology 
(WBE). Average concentrations of opioids (City 1; City 2) were highest for morphine 
(713 ± 38, 306 ± 29 ng/L) and varied by for the remainder of the screened analytes. 
Furthermore, concentrations of the powerful opioid fentanyl (1.7 ± 0.2, 1.0 ± 0.5 ng/L) in 
wastewater were reported for the first time in the literature for the U.S. (Chapter 4). To 
gauge narcotic consumption within college-aged adults the WBE process used in Chapter 
4 was applied to wastewater collected from a large university in the Southwestern U.S. 
Estimated narcotics consumption, in units of mg/day/1,000 persons showed the following 
rank order: cocaine (470 ± 42), heroin (474 ± 32), amphetamine (302 ± 14) and 
methylphenidate (236 ± 28). Most parental drugs and their respective metabolites showed 
detection frequencies in campus wastewater of 80% or more, with the notable exception 
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of fentanyl, norfentanyl, buprenorphine, and norbuprenorphine. Estimated consumption 
of all narcotics, aside from attention-deficit/hyperactivity disorder medication, were 
higher than values reported in previous U.S. WBE studies for U.S. campuses (Chapter 5). 
The analyses presented here have identified variation in narcotic consumption habits 
across different U.S. communities, which can be gauged through UMM. Application of 
these techniques should be implemented throughout U.S. communities to provide insight 
into ongoing substance abuse and health issues within a community. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
DEDICATION 
I would like to dedicate this work to my fiancée and future wife, Yer Jalan Atthirari Anni, 
Dr. Lydia Meador, as well as my family, Shakir, Kathy, and Sara Gushgari. I would not 
be where I am today if it was not for your constant support, advice, and love that you all 
have shown me. I would also like to thank my friends Robbie, Jeff, Joe, and Richie for 
the camping, hunting, and beer consumption (not while hunting) that kept me grounded 
throughout my PhD studies. I am truly blessed to have you all in my life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
ACKNOWLEDGEMENTS  
I would like to acknowledge my advisor, Dr. Rolf Halden, for the support, advice, and 
guidance that he has shown me over the past four years – both in my academic and 
personal life. I would also like to acknowledge Dr. Arjun Venkatesan for the pivotal role 
he has played in my research, and the advice he has given me throughout my doctoral 
studies. Additionally, thanks to Dr. Matthew Fraser, Dr. Edward Kavazanjian, and Dr. 
Giuseppe Mascaro for their exceptional involvement. Thanks also to Dr. Arjun 
Venkatesan, Erin Driver, Joshua Steele, Arjun Magge, Matteo Vaiente, Dr. Daniel 
Magee, Dr. Jing Chen, and Dr. Akash Sadaria for their contributions to this research, and 
their assistance in developing this dissertation document. Funding for my research came 
in part from the National Institute for Environmental Health Sciences (award numbers 
R01ES015445 and R01ES020889, and their supplements), and the Virginia G. Piper 
Charitable Trust (award number LRT 05/01/12). 
 
 
 
 
 
 
 
 
 
v 
 
TABLE OF CONTENTS 
Page 
LIST OF TABLES ............................................................................................................. xi 
LIST OF FIGURES ......................................................................................................... xiv 
CHAPTER 
1 - INTRODUCTION ................................................................................................... 1 
1.1 N-Nitrosamines in Wastewater ......................................................................... 3 
1.2 U.S. Prescription and Illegal Narcotic Use ....................................................... 5 
1.3 Data Gaps .......................................................................................................... 6 
1.4 Primary Goals and Strategy .............................................................................. 8 
1.5 Hypotheses ........................................................................................................ 9 
1.6 Specific Aims .................................................................................................... 9 
2 - CRITIAL REVIEW OF MAJOR SOURCES OF HUMAN EXPOSURE TO N-
NITROSAMINES ....................................................................................................... 13 
ABSTRACT .......................................................................................................... 13 
2.1 Introduction ..................................................................................................... 14 
2.2 Materials and Methods .................................................................................... 17 
2.2.1 Literature Search .................................................................................... 17 
2.2.2 Data Extraction and Analysis................................................................. 18 
2.2.3 Exposure and Attributable Risk Analyses ............................................. 18 
vi 
 
CHAPTER                                                                                                                      Page 
2.3 Results ............................................................................................................. 20 
2.3.1 N-Nitrosamine Contamination Data ...................................................... 20 
2.3.2 Cancer Incidence Rate Changes in Nations Consuming Large Quantities 
of Beer ............................................................................................................. 29 
2.4 Discussion ....................................................................................................... 31 
2.4.1 N-Nitrosamine Exposure Estimations.................................................... 31 
2.4.2 Attributable Risk Evaluation.................................................................. 33 
2.4.3 Reduction in the Daily N-nitrosamine Load .......................................... 34 
2.4.4 Potential Biases ...................................................................................... 39 
2.4.5 Future Scope .......................................................................................... 40 
2.5 Conclusion ...................................................................................................... 41 
3 - OCCURRENCE OF N-NITROSAMINES IN U.S. FRESHWATER SEDIMENTS 
NEAR WASTEWATER TREATMENT PLANTS ................................................... 45 
ABSTRACT .......................................................................................................... 45 
3.1 Introduction ..................................................................................................... 46 
3.2 Materials and Methods .................................................................................... 49 
3.2.1 Sediment Samples .................................................................................. 49 
3.2.2 N-Nitrosamine Analysis......................................................................... 50 
3.2.3 Statistical Analysis ................................................................................. 50 
vii 
 
CHAPTER                                                                                                                      Page 
3.3 Results and Discussion ................................................................................... 51 
3.3.1 Method Performance .............................................................................. 51 
3.3.2 Occurrence of N-nitrosamines in U.S. Freshwater Sediments .............. 52 
3.3.3 Potential Sources of Detected N-Nitrosamines ...................................... 52 
3.3.4 Principal Component Analysis of Data Relating to Nitrosamine 
Occurrences in Sediments ............................................................................... 56 
3.3.5 Carcinogenic Potential and Aquatic Toxicity of N-Nitrosamines in 
Sediment Porewater ........................................................................................ 59 
3.3.6 Study Limitations, Data Gaps, and Research Needs.............................. 61 
3.4 Conclusion ...................................................................................................... 63 
4 - TRACKING OPIOID CONSUMPTION IN TWO UNITED STATES CITIES BY 
WASTEWATER-BASED URBAN METABOLISM METROLOGY...................... 65 
ABSTRACT .......................................................................................................... 65 
4.1 Introduction ..................................................................................................... 66 
4.2 Materials and Methods .................................................................................... 69 
4.2.1 Study Locations and Wastewater Sampling Methods ........................... 69 
4.2.2 Target Analytes ...................................................................................... 70 
4.2.3 Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry 
(ID-LC-MS/MS) ............................................................................................. 70 
viii 
 
CHAPTER                                                                                                                      Page 
4.2.4 Analyte Concentrations in Raw Wastewater and Mass Loads .............. 71 
4.2.5 Estimation of Mass and Dose Per-Capita Opioid Consumption ............ 72 
4.2.6 Overdose-Death and Black-Market Value Estimates ............................ 73 
4.2.7 Statistical Analysis ................................................................................. 74 
4.3 Results and Discussion ................................................................................... 74 
4.3.1 Method Performance .............................................................................. 74 
4.3.2 Concentrations of Opioids and Metabolites in Raw Wastewater .......... 75 
4.3.3 Estimated Opioid Consumption ............................................................. 77 
4.3.4 User Count, Estimated Overdose-Deaths, and Monetary Black-Market 
Contribution .................................................................................................... 80 
4.3.5 Study Limitations ................................................................................... 82 
4.4 Conclusion ...................................................................................................... 83 
5 - APPLICATION OF WASTEWATER-BASED EPIDEMIOLOGY TRACKING 
NARCOTIC USE AT A SOUTHWESTERN U.S. UNIVERSITY ........................... 87 
ABSTRACT .......................................................................................................... 87 
5.1 Introduction ..................................................................................................... 88 
5.2 Materials and Methods .................................................................................... 90 
5.2.1 Study Location and Methods of Wastewater Sampling ......................... 90 
5.2.2 Target Analytes ...................................................................................... 92 
ix 
 
CHAPTER                                                                                                                      Page 
5.2.3 Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry 
(ID-LC-MS/MS) ............................................................................................. 93 
5.2.4 Analyte Concentrations in Raw Wastewater and Mass Loads .............. 94 
5.2.5 Estimation of Mass Per-Capita Narcotic Consumption ......................... 94 
5.2.6 Estimation of Overdoses, Overdose-Deaths, and Black-Market Value . 96 
5.2.7 Statistical Analysis ................................................................................. 96 
5.3 Results and Discussion ................................................................................... 97 
5.3.1 Method Performance .............................................................................. 97 
5.3.2 Concentrations of Narcotics and Metabolites in Raw Wastewater ........ 97 
5.3.3 Substance Consumption Estimates ...................................................... 101 
5.3.4 Drug User Count, Estimated Overdose-Deaths, and Estimated Black-
Market Value ................................................................................................ 104 
5.3.5 Impact of Elimination Half-Life .......................................................... 106 
5.3.6 Study Limitations ................................................................................. 107 
5.4 Conclusions ................................................................................................... 109 
6 - RESEARCH IMPLICATIONS AND RECOMMENDATIONS ........................ 111 
6.1 Considerations for Further Development of WBE Analysis Methods ......... 114 
6.2 Application of WBE to N-Nitrosamine Exposure ........................................ 115 
6.3 Widespread Spatial and Temporal WBE Testing ......................................... 117 
x 
 
CHAPTER                                                                                                                      Page 
6.4 Recommendations for Future Research ........................................................ 118 
REFERENCES ............................................................................................................... 121 
APPENDIX 
A - SUPPLEMENTAL MATERIAL FOR CHAPTER 2......................................... 145 
B - SUPPLEMENTAL MATERIAL FOR CHAPTER 3 ......................................... 147 
C - SUPPLEMENTAL MATERIAL FOR CHAPTER 4 ......................................... 155 
D - SUPPLEMENTAL MATERIAL FOR CHAPTER 5......................................... 163 
E - NARCOTIC ANALYTE CHROMATOGRAMS FOR CHAPTERS 4 AND 5 175 
 
 
 
 
 
 
 
 
 
xi 
 
LIST OF TABLES 
Table                                                                                                                               Page 
1. Summary Facts on N-Nitrosamines Covered in This Critical Review.* .............. 23 
2. Detection Frequency, Average Analyte Concentrations in Raw Wastewater ± 
Standard Deviations (SD), and Maximum Concentrations per Opioid 
Consumption Indicator of All Sample Concentrations. ........................................ 77 
3. Existing Regulations Involving N-Nitrosamine Congener Contamination Within 
Water Sources. .................................................................................................... 146 
4. Method Performance and Concentrations of N-Nitrosamines in Freshwater 
Sediments ............................................................................................................ 152 
5. LC-ESI-MS/MS Parameters for Analysis of N-Nitrosamines ............................ 153 
6. n-Octanol-Water Partitioning Coefficient of N-Nitrosamines. ........................... 154 
7. Demographic Information for City 1 and City 2, Obtained from the U.S. Census 
Bureau 2010 American Fact Finder Statistics. ................................................... 156 
8. Optimized Conditions for the Ionization and Fragmentation of the Opioid Parent 
and Metabolite Analytes Screened for in This Method. ..................................... 156 
9. Method Detection Limits for Opioid Analytes. .................................................. 157 
10. Opioid Narcotics, Respective Consumption Indicator Compounds, Excretion Rate 
of Respective Consumption Indicators, Correction Factors Used for Each 
Consumption Indicator, and Average Prescribed Oral Dose per Opioid per Mayo 
Clinic Doctor Guidelines. ................................................................................... 157 
11. State Overdose, Overdose-Deaths, and Ratio Information. ................................ 157 
 
xii 
 
Table                                                                                                                               Page 
12. Average ± Standard Error, Minimum, and Maximum Raw Wastewater Analyte 
Concentrations Across the Two Cities. ............................................................... 158 
13. Average ± Standard Error, Minimum, and Maximum Analyte Daily Mass 
Loading Across the Two Cities........................................................................... 159 
14. Average ± Standard Error, Minimum, and Maximum Analyte Population 
Normalized Mass Load Consumption Across the Two Cities. ........................... 160 
15. Analyte Concentration Changes Across the Study Period for City 1 and City 2.
............................................................................................................................. 161 
16. Dose-Estimated Usage for City 1 and City 2. ..................................................... 161 
17. Sewer Length and Approximate Sewage Retention Time Information. ............. 164 
18. Optimized Conditions for the Ionization and Fragmentation of the Opioid Parent 
and Metabolite Analytes Screened for in This Method. ..................................... 165 
19. Method Detection Limits for Narcotic Analytes. ............................................... 166 
20. Screened Narcotics, Respective Consumption Indicator Compounds, Excretion 
Rate of Respective Consumption Indicators, Correction Factors Used for Each 
Consumption Indicator, and Average Prescribed Oral Dose per Opioid per Mayo 
Clinic Doctor Guidelines. ................................................................................... 167 
21. Sampling Location 1 Narcotic Analyte Raw Wastewater Concentration Average ± 
Standard Deviation, Minimum and Maximum Concentrations Observed, and 
Detection Frequency. .......................................................................................... 168 
 
 
xiii 
 
Table                                                                                                                               Page 
22. Sampling Location 2 Narcotic Analyte Raw Wastewater Concentration Average ± 
Standard Deviation, Minimum and Maximum Concentrations Observed, and 
Detection Frequency. .......................................................................................... 169 
23. Average Estimated Consumption, Dose Consumption, and Estimated Number of 
Users Within the University Study Area. ........................................................... 170 
24. Analyte Elimination Half-Lives. ......................................................................... 171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
LIST OF FIGURES 
Figure                                                                                                                             Page 
1. Possible Matrices Used in Urban Metabolism Metrology Approaches. ................. 2 
2. Sampling Procedure, Data Analysis, and Results Presented in Wastewater-Based 
Epidemiological Monitoring. .................................................................................. 3 
3. Publication Activity and Timeline of Notable Events of N-Nitrosamine-Directed 
Research. ............................................................................................................... 21 
4. Average and Median TNA Concentrations in Various Categories Of Personal 
Care Products, Plotted on a Logarithmic Scale. ................................................... 25 
5. (A) Average and Median Concentrations (± Standard Error) of Total N-
Nitrosamines (TNA) in Various Food Categories. (B) Contribution of Individual 
N-Nitrosamine Congeners to TNA Levels Detected in Various Food Category. . 26 
6. Representation of N-Nitrosamine Levels in Domestic and International Beer and 
Tobacco Products. ................................................................................................. 30 
7. Estimations of Total N-Nitrosamine Exposure (TNE) by Diet and Lifestyle. ..... 32 
8. Number of Expected Cancer Cases in the U.S. Attributable to Ingestion and 
Inhalation of the N-Nitrosamine Class of Emerging Contaminants. .................... 34 
9. (A) Box and Whisker Plot of Concentrations of N-Nitrosamines in n Samples of 
Freshwater Sediments Collected Near 14 U.S. Wastewater Treatment Plants. (B) 
U.S. Regional Map Showing Average N-Nitrosamine Concentration for 
Corresponding U.S. Regions and the Number of Samples Analyzed per Region 
(n). ......................................................................................................................... 50 
 
xv 
 
Figure                                                                                                                             Page 
10. Principal Component Analysis of the N-Nitrosamine Levels and Parameters of 
Sediment and Water Quality from the Corresponding Sampling Locations. ....... 56 
11. Comparison of Concentrations of the Sum of N-Nitrosamines Detected in Paired 
Sediment Samples Obtained Within a Distance of 3,000 M Upstream and 
Downstream from WWTP Discharge Locations .................................................. 57 
12. Parent Opioid Concentrations Determined in 24-Hour Time-Weighted Composite 
Wastewater Samples for the Two Cities Over the Sampling Campaign from 
March 2015 to April 2017..................................................................................... 76 
13. Estimation Consumption Values for Codeine, Oxycodone and Fentanyl Derived 
from Opioid Parent Compound Analysis. ............................................................. 79 
14. Box Plots of Analyte Concentrations Identified in Raw Wastewater (ng/L) of All 
Analytes Detected During the August 2017-December 2017 Sampling Campaign.
............................................................................................................................... 98 
15. Average Drug Residue Mass Loads per Day and a Comparison Between Weekend 
and Weekday Mass Load Occurrence for Cocaine, Its Metabolite 
Benzoylecgonine, And MDMA. ......................................................................... 100 
16. Estimated Campus Population Consumption of the Following Substances of 
Potential Abuse. .................................................................................................. 102 
17. Uncertainty in Various Steps of WBE Data Modeling and Estimations. ........... 114 
18. LC-MS/MS Chromatograms of Standards, Sample Extracts and Matrix Spike 
Samples of Three Detected N-Nitrosamines. ...................................................... 150 
 
xvi 
 
Figure                                                                                                                             Page 
19. Stability Test for the Analyzed N-Nitrosamines in Fresh Sediments During 
Storage at –20C Analyzed Over a Period of Eight Months. ............................... 151 
20. Comparison Of Raw Wastewater Parent Opioid And Opioid Metabolite 
Concentrations During The 2016-2017 Sampling Period. Error Bars Represent 
Calculated Standard Error. .................................................................................. 162 
21. Total Daily Wastewater Loading and Estimation Consumption Values for the 
Suite of Opioids Derived from Opioid Metabolite Analysis. ............................. 162 
22. Raw Wastewater Analyte Concentrations (ng/L) of All Analytes Detected During 
the August 2017-December 2017 Sampling Campaign...................................... 172 
23. Average Drug Residue Mass Loads per Day and a Comparison Between Weekend 
and Weekday Mass Load Opioid Occurrence for Morphine-3-Glucuronide, 
Oxycodone, Noroxycodone, Codeine, Norcodeine, 6-Acetylmorphine, and EDDP.
............................................................................................................................. 173 
24. Average Drug Residue Mass Loads per Day and a Comparison Between Weekend 
and Weekday Mass Load Prescription Occurrence for Alprazolam, Alpha- 
Hydroxyalprazolam, Methylphenidate, And Amphetamine. .............................. 174 
25. Total Ion Count Chromatograms for Morphine: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 176 
26. Total Ion Count Chromatograms for Morphine-3-Glucuronide: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 176 
27. Total Ion Count Chromatograms for Codeine: Standard, Raw Wastewater, and the 
Deionized Water Blank. ...................................................................................... 177 
xvii 
 
Figure                                                                                                                             Page 
28. Total Ion Count Chromatograms for Norcodine: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 177 
29. Total Ion Count Chromatograms for Oxycodone: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 178 
30. Total Ion Count Chromatograms for Noroxycodone: Standard, Raw Wastewater, 
and the Deionized Water Blank. ......................................................................... 178 
31. Total Ion Count Chromatograms for Fentanyl: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 179 
32. Total Ion Count Chromatograms for Norfentanyl: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 179 
33. Total Ion Count Chromatograms for Heroin: Standard, Raw Wastewater, and the 
Deionized Water Blank. ...................................................................................... 180 
34. Total Ion Count Chromatograms for 6-Acetylmorphine: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 180 
35. Total Ion Count Chromatograms for EDDP: Standard, Raw Wastewater, and the 
Deionized Water Blank. ...................................................................................... 181 
36. Total Ion Count Chromatograms for Buprenorphine: Standard, Raw Wastewater, 
and the Deionized Water Blank. ......................................................................... 181 
37.  Total Ion Count Chromatograms for Norbuprenorphine: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 182 
38.  Total Ion Count Chromatograms for Amphetamine: Standard, Raw Wastewater, 
and the Deionized Water Blank. ......................................................................... 182 
xviii 
 
Figure                                                                                                                             Page 
39. Total Ion Count Chromatograms for Methylphenidate: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 183 
40. Total Ion Count Chromatograms for Alprazolam: Standard, Raw Wastewater, and 
the Deionized Water Blank. ................................................................................ 183 
41. Total Ion Count Chromatograms for Alpha-Hydrozyalprazolam: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 184 
42. Total Ion Count Chromatograms for Cocaine: Standard, Raw Wastewater, and the 
Deionized Water Blank. ...................................................................................... 184 
43. Total Ion Count Chromatograms for Benzoylecgonine: Standard, Raw 
Wastewater, and the Deionized Water Blank. .................................................... 185 
44. Total Ion Count Chromatograms for MDMA: Standard, Raw Wastewater, and the 
Deionized Water Blank. ...................................................................................... 185 
 
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER 1 
 
INTRODUCTION 
Access to reliable data on human behavior and population health is vital for 
public health officials, scientific researchers, government officials, and those involved in 
the science and practice of healthcare delivery. Methods of data collection have 
traditionally included socio-epidemiological surveys (Kim et al. 2015), crime statistics 
and seizure data, and analysis of medical records (Van Nuijs et al. 2011). These methods 
have proven valuable but also are known to be susceptible to potentially substantial bias 
and thus do not always represent the true nature of human behavior and population health 
within a community of interest. Urban metabolism metrology (UMM) is the science of 
measuring and interpreting the occurrence and concentrations of signature compounds 
and biomarkers informative of human activities and human health in communities large 
and small (Halden 2016). The UMM approach encompasses analytical work on an array 
of environmental matrixes including raw and treated wastewater (Archer et al. 2018, Baz-
Lomba et al. 2016, Zuccato et al. 2008, Zuccato et al. 2005), sewage sludges, freshwater 
and coastal sediments impacted by urban discharges (Gushgari et al. 2016), as well as 
dust, condensate (Roll et al. 2015) and other process streams of the natural and built 
environment (Fig. 1). The goal of UMM is to detect and quantify trends in population 
health using robust metrics that can be tracked in real-time or near-real time.  
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Fig. 1 - Possible matrices used in urban metabolism metrology approaches. Matrices 
studied in this thesis include wastewater and freshwater sediments. 
 
 Perhaps the most developed subset of UMM is wastewater-based epidemiology 
(WBE) - the process of analyzing samples of composited raw wastewater to identify 
compounds providing insight into human health and behavior (Fig. 2). This process 
typically begins with the collection of raw wastewater over a period of time (Irvine et al. 
2011) sufficient enough to capture inputs from most or all people present in a sewershed. 
Collected samples can be flow rate-adjusted or time-adjusted to best reflect the 
characteristic temporal chemistry of a study population. These samples have historically 
been collected at the inlet of wastewater treatment plants (Kim et al. 2015) but samples 
have also been obtained from building discharge points or along pipes traversing the 
sewershed (Postigo et al. 2011) to obtain insights on specific geographic areas or 
neighborhoods. Wastewater samples then typically are processed and screened for the 
occurrence of target analytes with output data being reported either as a concentration, as 
a mass load per time, or as a mass load per time further adjusted for the number of people 
known or presumed to be present in the sampling area (Zuccato et al. 2008). The data 
derived from this analysis can then been viewed on its own or alongside other methods of 
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collecting population trend data to obtain a more complete understanding of sensitive 
topics such as use of prescription opioids and illicit narcotics. 
 
Fig. 2 - Sampling procedure, data analysis, and results presented in wastewater-based 
epidemiological monitoring. 
 
1.1 N-Nitrosamines in wastewater 
 N-Nitrosamines are a class of carcinogenic water treatment disinfection 
byproducts that have seen increased research attention due to their formation during 
drinking water treatment and post-treatment distribution (Najm and Trussell 2001). N-
Nitrosamines have historically been considered disinfection byproducts but also are 
contaminants of foods (Song and Hu 1988), tobacco (Hecht 2014b), certain alcoholic 
beverages (Goff and Fine 1979), and an array of personal care products (Shen and 
Andrews 2011). While over 300 congeners of the N-nitroso class of chemicals exist 
(Hecht 1997) research to date has focused only on a select number of N-nitrosamines 
known or suspected to play a role in causing cancer in humans. Congeners of N-
nitrosamine have been shown in animal models to induce cancers of the liver, lung, 
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esophagus, nasal mucosa, bladder, tongue, forestomach, and pancreas (Hecht 1997), with 
site-specific tumor development being dependent on both the N-nitrosamine congener 
administered and the test species exposed (Hecht 1997). 
Regulation of these contaminants has been slow to catch up with scientific 
findings but progress in this realm has been accomplished. The International Agency for 
Research on Cancer (IARC) has classified 24 different N-nitrosamines with respect to 
their carcinogenetic potential to humans, with two of these being classified as known 
human carcinogens and the remainder being split between the categories of probable 
carcinogen and possible carcinogen (Internation Agency for Research on Cancer 2015). 
The U.S. Environmental Protection Agency (USEPA) has also listed five N-nitrosamines 
on their Contaminant Candidate List 3 (CCL3) and its update, which is currently in draft 
format (CCL4) (U.S. Environmental Protection Agency 2014). The overall N-nitrosamine 
research focus has spurred the development of several water quality regulations for select 
N-nitrosamine congeners. The state of California has adopted stringent regulations 
regarding the presence of N-nitrosamines in drinking water, with response levels for N-
nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA) and N-nitrosodi-n-
propylamine (NDPA) as 100 ng*L-1, 300 ng*L-1, and 500 ng*L-1, respectively. 
Furthermore, Massachusetts drinking water guidelines outline a regulatory limit of 0.01 
µg/L for NDMA (EPA 2015), and Arizona has set regulatory limits for NDMA (0.001 
µg/L), N-nitrosodiphenylamine (NDPhA) (7.1 µg/L), and NDPA (0.005 µg/L) in their 
National Pollutant Discharge Elimination System Permit Program (Arizona Department 
of Environmental Quality 2015). 
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1.2 U.S. prescription and illegal narcotic use 
 Abuse of prescription medication and illegal narcotics has become an increasingly 
pervasive problem within the United States with 10.1% of U.S. residents ages 12 and 
older admitting to illicit narcotic consumption within the past month and 2.4% of U.S. 
residents ages 12 and older admitting to nonmedical use of a psychotherapeutic drug in 
the past month (CDC 2017). Prescription and illegally sourced opioids raise additional 
concern as opioid-related overdoses have been found responsible for 66.5% and 63.1%, 
respectively, of all drug overdose deaths reported in 2014 and 2015 (Rudd 2016, Warner 
et al. 2016). Opioids accounted for six of the ten narcotics most commonly involved in 
drug-overdose deaths, namely heroin (23.1%), oxycodone (11.5%), fentanyl (8.9%), 
morphine (8.5%), methadone (7.4%) and hydrocodone (7.4%) (Warner et al. 2016). From 
2010 to 2015, U.S. death rates from drug overdoses increased from 12.3 to 16.3 per 
100,000 population, driven primarily by consumption of heroin and fentanyl (Rudd 
2016).  
 Geographical variance of narcotics abuse has been noted, likely is multi-factorial 
and deemed to be influenced by: resident narcotic tolerance, frequency of use, degree of 
dependence, social factors, and economic factors (Harocopos et al. 2016, Warner et al. 
2016). Available U.S. narcotic abuse statistics may not accurately forecast the scope of 
drug addiction within a specific U.S. community due to these aforementioned factors. 
Due to the significant time delay associated with current analyses these sources of data 
can also be considered retrospective and may not capture the true scope of narcotic abuse 
within the target region at the present time. Researchers have speculated that the frequent 
implementation of WBE may add significant value as the process permits the collection 
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of data in near-real time for many communities. This sort of data acquisition via analysis 
of municipal sewage potentially can provide municipalities with the information needed 
to properly gauge community narcotic abuse and to track the efficacy of implemented 
programs designed to combat substance abuse.  
1.3 Data gaps 
Compared to European and Asian countries, wastewater epidemiology as an 
approach to study and diagnose narcotics consumption and abuse in the United States has 
seen limited use (Burgard et al. 2013, Heuett et al. 2015, Panawennage et al. 2011, 
Subedi and Kannan 2014). Studies which have examined U.S. wastewaters for drug use 
prevalence have primarily focused on US DEA schedule I and II narcotics (Banta‐Green 
et al. 2009, Gerrity et al. 2011, Subedi and Kannan 2014). Few U.S. based studies screen 
wastewater for opioids aside from heroin, and to the author’s knowledge no wastewater 
epidemiological study in the U.S. has screened for fentanyl use despite the recent drastic 
increase in fentanyl-related overdose deaths. WBE testing at U.S. universities has seen 
some application but analyte screening has primarily been limited to ADHD medication 
(Burgard et al. 2013, Moore et al. 2014). Two university-based studies have expanded on 
this to include a wider suite of narcotics (Heuett et al. 2015, Panawennage et al. 2011), 
but reported infrequent detections for many of their targeted analytes. In principle, the 
WBE approach can be applied to U.S. communities to study indicators of population 
health such as narcotic consumption and carcinogen exposure. Increased spatial 
screenings will provide national averages which individual municipalities can benchmark 
their data against and routine analysis will additionally provide a metric to gauge the 
efficacy of implemented substance abuse practices in near-real time.  
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The peer-reviewed WBE literature indicates that both parental drugs (Kim et al. 
2015, Zuccato et al. 2005) and their specific metabolites (Gatidou et al. 2016, Subedi and 
Kannan 2014) can serve to estimate drug consumption. Specific analytes are chosen 
based on characteristics which favor WBE such as in-sewer stability (Castiglioni et al. 
2014) and often both parent and metabolite compounds are used to estimate drug 
consumption (Baker et al. 2014). Some researchers have continued to use parent narcotics 
in their analyses due to unfavorable pharmacokinetic and degradation parameters 
associated with specific metabolites (Baker et al. 2014, Burgard et al. 2013). Direct 
comparison between two sampling locations may suffer from limitations due to 
differences in analytical approaches. The “elimination half-life” from the human body of 
various narcotics and metabolites may add further complexity. 
WBE has seen limited application outside of narcotic use (Fattore et al. 2016, 
González-Mariño et al. 2017, Rousis et al. 2017) but could provide valuable insight into 
multiple parameters of human health and wellness including carcinogen exposure (Lai et 
al. 2017). Due to seemingly ubiquitous presence of carcinogenic N-nitrosamines in water 
(Ma et al. 2012, Schreiber and Mitch 2006) and wastewater (Krauss and Hollender 2008, 
Krauss et al. 2009) it is important to understand the average daily human exposure to the 
disinfection byproducts. Understanding average daily N-nitrosamine exposure could 
provide insight into the carcinogenic risk associated with the compounds and could be 
further studied through WBE approaches.  
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1.4 Primary goals and strategy 
 The goal of this PhD thesis was to investigate the occurrence and quantity of 
select harmful chemicals and chemical indicators of narcotic use in various 
environmental matrices and to explore the analytical value of UMM in evidence-formed 
public health decision making. N-Nitrosamine contamination in solid matrices was 
historically ignored due to the classes high affinity for aqueous matrices (Gushgari et al. 
2016, Venkatesan et al. 2014) – but their recent quantification in biosolids (Venkatesan et 
al. 2014) identifies that contamination in other solid matrices related to water and 
wastewater treatment may exist. Nationwide existence and prevalence of N-nitrosamine 
contaminated freshwater sediments was examined by identifying contamination in 
freshwater sediment samples taken from multiple locations near wastewater treatment 
plants across the United States. 
 Wastewater-based epidemiology could be a valuable analytical tool in evidence-
informed public health decision making (Yang et al. 2015) but its current capabilities are 
restricted due to its limited application within the United States (Subedi and Kannan 
2014). Through solid phase extraction cleanup and pre-concentration followed by tandem 
mass spectrometry quantification concentrations of narcotic use indicator compounds 
were analyzed in 24-hour composite raw wastewater samples for three geographically 
distinct regions of the United States. Analyte concentrations in raw wastewater were then 
compared to average metabolization and excretion rates to estimate narcotic consumption 
in these regions and were compared to national statistics and relevant WBE literature.  
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1.5 Hypotheses 
I hypothesize that (i) N-nitrosamine exposure from the ingestion pathway due to 
food and alcohol consumption constitutes a carcinogenic risk; (ii) freshwater sediments 
downstream of U.S. wastewater treatment plants contain higher levels of N-nitrosamines 
than sediments located upstream; (iii) high rates of opioid consumption in U.S. 
communities are reflected by drug indicator compounds identified in municipal 
wastewater; and (iv) analyte masses in campus-generated wastewater for known 
recreational use narcotics will show statistical differences (α=0.05) between weekday and 
weekend mass loads. 
1.6 Specific aims 
Specific aims of this dissertation were to: 
(i) quantify the approximate N-nitrosamine daily exposure to human beings 
through the inhalation, ingestion, and dermal sorption pathways;  
(ii) determine the attributable carcinogenic risk posed by N-nitrosamine congeners 
to the general population of the U.S. from main exposure sources; 
(iii) determine the prevalence and profile of N-nitrosamine contamination within 
U.S. freshwater sediments local to wastewater treatment plants; 
(iv) identify water quality parameters which show correlation with N-nitrosamine 
sediment contamination; 
(v) implement WBE to identify concentrations of opioid consumption indicators 
in wastewater to estimate the prevalence of opioid use within two small 
(25,000-200,000 residents) midwestern U.S. communities; and 
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(vi) implement WBE to identify concentrations of narcotic consumption indicators 
in wastewater to estimate the incidence of prescription and illegal narcotic 
consumption at a southwestern U.S. university campus. 
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TRANSITION 1 
 This dissertation is comprised of individual studies focused on the fate and 
occurrence in the urban wastewater infrastructure of two classes of analytes related to 
human health: N-nitrosamines and narcotics of the class of opioids. At the beginning of 
this project sufficient literature pertaining to N-nitrosamine contamination in a variety of 
commonly encountered environmental and synthetic matrices existed – but few studies 
had attempted to model the carcinogenic impact of daily N-nitrosamine exposure from a 
combination of potable water, food products, beverages, tobacco use, and personal care 
products. Furthermore, no studies had attempted to address the potential reduction in 
daily N-nitrosamine loading that can be achieved through personal intervention. 
 In Chapter 2, published data on N-nitrosamine occurrence was compiled for 
eleven N-nitrosamines congeners, specifically N-nitrosonornicotine, 4-(N-
nitrosomethylamino)-1-(3-pyridyl)-1-butanone, N-nitrosodimethylamine, N-
nitrosodiethylamine, N-nitrosomorpholine, N-nitrosopiperidine, N-nitrosodi-n-
butylamine, N-nitrosopyrrolidine, N-nitrosodiethanolamine, N-nitrosomethylethylamine, 
and N-nitrosodiphenylamine; data originated from five commonly monitored matrices, 
namely food, water, tobacco products, alcoholic beverages, and personal care products. 
Estimated daily exposure values were modeled using occurrence data obtained from a 
comprehensive literature review for six different scenarios of personal diets and lifestyle 
choices. A risk analysis also was conducted to determine the number of U.S. cancer cases 
attributable to exposure to the N-nitroso class of contaminants. Finally, reducible N-
nitrosamine exposure achievable through personal intervention was estimated and areas 
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of suggested further research were identified to advance our current understanding of N-
nitrosamine exposure and the likely effectiveness of exposure prevention strategies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
CHAPTER 2 
 
CRITIAL REVIEW OF MAJOR SOURCES OF HUMAN EXPOSURE TO N-
NITROSAMINES 
ABSTRACT 
More than 24 N-nitrosamine compounds contribute to the total N-nitrosamine (TNA) 
burden monitored routinely to assess human exposure to this important group of known 
and suspected human carcinogens. A literature review (n = 122) identified multiple 
sources of human exposure to TNAs, including waters (40 ± 10.5 ng/L; average and 
standard deviation), food and beverages (6.7 ± 0.8 ng/g), tobacco (16,100 ± 3,650 ng/g) 
and personal care products (1,500 ± 750 ng/g). Due to source control interventions, levels 
of TNAs in beer have dropped by about 96% between 1980 and 1990, whereas N-
nitrosamine levels in other known sources have shown little to no change. Average daily 
TNA exposure in the U.S. in units of ng/d is estimated at 25,000 ± 4,950, driven by 
consumption of tobacco products (22,000 ± 4,350), food (1,900 ± 380), alcohol (1,000 ± 
200), and drinking water (120 ± 24). Behavioral choices of individuals in non-
occupational settings were calculated to result in a spectrum of exposure values ranging 
from a lower bound of 1,900 ± 380 ng/d to a higher bound of 25,000 ± 4,950 ng/d, 
indicating opportunities for a possible reduction in TNA exposure by up to 92% through 
deliberate choices in diet and lifestyle. Human exposure to TNAs from ingestion and 
(tobacco-smoke related) inhalation, respectively, are estimated to account for about 2,600 
± 1,050 and 3,400 ± 1,900 expected lifetime cancer cases per one million U.S. residents – 
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which translates to an expected 1,940,000 ± 950,000 attributable lifetime cancer cases 
across the United States. 
2.1 Introduction 
N-Nitrosamines have been identified as important environmental pollutants due to 
their near-ubiquitous presence in many environmental matrices, albeit at typically low 
concentrations in the nanogram per kilogram and nanogram per liter range. Characterized 
by a nitroso group bonded to an amine, this hydrophilic family of compounds consists of 
at least 300 previously documented congeners (Hecht 1997). While structural diversity is 
extensive, research has primarily focused on a small subset of N-nitrosamine congeners. 
N-nitrosamines are monitored and investigated for their site-specific carcinogenic impact 
noted in over 30 test animal species (Hecht 1997) and their well-documented occurrence 
in chlorinated and chloraminated waters (EPA 2011), food products (Park et al. 2015), 
tobacco products (Brunnemann and Hoffmann 2008), and personal care products (Shen 
and Andrews 2011). N-nitrosamine-induced tumors of the liver, lung, esophagus, nasal 
mucosa, bladder, tongue, forestomach, and pancreas have been documented (Hecht 
1997), with site-specific tumor development being dependent on both the N-nitrosamine 
congener administered and the test species exposed (Hecht 1997). Site-specific N-
nitrosamine induced tumors have been observed in specific target organs irrespective of 
the route of administration (Bartsch and Montesano 1984, Hill et al. 1973, Larsson et al. 
2006, Lijinsky 1992, Wilkens et al. 1996), and a linear dose-response relationship of N-
nitrosodimethylamine (NDMA) in the sub-parts-per-million exposure range has been 
noted along with absence of a discernible “safe threshold” concentration (Peto et al. 
1991).  
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The chemical interaction of nitrous acid with primary aromatic amines was first 
observed and published by Peter Griess in 1864 (Griess 1864), and further researched 
through the work of Baeyer and Caro, and Otto Witt in the 1870s (Witt 1878). Now in 
extensive use, the term “nitrosamine” was first introduced by Otto Witt in his 1878 
publication to describe “any substituted ammonia which contains, instead of at least one 
atom of hydrogen, the univalent nitrosyl group, -NO, in immediate connection with the 
ammoniacal nitrogen” (Witt 1878). Growth of malignant primary hepatic tumors in 
animal test species exposed to NDMA was observed in 1956 (Magee and Barnes 1956), 
which sparked the development of a large body of literature on the carcinogenicity and 
toxicity of the N-nitrosamine class of contaminants. Their role as environmental 
carcinogens was first proposed by William Lijinsky in 1970 (Lijinsky 1970), which 
fostered research on N-nitrosamine occurrence in environmental media, such as ambient 
water, aquatic sediments and municipal sewage sludge (Gushgari et al. 2016, Schreiber 
and Mitch 2006, Venkatesan et al. 2014, Zeng and Mitch 2015). Studies on N-
nitrosamines mainly have been concerned with the quantification of N-nitrosamines from 
different sources, assessments of cancer impact using animal models, and the modeling of 
cancer risks related to specific N-nitrosamine/cell interactions. Cancer risk of select N-
nitrosamines, most notably NDMA, has been shown to exceed that of many known 
potent carcinogens, including: asbestos, benzo[a]pyrene, and polychlorinated biphenyls 
(OEHHA 2009). Slope factors for cancers attributed to N-nitrosamine ingestion or 
inhalation are available for only for a select few N-nitrosamines, thus the proposed 
carcinogenic impact of the class of N-nitrosamines is still poorly defined and potentially 
underestimated.  
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The International Agency for Research on Cancer (IARC) has classified 24 
different N-nitrosamines with respect to their carcinogenetic potential to humans, with 
two congeners being classified as known human carcinogens and the remainder being 
split between the categories of probably carcinogenic and possibly carcinogenic 
(Internation Agency for Research on Cancer 2015). The U.S. Environmental Protection 
Agency (USEPA) has also listed five N-nitrosamines in their two most recent 
Contaminant Candidate Lists (CCL3 and CCL4) (U.S. Environmental Protection Agency 
2014). Overall, research on N-nitrosamines has spurred the development of a number of 
water quality regulations for select congeners. The State of California has adopted 
stringent regulations regarding the maximum levels of N-nitrosamines in drinking water, 
with response levels for N-Nitrosodiethylamine (NDEA), NDMA and N-Nitrosodi-n-
propylamine (NDPA) as low as 100, 300, and 500 ng/L, respectively. Furthermore, 
drinking water guidelines for the State of Massachusetts outline a regulatory limit of 10 
ng/L for NDMA (EPA 2015), and Arizona has set regulatory limits for NDMA (1 ng/L), 
N-nitrosodiphenylamine (NDPhA) (7,100 ng/L), and NDPA (5 ng/L) in their National 
Pollutant Discharge Elimination System Permit Program (Arizona Department of 
Environmental Quality 2015). 
Whereas a fair amount of studies have documented the occurrence of N-
nitrosamines in environmental matrices (De Mey et al. 2017, Kim et al. 2013, Qiu et al. 
2017, Rattray and Cochran 2014) and attempts to correlate these exposures to site 
specific tumor occurrence (Fritschi et al. 2015, Gankhuyag et al. 2017, Kao et al. 2017, 
Stepanov et al. 2014), thus far still lacking are quantitative analyses of the relative 
importance of major TNA sources on cancer risk and an identification of opportunities 
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for source and exposure reduction. Therefore, the present analysis of the scientific 
literature was designed to identify sources of N-nitrosamine exposure which could be 
curtailed through individual lifestyle choices. Specifically, average N-nitrosamine levels 
within commonly contaminated matrices were evaluated in conjunction with dietary and 
lifestyle data to estimate average daily exposures for select N-nitrosamine congeners. 
These exposure values were then compared to oral or inhalation cancer slope factors, 
when available, to estimate specific carcinogenic risks as well as the number of expected 
cancer cases in the U.S. population attributable to the N-nitrosamine class of emerging 
contaminants. 
2.2 Materials and methods 
2.2.1 Literature search 
Peer-reviewed literature published prior to 2017 was searched using Google 
Scholar and Arizona State University’s Library One search engines. Search terms used 
individually and in combinations included chemical names (Nitrosamine, N-Nitrosamine, 
Nitrosamines, and N-Nitrosamines”), media of interest (water, food, personal care 
product, alcohol, or tobacco), and routes of exposure (ingestion, inhalation, dermal 
adsorption). We included journal articles focusing on N-nitrosamine concentrations in 
potable water, food, alcohol, tobacco, and personal care products. Peer-reviewed articles 
which did not present concentration data within the manuscript or supplemental 
information were omitted from the analysis, as were articles which were not translated to 
English from their original publishing language. Journal articles which presented 
concentrations of N-nitrosamines for products other than the aforementioned five major 
categories were omitted from analysis.  
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 Literature for average U.S. smoking statistics, average daily water intake, and 
average food consumption statistics were searched for using the Google Scholar search 
engine. Oral cancer slope factors were obtained from the U.S. EPA Integrated Risk 
Integration System (IRIS) (USEPA 2017) for: NDMA, N-nitrosomorpholine (NMOR), 
N-nitrosomethylethylamine (NMEA), N-nitrosopyrrolidine (NPYR), NDEA, NDPA, and 
NDPhA. Inhalation cancer slope factors were also obtained from the U.S. EPA IRIS 
(USEPA 2017) database for: N-nitrosonornicotine (NNN), 4-(N-nitrosomethylamine)-1-
(3-pyridyl)-1-butanone (NNK), and NDMA. N-Nitrosamine congeners which did not 
have cancer slope factors were omitted from the attributable risk analysis. 
2.2.2 Data extraction and analysis 
Publication literature reporting N-nitrosamineconcentrations by media meeting 
the eligibility criteria were extracted from Google Scholar and compiled into EndNote 
citation manager (vX7.7, Thomas Reuters, New York, USA). The final literature set (n = 
122) was reviewed for establishing average N-nitrosamine concentrations in products 
within the five matrix categories, as well as average U.S. health and product usage 
statistics. Individual product concentrations were compiled in Microsoft Excel and 
analyzed using the JMP Pro 12.1.0 data analysis software and Microsoft Excel. Figures 
were created using a combination of Microsoft’s Office Suite programs and Origin Pro. 
2.2.3 Exposure and attributable risk analyses 
For average exposure assessment purposes, average N-nitrosamine concentrations 
were considered alongside average U.S. citizen use data to estimate average exposure 
levels. Average daily smoking values were estimated as 14.2 cigarettes per day (FSPTCA 
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2010), average water intake was estimated to be 3 liters per day (Gleick 1998), and 
average food intake was estimated from the American Heart Association’s 2,000-Calorie 
level dietary guidelines. Average exposure values were then compared to oral and 
inhalation cancer slope factors (when available), obtained from the U.S. Environmental 
Protection Agency (USEPA) for attributable risk analyses purposes. 
 To gauge the carcinogenic impact of the N-nitrosamine class of emerging 
contaminants, an attributable carcinogenic risk evaluation was completed for select N-
nitrosamines when necessary data was available. Results obtained from this analysis 
detail the expected number of lifetime cancer cases that can be attributed to exposure to 
the N-nitrosamine congeners included in the analysis. Exposure concentration levels (in 
mg per kilogram body weight per day, mg/kg-d) from different routes of exposure were 
calculated from data ascertained from the comprehensive literature review using the two 
equations below: 
CIng (
mg
kg−day
) =
(CNW∗2
L
d
)+(CNM∗80
g
d
 )+(CNF∗50
g
d
)+(CNC∗200
g
d
)+(CNV∗375
g
d
)
60.55 kg
             Eq. 1 
CInhalation (
mg
kg−day
) =
(CNTC∗20
cigarette
d
)
60.55 kg
       Eq. 2 
Where: 
CNW: Average N − Nitrosamine Water Concentration (mg/day) 
CNM: Average N − Nitrosamine Meat Concentration (mg/day) 
CNF: Average N − Nitrosamine Fat, Oil, and Sweets Concentration (mg/day) 
CNC: Average N − Nitrosamine Carbohydrate Concentration (mg/day) 
CNV: Average N − Nitrosamine Vegetable Concentration (mg/day) 
CNTC: Average N − Nitrosamine Cigarette Smoke Concentration (mg/day) 
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Exposure concentrations were then multiplied by the oral slope factor or 
inhalation slope factor obtained from the U.S. Environmental Protection Agency 
(USEPA) in order to gauge individual cancer risk, and then multiplied by 1,000,000 for 
population normalization purposes. This process was repeated for each N-nitrosamine 
where USEPA oral and/or inhalation slope factors were available, and finally summed up 
to obtain an initial estimate of the “total N-nitrosamine risk” for both inhalation and 
ingestion exposure pathways. 
2.3 Results 
2.3.1 N-Nitrosamine contamination data 
The exclusion criteria utilized in the literature review resulted in a pool of 122 relevant 
studies on N-nitrosamine occurrence, encompassing contamination of food products, 
water, tobacco, alcohol, and personal care products. Publications on N-nitrosamines have 
increased in number since the 1950s with a further uptick by 120% from 2000 to 2015, a 
time period during which regulatory activity also increased for these emerging 
contaminants and human carcinogens (Fig. 3). 
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Fig. 3 - Publication activity (three-year moving average) and timeline of notable events 
of N-nitrosamine-directed research. Abbreviations: AWQC, Ambient water quality 
criteria; WHO, World Health Organization; DW, drinking water. 
Out of the 122 studies considered, 56 studies provided quantitative information on 
some 262 N-nitrosamine contaminated food products (Campillo et al. 2011, Coffacci et 
al. 2013, DOMAŃSKA-BLICHARZ et al. 2005, Fajen et al. 1979, Gavinelli et al. 1988, 
Glória et al. 1997, Goff and Fine 1979, Hedler et al. 1979, Herrmann et al. 2015, 
Izquierdo-Pulido et al. 1996, Jawad 2012, Jo et al. 2010, Jurado-Sánchez et al. 2007, Kim 
and Shin 2013, Kocak et al. 2012, Kubacki et al. 1989, Mavelle et al. 1991, McWeeny 
1983, Mitacek et al. 1999, Okafor and Nwogbo 2005, Oliveira et al. 1995, Ozel et al. 
2010, Park et al. 2015, Scanlan 1983, Scanlan et al. 1990, Seo et al. 2015, Song and Hu 
1988, Spiegelhalder and Preussmann 1984, Tricker et al. 1991b, Weston 1983, 
Yurchenko and Mölder 2006, 2007), 140 contaminated nicotine-containing products 
(Adams et al. 1987, Brunnemann and Hoffmann 2008, Ding et al. 2008, Fischer et al. 
1990, Hoffmann et al. 1979, Kim and Shin 2013, Laugesen 2008, Mostafa et al. 1994, 
Österdahl et al. 2004, Rickert et al. 2008, Rühl et al. 1979, Stepanov et al. 2012, Tricker 
et al. 1991a, Tricker et al. 1991b, Wu et al. 2005, Xiong et al. 2010), 74 contaminated 
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personal care products (Fan et al. 1977, Schothorst and Somers 2005, Schothorst and 
Stephany 2001, Spiegelhalder and Preussmann 1984), 64 contaminated alcoholic 
beverages, and 36 potable water N-nitrosamine concentrations (Charrois et al. 2004, 
Planas et al. 2008, Wang et al. 2011, Zhao et al. 2006). Tobacco product concentrations, 
governed primarily by the tobacco-specific N-nitrosamines NNN and NNK (Brunnemann 
and Hoffmann 2008, Tricker et al. 1991a), were consistently reported to have the highest 
levels of N-nitrosamines (TNA: 16,100 ± 3,651 ng/g) of all media categories, followed by 
personal care products (TNA: 1,507 ± 752 ng/g), food products (TNA: 6.7 ± 0.8 ng/g), 
potable waters (TNA: 39.4 ± 10.5 ng/L), and alcoholic beverages (TNA: 2.9 ± 0.4 ng/L). 
Nicotine-containing products also constituted the largest range of concentrations of any 
media (range: 0-326,000 ng/g), followed by personal care products (range: 0-49,000 
ng/g), food products (range: 0-120.8 ng/g), potable waters (range: 2.8-309 ng/L), and 
alcoholic beverages (range: 0-17.4 ng/L). It is important to note that significant variation 
exists in the concentration of N-nitrosamines populating the sub-classes within the matrix 
categories. 
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Table 1 - Summary facts on N-nitrosamines covered in this critical review.* 
 
* IARC classifications were obtained from the “IARC Monographs on the Evaluation of Carcinogenic Risks to Humans”. USEPA Oral Slope Factors 
were obtained from OEHHA’s “Technical Support Document for Cancer Potency Factors 2009 – Appendix A”. N-Nitrosamine congener structures were 
recreated by the primary author from WHO’s “Concise International Chemical Assessment Documents” when available, and from “PubChem.” 
 
 While over 300 congeners of the N-nitrosamine class of contaminants are known 
to exist, the peer-reviewed literature focuses primarily on a select group of N-
nitrosamines (Table 1). Studies concerned with the occurrence of N-nitrosamines within 
tobacco products mainly focused on four tobacco-specific N-nitrosamines: NNK, NNN, 
N-Nitrosoanatabine (NAT), and N-nitrosoanabasine (NAB) (Kim and Shin 2013, 
Stepanov et al. 2006, Stepanov et al. 2012, Xiong et al. 2010). Two of these N-
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nitrosamines, NNN and NNK, are the only congeners of the N-nitroso class that have 
been identified as ‘known human carcinogens’ (Internation Agency for Research on 
Cancer 2015). Of these tobacco-specific N-nitrosamines, tobacco product nitrosamine 
concentrations were predominantly governed by NNN (n=140, mean: 7,400 ± 1,500 
ng/g), followed by NAT (n=102, mean: 4,600 ± 1,550 ng/g), NNK (n=140, mean: 3,200 
± 1,150 ng/g), and NAB (n=102, mean: 950 ± 310 ng/g). Cigarettes were found to have 
the highest concentrations of the tobacco-specific N-nitrosamines (TNA: 52,600 ± 19,650 
ng/g, range: 590-326,060 ng/g), followed by cigars (TNA: 45,900 ± 34,100 ng/g, range: 
11,800-80,000 ng/g), chewing tobacco (TNA: 5,850 ± 2,450 ng/g, range: 270-41,400 
ng/g), and snuff products (TNA: 5,400 ± 1,250 ng/g, range: 19-77,100 ng/g). 
Interestingly, tobacco-specific N-nitrosamines were also found in electronic cigarette 
fluid (TNA: 1,430 ± 700, range: 0-3,870 ng/g) and nicotine cessation products (TNA: 450 
± 150 ng/g, range: 0-983 ng/g) (Hoffmann et al. 1979, Kim and Shin 2013). 
Concentrations in these products were, respectively, 97.3% and 99.2% lower than the 
average concentration in traditional cigarettes (Brunnemann and Hoffmann 2008, Tricker 
et al. 1991a, Wu et al. 2005). Furthermore, N-nitrosamine concentrations measured in 
mainstream (TNA: 1,530 ± 670 ng/cigarette, range: 112.7-9,700 ng/cigarette) and 
sidestream (TNA: 6,550 ± 3,400 ng/cigarette, range: 340-32,300 ng/cigarette) 
significantly violate OEHHA’s “no significant risk level” (NSRL) for NNN (500 ng/day) 
and of NNK (14 ng/day) (OEHHA 2009).  
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Fig. 4 - Average and median TNA concentrations in various categories of personal care 
products, plotted on a logarithmic scale. Term “n” denotes the number of individual 
product concentrations obtained through literature review. “Other” category denotes 
products which did not fit into additional categories. Only NDELA was examined in this 
analysis, due to the lack of testing additional N-nitrosamine congeners within PPCP’s. 
 The high levels of N-nitrosamines observed in personal care products is primarily 
due to the presence of N-nitrosodiethanolamine (NDELA), accounting for 99% of all 
observed N-nitrosamines within care products. The remaining 1% of observed 
contamination stems from NMOR (~0.99%) and NDMA (~0.01%). Cosmetic products 
(Fig. 4) were found to have the highest average total N-nitrosamine concentration (TNA: 
13,000 ± 8,100 ng/g, range: 400-49,000 ng/g), but were heavily weighted by two samples 
with concentrations above 20,000 ng/g. Hair care products (TNA: 1,900 ± 1,900 ng/g, 
range: 0-7,644 ng/g), soaps (TNA: 300 ± 150 ng/g, range: 0-3,746 ng/g), shampoos 
(TNA: 220 ± 50 ng/g, range: 23-1,287 ng/g), and lotions (TNA: 100 ± 25 ng/g, range: 22-
230 ng/g) were all shown to have quantifiable N-nitrosamine concentrations with 
NDELA constituting the major congener in all cases. Two personal care products, an 
unidentified children’s care product (TNA: 1,500 ng/g) and a facial cleaner (TNA: 200 
ng/g), were averaged together to obtain the “other” category. 
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Fig. 5 - (a) Average and median concentrations (± standard error) of total N-nitrosamines 
(TNA) in various food categories. (b) Contribution of individual N-nitrosamine 
congeners to TNA levels detected in various food category, listed in descending order of 
concentrations reported. Term “n” denotes the number of studies one or more N-
nitrosamines were detected. 
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 N-Nitrosamine concentrations in food and alcohol products (Fig. 5) represented 
the largest category of data in this analysis, with data collected from 31 peer-reviewed 
articles. Currently available literature cites over 300 different reports of N-nitrosamine 
contaminated foods and beverages containing detectable levels of various N-
nitrosamines, including: fats, oils, and sweets (TNA: 0-44 ng/g, n=21), meat products 
(TNA: 0.1-121 ng/g, n=118), fish products (TNA: 0-43.9 ng/g, n=59), canned vegetables 
(TNA: 0.02-40.5 ng/g, n=21), beverages (TNA: 0.2-45.7 ng/mL, n=13), condiments 
(TNA: 0.3-29.59 ng/g, n=10), grains (TNA: 0.2-4.6 ng/g, n=8), dairy products (TNA: 0-
1.6 ng/g, n=8), fruit (TNA: 8.1 ng/g, n=1), rice (TNA: 1.5 ng/g, n=1), drink mixes 
(TNA: 0.9 ng/g, n=1), and tofu (TNA: 0.2 ng/ng, n=1) (Campillo et al. 2011, Coffacci et 
al. 2013, DOMAŃSKA-BLICHARZ et al. 2005, Gavinelli et al. 1988, Glória et al. 1997, 
Goff and Fine 1979, Hedler et al. 1979, Herrmann et al. 2015, Izquierdo-Pulido et al. 
1996, Jawad 2012, Jo et al. 2010, Jurado-Sánchez et al. 2007, Kim and Shin 2013, Kocak 
et al. 2012, Mavelle et al. 1991, McWeeny 1983, Mitacek et al. 1999, Okafor and 
Nwogbo 2005, Oliveira et al. 1995, Ozel et al. 2010, Park et al. 2015, Scanlan et al. 1990, 
Seo et al. 2015, Song and Hu 1988, Tricker et al. 1991b, Yurchenko and Mölder 2006, 
2007). The four food classes with the highest average N-nitrosamine concentration levels 
were identified as fats, oils, and sweets (average TNA: 8.9 ± 3.2 ng/g), meats (average 
TNA: 8.1 ± 1.4 ng/g), fish (average TNA: 5.6 ± 1.0 ng/g), and vegetables (average TNA: 
5.4 ± 1.9 ng/g). NDMA (average: 2.2 ± 0.3 ng/g) was found to have the highest average 
concentration of all congeners across all food categories, followed by NDBA (average: 
1.5 ± 0.5 ng/g), NPYR (average: 1.5 ± 0.2 ng/g), NDEA (average: 0.9 ± 0.3 ng/g), NPIP 
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(average: 0.5 ± 0.1 ng/g), NMOR (average: 0.05 ± 0.01 ng/g), NMEA (average: 0.04 ± 
0.01 ng/g), and finally NDPA (average: 0.02 ± 0.01 ng/g). 
 N-Nitrosamine formation in potable water is a well-documented phenomenon 
(Charrois et al. 2004, Planas et al. 2008), and thus values for potable water were obtained 
specifically for a comparison to other matrices and for estimating the attributable risk. 
The average total N-nitrosamine concentration in U.S. potable waters was 39.4 ± 10.5 
ng/L, with a range of values between 2.8-309.0 ng/L. The average NDMA concentration 
(17.7 ± 4.7 ng/L) in potable waters exceeded those of all other congeners, but notable 
levels also were observed for other congeners listed in the following as average 
concentrations ± standard deviation: NPIP (7.9 ± 4.0 ng/L), NPYR (5.5 ± 2.6 ng/L), 
NDEA (4.2 ± 0.8 ng/L), NDBA (1.7 ± 0.6 ng/L), NMOR (0.9 ± 0.2 ng/L), NMEA (0.6 ± 
0.1 ng/L), NDPhA (0.6 ± 0.2 ng/L), and NDPA (0.4 ± 0.03 ng/L). While levels of N-
nitrosamines have been identified in surface water (Schreiber and Mitch 2006), 
wastewater(Krauss and Hollender 2008, Krauss et al. 2009), biosolids, and freshwater 
sediments (Gushgari et al. 2016, Venkatesan et al. 2014), these sources are not expected 
to represent a direct route of human exposure, and thus were omitted from analyses.  
In addition to the aforementioned contaminated matrices there are a number of 
additional potential sources of human exposure that warrant discussion. Firstly, a number 
of N-nitrosamines have been detected in commonly used rubber and latex products 
(Altkofer et al. 2005, Fajen et al. 1979, Havery and Fazio 1982). Car tires, child care 
products, rubber balloons, and condoms have all shown to not only contain, but readily 
release N-nitrosamines into surrounding matrixes. One source cites that human exposure 
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to N-nitrosamines from the use of condoms could exceed exposure from foods 1.5- to 3-
fold (Altkofer et al. 2005). Occupational exposure is another important, but selective 
route of human N-nitrosamine exposure. While not applicable to the population as a 
whole, certain occupations (especially those involved in manufacturing processes) can be 
associated with a higher risk of N-nitrosamine induced tumor development (Cocco et al. 
1996, De Vocht et al. 2007, Spiegelhalder and Preussmann 1983). Furthermore, a 
considerable number of additional exposure mechanisms have been postulated that 
theoretically could further increase the total human N-nitrosamine exposure, but many of 
these have not yet been verified and quantified in laboratory or field studies (Altkofer et 
al. 2005, Havery and Fazio 1982, Hecht 1997, Schothorst and Somers 2005). 
2.3.2 Cancer incidence rate changes in nations consuming large quantities of beer 
This literature review also reveals a notable decrease in N-nitrosamine 
concentrations in beers and other malt beverages from the 1980s to the 1990s (Fig. 6). 
This decrease in concentration has been attributed primarily to manipulation of 
manufacturing methods targeted at reducing N-nitrosamine occurrence (McWeeny 1983). 
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Fig. 6 - Representation of N-nitrosamine levels in domestic and international beer and 
tobacco products. (a) Comparison of TNA levels in beer products, from 1980-1989 and 
1990-2015. Value “n” denotes number of reported values obtained from literature. (b) 
Comparison of TNA levels in mainstream cigarette smoke, from 1980-1989 and 1990-
2015. Error bars represent ± standard error. Value “n” denotes number of reported values 
obtained from literature. 
 To gauge the impact of N-nitrosamine reduction in beer on cancer incidence, 
tumor occurrence rates were compared in two countries with high levels of per-capita 
beer consumption. In the Czech Republic, overall cancer incidence from 1977 to 2011 
increased 32% for males and 22.8% for females (Dušek et al. 2010). In this same 
timeframe, the incidence of tumors of the pancreas, kidney and bladder increased by 
56%, 171%, and 82%, respectively (Dušek et al. 2010). In contrast, a cancer registry of 
the Federal State of Saarland, Germany has noted a decrease in mortality from cancers 
from 1950-2002 for both male and female populations (Becker et al. 2007). However, the 
overall incidence of cancer (from 1970-2002) in this same region did not decrease, and 
the occurrence of certain site-specific cancers decreased only slightly (laryngeal, -3.3%; 
lung, -1.8%; stomach, -2.7%). In this same timeframe, lung cancer cases in females 
increased by 4.9% and prostate cancer cases in males by 5.7%, whereas normalized 
occurrence rates of all other site-specific cancers showed neither a significant increase 
nor a decrease (Becker et al. 2007). These findings suggest that while a significant 
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reduction in beer-borne nitrosamines has been achieved, total tumor occurrence and 
occurrence of site-specific tumors associated with NDMA exposure have nevertheless 
increased. Observations summarized here in regard to the occurrence of and mortality 
caused by cancer may be influenced by a variety of factors, including a demographic shift 
toward an increase in the average age of the general population over the study period and 
the advent of life-prolonging cancer treatments.  
2.4 Discussion 
2.4.1 N-Nitrosamine Exposure Estimations 
Approximate daily N-nitrosamine exposure levels were estimated from the data 
ascertained from the comprehensive literature review and average American consumption 
habits. Average daily smoking values were estimated as 14.2 cigarettes per day (FSPTCA 
2010), average water intake was estimated to be 3 liters per day (Gleick 1998), and 
average food intake was estimated from the American Heart Association’s 2,000-Calorie 
level dietary guidelines. Daily intake values for food sub-classifications were estimated 
as 500 grams/day of vegetables, 170 grams/day of meats, and 168 grams/day of fats, 
sweets and oils (AHA 2016). This estimation of exposure deliberately omitted uptake 
from personal care products due to the large uncertainties associated with the use and 
type of personal care products and the highly variable level of N-nitrosamines found 
therein. Results from the N-nitrosamine intake estimates are presented in six categories of 
varying diets and lifestyle choices (Fig. 7). 
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Fig. 7 - Estimations of total N-Nitrosamine exposure (TNE) by diet and lifestyle. Error 
bars represent +/- 20% of N-nitrosamine daily load from the corresponding source. 
Not surprisingly, tobacco use was identified to constitute the largest source of 
daily N-nitrosamine intake across all considered categories, at a rate of 21,800 ± 4,350 
ng/day. Uptake of N-nitrosamines from food intake, irrespective of dietary choices, was 
identified as the second largest source of N-nitrosamine exposure, with daily intake 
values ranging from 1,800 ± 350 ng/day (vegetarian diet) to 1,900 ± 380 ng/day (western 
diet). Consumption of beer or other malt beverages was found to contribute an estimated 
intake of 1,000 ± 200 ng/day of N-nitrosamine, whereas exposure from ingestion of 
potable water was consistently found to contribute the smallest daily dose of N-
nitrosamine exposure at a rate of 120 ± 24 ng/day. Thus, individuals subscribing to a 
western diet, regularly consuming beer, and smoking tobacco are expected to incur the 
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majority of their daily exposure from tobacco use (88%), with food ingestion (8%), beer 
consumption (4%), and potable water ingestion (<1%) accounting for the remainder. In 
contrast, individuals electing a western diet but refraining from alcohol and tobacco 
consumption would have a 92% lower daily nitrosamine exposure, with the governing 
factors constituting ingestion of food (94%) and potable water (6%).  
2.4.2 Attributable Risk Evaluation 
Based on currently available data, we calculated that N-nitrosamines contribute 
2,600 ± 1,050 and 3,400 ± 1,900 expected lifetime cancer cases per 1 million people in 
the U.S. from exposure through ingestion and inhalation pathways, respectively. This 
lifetime cancer incidence rate translates into 840,000 ± 340,000  and 1,100,000 ± 610,000 
lifetime cases for the U.S population as a whole, or a total attributable number of lifetime 
cancer cases from N-nitrosamines of 1,940,000 ± 950,000. When compared to U.S. 
average cancer incidence rates, these values account for between 1-2% of the expected 
total lifetime U.S. cancer cases (NCI 2017). Inhalation was found to pose the most 
significant N-nitrosamine associated carcinogenic risk (58%), but the combined risk 
(42%) from ingestion of food and potable water nearly rivaled this value. Attributable 
cancer cases due to inhalation were limited to the tobacco-specific N-nitrosamines NNN 
and NNK, as additional congener data in mainstream cigarette smoke was unavailable. A 
significant number of attributable expected cancer cases from exposure to both NNN and 
NNK (approximately 450 ± 190 and 3,000 ± 1,700 per 1,000,000 population, 
respectively) was found, with NNK contributing 87% of the total N-nitrosamine risk 
through the inhalation pathway. This is due to the higher inhalation slope factor of NNK 
(19.2 (mg/kg-d)-1) compared to that of NNN (1.4 (mg/kg-d)-1). Attributable carcinogenic 
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risk due to ingestion of N-nitrosamines was dominated by the two congeners NDEA 
(55%) and NDMA (43%), and to a much lower extent NDBA (1.5%) (Fig. 8). The 
combined additional congeners, NMOR, NMEA, NPYR, and NDPA, accounted for less 
than 1% of the total attributable N-nitrosamine cancer risk. A similar analysis of 
attributable cancer risk from dermal exposure was attempted, but uncertainties regarding 
the parameters used in the equations made the values obtained from this analysis 
impractical. 
 
Fig. 8 - Number of expected cancer cases in the U.S. attributable to ingestion and 
inhalation of the N-nitrosamine class of emerging contaminants. “Other NAs” refers to 
the combined attributable cancer burden posed by: NDBA, NPYR, NMOR, NMEA, 
NDPA, and NDPhA. 
2.4.3 Reduction in the Daily N-nitrosamine Load 
Whereas exposure to N-nitrosamines appears to be both pervasive and largely 
unavoidable, certain lifestyle changes and municipal actions may help to potentially 
attenuate daily intake. Judging from currently available information, the most important 
lifestyle choice an individual can make clearly is to abstain from smoking and use of 
other tobacco products. Notwithstanding the abundance of adverse health effects and 
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consequences associated with the use of tobacco products, our analysis showed that daily 
tobacco use contributes a substantial daily concentration (average: 21,800 ± 4,350 
ng/day) of tobacco-specific N-nitrosamines to users. Daily doses of tobacco-related 
exposure were calculated to exceed by a factor of 10 the baseline exposure from 
combined intake of water and food, and are also associated with exposure to the only two 
nitrosamines that are classified by the IARC as ‘known human carcinogens’ (Internation 
Agency for Research on Cancer 2015).  
Altering the dietary lifestyle was found to constitute another, less important 
avenue for reducing the total daily N-nitrosamine exposure of individuals, but unlike 
cessation of tobacco products, this is a more difficult task that involves altering diets and 
cooking methods. The literature shows meats and fish products to contain notable 
concentrations of a wide array of N-nitrosamines, whose occurrences have been 
correlated with the use of preservatives (Herrmann et al. 2015) and cooking methods 
(Drabik-Markiewicz et al. 2009) and, lesser so, with additional factors such as pesticide 
use (Park et al. 2015). Somewhat unexpectedly, the vegetable food category also was 
found to be associated with a substantial intake of N-nitrosamines (Coffacci et al. 2013, 
Seo et al. 2015, Tricker et al. 1991b), but these concentrations appear to be dominated by 
preservatives added to vegetables rather than to chemistry innate to the plant itself 
(Coffacci et al. 2013). This modeling of exposure was conducted with the assumption 
that all vegetable food sources contain the average N-nitrosamine levels calculated from 
published data. In reality, some vegetables may contain negligible to no levels of N-
nitrosamines, whereas others may greatly exceed the average value found through this 
analysis, leading to a potentially significant variation in exposure levels of individual 
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consumers. While a substantial portion of the population relies on meat and fish products 
for protein, intake of alternative, plant-based protein sources may aid in N-nitrosamine 
avoidance. Furthermore, following a teetotaler lifestyle has the potential to reduce daily 
N-nitrosamine exposure even further. 
Proteins are rich in nitrogen and thus deserve consideration as potential vehicles 
of N-nitrosamine exposure. To further explore this notion, N-nitrosamine exposure from 
protein sources was examined quantitatively. An average daily protein intake of 51 ± 5 
grams was assumed, and the resulting exposure from beef, lamb, pork, poultry, and tofu 
were estimated. Tofu as a protein source was determined to pose the lowest risk, 
constituting a N-nitrosamine load of 145 ± 10 ng per day per person. This was followed 
by lamb (1,100 ± 50 ng/day), pork (1,200 ± 75 ng/day), poultry (1,950 ± 230 ng/day), and 
beef (2,350 ± 350 ng/day). This analysis indicates that adhering to alternative sources of 
protein other than meat (and the cooking habits associated therewith) can reduce the total 
daily dose of N-nitrosamines an individual incurs. It should also be noted that studies 
which have examined N-nitrosamine contamination in tofu are rare when compared to 
studies focusing on other protein sources, and data regarding N-nitrosamine 
contamination in other vegetarian protein sources was not available, an important 
limitation of this analysis. 
Careful use and avoidance of certain personal care products also has the potential 
to significantly reduce daily N-nitrosamine exposure, but further research is necessary to 
gauge how impactful this source of exposure actually may be. This literature review did 
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not uncover any notable trends regarding specific personal care products which should be 
avoided. 
There also exist multiple sources of N-nitrosamine intake that are difficult or 
impossible to avoid, such as exposure from ingestion, absorption and inhalation of N-
nitrosamines contained in municipal drinking water (Soltermann et al. 2012). Here, the 
responsibility for source control and monitoring lies with municipalities, water purveyors 
and regulatory agencies to protect the public. While advanced water treatment options 
have shown to remove N-nitrosamines and their respective precursors (Farré et al. 2011, 
Planas et al. 2008, Plumlee et al. 2008), the use of residual chlorine or chloramine within 
distribution lines may negate whatever TNA reduction may have been achieved upstream 
in the urban water cycle (Zhao et al. 2006).  
Furthermore, manipulation of manufacturing methods, addition of stringent 
“notification” and “action” levels for contamination, and additional regulations all 
constitute theoretically viable methods of contaminant control, some of which have 
previously been shown to lead to risk reduction (EPA 2011). Successful implementation 
of these methods can be seen through the switch from chlorination to chloramination for 
the reduction of associated disinfection byproducts (Brodtmann Jr and Russo 1979), and 
through the reduction of N-nitrosamines in alcoholic beverages and beer products from 
the 1980s to the 1990s (McWeeny 1983).  
Considering the high risk posed by these carcinogenic emerging contaminants, 
municipal regulation of the N-nitroso class of compounds at the Federal level within the 
United States is still slow to evolve. Many N-nitrosamine congeners have been included 
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in the EPA’s contaminant candidate list (CCL), but no maximum contaminant levels or 
goals have been set for the contaminants within the national primary drinking water 
regulations. In contrast, a number of U.S. states and other countries have adopted action 
levels, public health goals, and regulatory limits for some N-nitrosamine congeners 
(Appendix A: Table 3). While limits for NDMA appear in all N-nitrosamine related 
regulation, the respective maximum limits of NDMA, as well as regulation of other N-
nitrosamine congeners vary. Further regulation of a wider suite of N-nitrosamines at the 
federal level has the potential to positively impact the quality of life for millions of 
Americans, in addition to any economic benefits the implemented actions would entail.   
Regulatory oversight in the cosmetics industry could result in a significant daily 
N-nitrosamine reduction – but regulation of N-nitrosamines in personal care products 
would be difficult due to the numerous existing laws and regulations which currently 
govern the manufacturing and sale of cosmetics and personal care products. N-
nitrosamines in these media have the potential for human exposure through two 
pathways: (1) dermal sorption from applied personal care products and cosmetics through 
the skin (Bronaugh et al. 1981), and (2) black-water and gray-water contamination which 
introduces large quantities of N-nitrosamines to natural and man-made water systems 
(Shen and Andrews 2011, Zeng and Mitch 2015). Exposure levels due to dermal 
adsorption (DA) are dependent on many factors, including: type of cosmetic or care 
product used, volume of product applied, contact time of the product, and the solubility 
of constituents within product (Bronaugh et al. 1981). Under current U.S. law, no specific 
tests to demonstrate product safety are required prior to product sales (U.S. Food and 
Drug Administration 2016). Furthermore, companies are not required to share their 
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product safety information with the U.S. Food and Drug Administration (FDA) (U.S. 
Food and Drug Administration 2016). Addressing these product safety loopholes could 
lead to the reduction of some of the very high N-nitrosamine concentrations found in 
some cosmetic products (up to 49,000 ng/g) (Fan et al. 1977). 
2.4.4 Potential Biases 
While the results presented in this study are relatively well supported by current 
literature, it is important to consider the potential biases which may have propagated 
through this study.  
Differing treatment of non-detect values within the studies is a potential concern. 
While many peer-reviewed articles have suggested multiple ways to treat non-detect 
values (Kayhanian et al. 2002, Krishnamoorthy et al. 2009), most studies which 
considered N-nitrosamine food concentrations treated non-detects as zero. This may not 
be a true representation of N-nitrosamine concentrations in these foods, and therefore 
may have indirectly caused an underestimate of the true average N-nitrosamine 
concentrations within food products. Extremely high concentrations of N-nitrosamines in 
food have been reported in the literature. If these values represent “outliers” rather than 
being representative, actual daily doses may be lower than the numbers presented here. A 
bias in food products routinely analyzed for N-nitrosamine also may propagate bias into 
this analysis, as monitoring efforts are very limited when considering the large number of 
food products available to consumers. It is possible that many more food items contain 
one or multiple N-nitrosamines, which would further increase the calculated daily doses 
and may affect the ranking of the various exposure sources considered here. 
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While the average N-nitrosamine potable water concentration determined through 
this meta-analysis is in-line with other literature (EPA 2011), this value is subject to some 
uncertainty due to N-nitrosamine formation in water distribution systems. It has been 
shown that users of municipal water located far downstream from the distribution point 
have significantly higher N-nitrosamine concentrations in their drinking water than users 
closer to the treatment plant (Zhao et al. 2006). Furthermore, few studies have examined 
N-nitrosamine concentrations in additional sources of potable water, such as bottled water 
or water subjected to point-of-use treatment. These factors suggest that the average 
exposure due to ingestion of potable water could be orders of magnitude higher for 
certain individuals based upon unreported factors such as affluence, or distance from the 
drinking water treatment plant. Similar to the literature centering on N-nitrosamines in 
food, most literature dealing with water-related contamination focused on a small 
percentage of the total N-nitrosamine congeners in their analyses, which impedes the 
ability to fully understand the overall impacts (both environmentally and healthwise) of 
the N-nitroso class. The omission from monitoring efforts of congeners potentially 
present and important frequently included but was not limited to NNN, NNK, and 
NDELA. 
2.4.5 Future Scope 
One aspect of N-nitrosamine exposure which was not examined in this analysis, 
but could have a large impact on nitrosamine exposure, is the in vivo microbial formation 
of N-nitrosamines within the gut and microbiome. Studies have shown that in vivo nitrate 
reduction to nitrite can increase the formation of mutagenic N-nitrosamines within the 
human body (Lundberg et al. 2004). Intake of high-protein and low-carbohydrate diets 
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have been hypothesized to alter the microbiome community and change intestinal 
fermentation, subsequently leading to increased levels of hazardous metabolites such as 
N-nitrosamines (Schwabe and Jobin 2013). This area of research represents a potentially 
important but poorly understood avenue of human exposure of N-nitrosamines. 
 N-Nitrosamine contamination in personal care products was also identified as an 
area where a significant push in research is needed. While some product concentrations 
and experimental dermal sorption values for select N-nitrosamines are available, the data 
is not sufficient enough to perform a meaningful analysis on the carcinogenic impact of 
using cosmetics and personal care products. It is possible that exposure due to these 
sources could exceed that of exposure from ingestion of food or water. Research 
literature has also shown that the N-nitroso class is likely much more pervasive than was 
previously thought, as contamination in unlikely media such as sediments (Gushgari et al. 
2016), biosolids (Venkatesan et al. 2014), and fog particles (Wang et al. 2015) has been 
observed. For this reason, it is important for N-nitrosamine monitoring studies to further 
explore environmental matrices where contamination currently is not suspected or 
thought to be improbable. 
2.5 Conclusion 
N-nitrosamines are a diverse class of chemicals that feature over 300 congeners of 
known or suspected carcinogenicity. Environmental contamination with N-nitrosamines 
is widespread, including tobacco smoke, food, drinking water and personal care products 
as important exposure sources. Uptake of N-nitrosamines in humans occurs primarily 
through inhalation and ingestion routes, resulting in average total daily doses of 21,800 ± 
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4,350 ng/day in the U.S. Individual exposure burdens are known to vary significantly as a 
function of lifestyle choices such as smoking, elected diet and use of personal care 
products.  In the U.S., approximately 6,050 ± 2,950 cases of cancer per one million 
people are expected to result from everyday exposure. This lifetime cancer incidence rate 
translates into 1,940,000 ± 950,000 cases per year for the U.S population of 323.1 million 
people, making N-nitrosamines to account for about 1-3% of all cancer cases observed in 
the nation. Avoidance of exposure to N-nitrosamine is possible through interventions at 
the federal, state, municipal, commercial and individual level, with simple interventions 
such as foregoing smoking and drinking leading to intake reductions of 88% and 4%, 
respectively. While personal care products have been hypothesized to represent a 
significant contributor to daily N-nitrosamine exposure, currently available data do not 
allow a calculation of the attributable risk from this source of exposure. Future research 
directions to explore include the monitoring of N-nitrosamines specific to personal care 
products (e.g., to NDELA), and an integration of these and other congeners into risk 
assessments. 
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TRANSITION 2 
Average human exposure to the N-nitrosamine class of contaminants has been 
shown to account for a significant carcinogenic risk which potentially could be measured 
through UMM. Before UMM is applied to estimate human N-nitrosamine exposure it is 
important to understand the extent of environmental N-nitrosamine contamination. Due to 
the hydrophilic nature of the compounds they were not thought to partition onto solid 
matrices adjacent to natural and manmade watercourses. Municipal sewage sludge 
(biosolid) N-nitrosamine contamination was only recently shown through a 
comprehensive examination (n=74) of U.S. biosolid samples. The low N-nitrosamine 
method detection limits (0.06-5.7 ng/g dw) by LC-MS/MS allowed for the frequent 
detection at sub-parts per billion levels and called for further work in identification of N-
nitrosamine contamination within additional solid matrices which exist within both 
natural and manmade watercourses. 
 In Chapter 3, the pervasion of eight IARC classified N-nitrosamines (N-
nitrosodibutylamine, N-nitrosodiphenylamine, N-nitrosopyrrolidine, N-
nitrosodimethylamine, N-nitrosomethylethylamine, N-nitrosodiethylamine, N-nitroso-di-
n-propylamine, and N-nitrosopiperidine) was examined in 40 freshwater sediment 
samples upstream and downstream of U.S. wastewater treatment plants. Analyzed 
samples were obtained from the top 10 cm of surficial freshwater sediments. Samples 
were collected from the Southern, Midwestern and Western U.S. during spring, fall and 
winter seasons, respectively. N-Nitrosamines were analyzed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) featuring low method detection limits (0.06-5.7 
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ng/g dw). A principal component analysis (PCA) was also conducted using a 
comprehensive water quality dataset to identify water quality parameters which correlate 
with the occurrence of N-nitrosamines in freshwater sediments. 
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CHAPTER 3 
 
OCCURRENCE OF N-NITROSAMINES IN U.S. FRESHWATER SEDIMENTS 
NEAR WASTEWATER TREATMENT PLANTS 
ABSTRACT 
In the present study, 40 freshwater sediments collected near 14 wastewater treatment 
plants (WWTPs) across the United States were analyzed for eight N-nitrosamines by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS). Three N-nitrosamines 
were detected for the first time in freshwater sediments in units of ng/g dry weight at the 
specified detection frequency: N-nitrosodibutylamine (NDBA; 0.2-3.3; 58%), N-
nitrosodiphenylamine (NDPhA; 0.2-4.7; 50%), and N-nitrosopyrrolidine (NPYR; 3.4-
19.6; 18%). At least one N-nitrosamine was detected in 70% (28/40) of sediments 
analyzed. Non-detect values in units of ng/g dw were obtained for N-
nitrosodimethylamine (NDMA; <10.2), N-nitrosomethylethylamine (NMEA; <1.7), N-
nitrosodiethylamine (NDEA; <3.9), N-nitroso-di-n-propylamine (NDPA; <1.7), and N-
nitrosopiperidine (NPIP; <3.6). Principal component analysis specifically points to two of 
multiple potential pathways explaining N-nitrosamine occurrences in sediment: NDBA 
and NDPhA were positively correlated with bulk water ammonia and pH levels, and 
NPYR with sediment content of organic carbon and iron. Interestingly, N-nitrosamine 
occurrences up- and downstream of WWTPs were statistically indistinguishable (p 
>0.05). This is the first report on the occurrence of the carcinogenic N-nitrosamines 
NDBA, NDPhA, and NPYR in U.S. freshwater sediments. Discovery of this phenomenon 
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warrants further research on the compounds’ origin, environmental persistence, aquatic 
toxicity, and risks posed. 
3.1 Introduction 
 N-Nitrosamines are a large group of emerging contaminants of ecological and 
human health concern due to their carcinogenic potential. Over 300 congeners have been 
reported and may affect humans through a number of different exposure routes, including 
ingestion of food and water, use of tobacco products, occupational exposure, and the use 
of certain cosmetic or pharmaceutical products (Hecht 2014a). N-Nitrosamine sources in 
industrial, commercial and residential settings are known to increase the quantities 
detected in raw wastewater (Krauss et al. 2009). The International Agency for Research 
on Cancer (IARC) has classified 24 different N-nitrosamines with respect to their 
carcinogenic potential to humans. Two of these, N-nitrosonornicotine and 4-(N- 
nitrosomethylamino)-1-(3-pyridyl)-1-butanone, have been classified as Group 1 known 
human carcinogens (IARC). The remainder are classified as either probably carcinogenic 
to humans (Group 2A), possibly carcinogenic to humans (Group 2B), or not yet 
classifiable (Group 3) (IARC). Although the United States Environmental Protection 
Agency (U.S. EPA) recognizes the existence of sub-populations at risks of multiple 
exposures, quantifying the latter remains challenging and incomplete due to the 
ubiquitous nature of N-nitrosamines (Regulations 1980). As of today, a total of five N-
nitrosamines are included in the U.S. EPA Contaminant Candidate List 3 (CCL-3), and 
the same five have been listed again in the U.S. EPA CCL-4 draft: these are N-
nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-nitroso-di-n-
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propylamine (NDPA), N-nitrosodiphenylamine (NDPhA) and N-nitrosopyrrolidine 
(NPYR) (2014, Venkatesan et al. 2014).  
 One area of increasing concern is the unintentional formation of N-nitrosamines 
as disinfection byproducts (DBP) in drinking waters. For instance, chlorination and 
chloramination of waters containing secondary and tertiary amines can result in the 
formation of NDMA, a widely studied probable human carcinogen (2014, Mitch and 
Sedlak 2002, Wang et al. 2011). Other documented or hypothesized pathways of N-
nitrosamine formation include generation in waters containing ammonia, organic 
nitrogen, or other inorganic nitrogenous substances; UV-induced formation in the 
presence of chlorinated dimethylamine and monochloramine; and formation via oxidation 
of dimethylacetamide to hydroxylamine in ozonation processes (Lee and Westerhoff 
2009, Oya et al. 2008, Soltermann et al. 2012, Yang et al. 2009). 
Because of the lower partitioning coefficients of most N-nitrosamines, it is 
generally believed that N-nitrosamine occurrence is limited to only aqueous matrices; 
therefore, little research has been conducted on the occurrence and sorption behavior of 
these compounds in solid environmental matrices. A recent study reported the occurrence 
of eight N-nitrosamines in nationally representative U.S. biosolids samples with a 
detection frequency of 88%, suggesting either in situ formation or sorption of N-
nitrosamines to biosolids during secondary or sludge treatment in wastewater treatment 
plants (WWTPs) (Venkatesan et al. 2014). Detection frequency of N-nitrosamines in 
sludge samples linearly correlated with their n-octanol water partitioning coefficient 
(KOW), suggesting hydrophobic sorption as a mechanism governing N-nitrosamines 
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accumulation in solid environmental matrices (Venkatesan et al. 2014). Numerous N-
nitrosamines and their secondary amine precursors have been detected in WWTP 
effluent, as well as in wastewater-impacted aquatic environments (Akyuz and Ata 2006, 
Boyd et al. 2011, Krauss and Hollender 2008, Schreiber and Mitch 2006). It has also 
been shown that common water constituents, such as the presence of ammonia and 
chloramine, can increase the rate of N-nitrosamine formation (Kristiana et al. 2013). 
Motivated by a lack of data on N-nitrosamine occurrences in freshwater bed sediments 
proximal to WWTP discharges, we screened for the following eight N-nitrosamines: 
NDMA, N-nitrosomethylethylamine (NMEA), NDEA, NDPA, N-nitrosodibutylamine 
(NDBA), NPYR, N-nitrosopiperidine (NPIP), NDPhA. To the best of our knowledge, 
only one peer-reviewed study exist in the literature that reports the occurrence of NDMA 
in bulk sediments acquired from the Calumet River (Indiana Harbor, Indiana) (Hoke et al. 
1993). Reported NDMA concentrations from this study ranged from 0.16 to 1.69 mg/kg 
dry weight with a detection frequency of 60% (n = 10) (Hoke et al. 1993). Another study 
that examined the extraction methods of N-nitrosamines in solid matrices screened for N-
nitrosamines in freshwater sediments (n = 4), but were not able to detect levels above the 
method detection limit of the study (Jurado-Sánchez et al. 2013). In order to address this 
important knowledge gap, the objectives of the present study were to: (i) quantify and 
provide the first occurrence data of eight N-nitrosamines in freshwater bed sediments 
collected near WWTPs from three geographically distinct regions of the United States; 
and, (ii) apply principal component analyses of water and sediment quality parameters to 
inform on potential mechanisms explaining any given detections of harmful N-
nitrosamines in freshwater sediments. 
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3.2 Materials and methods 
Analytical standards of N-nitrosamines and other chemicals were purchased from 
Sigma-Aldrich (St. Louis, MO), including NDMA, NMEA, NDEA, NDPA, NDBA, 
NPYR, NPIP, NDPhA, dichloromethane (DCM) (HPLC grade), methanol (LC-MS 
grade), water (HPLC grade), ammonium acetate, and acetic acid. The deuterated isotopes 
NDMA-d6, NDPA-d14 and NDPhA-d6 were purchased from Cambridge Isotope 
Laboratories (Andover, MA). The deuterated isotope NPIP-d10 was purchased from 
C/D/N Isotopes Inc. (Quebec, Canada).  
3.2.1 Sediment samples  
Grab samples were collected from the top 10 cm of surficial freshwater sediments 
in 40 U.S. locations near 14 WWTPs between 2009 and 2015. Samples were collected 
from the Southern, Midwestern and Western U.S. during spring, fall and winter seasons, 
respectively. Due to confidentiality agreement with municipalities, the location of the 
facilities is not revealed in the present study and spatial analyses were not part of the 
scope of work. After collection, samples were stored in amber glass jars at -20 oC until 
analysis. The flow volume processed by the sampled WWTPs varied: three processed 
<3.8 million liters per day (ML/d), seven between 3.8 and 38 ML/d, two between 38 and 
380 ML/d, and two treated >380 ML/d. The majority of sediment samples (39 of 40) 
were collected within 3,000 m of the corresponding WWTP, either upstream (30% of the 
samples) or downstream of the plant (60% of the samples).  
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Fig. 9 - (a) Box and whisker plot of concentrations of N-nitrosamines in n samples of 
freshwater sediments collected near 14 U.S. wastewater treatment plants. Numbers above 
the boxes represent number of detects. (b) U.S. regional map showing average N-
nitrosamine concentration for corresponding U.S. regions and the number of samples 
analyzed per region (n). Bars represent the standard deviation of the mean of all samples 
analyzed in a specific region of the U.S. 
3.2.2 N-Nitrosamine analysis  
Sediments were spiked with deuterated surrogates and extracted using 
dichloromethane (2 mL per g of sediments) utilizing an isotope dilution method similar to 
the method described previously for sludge, with slight modifications [5]. The extract 
was then subjected to analysis by liquid chromatography electrospray ionization tandem 
mass spectrometry (LC-ESI-MS/MS) in positive ionization mode. A detailed explanation 
of the extraction method is available in the supporting information. 
3.2.3 Statistical analysis  
Analytical data of detected N-nitrosamine concentrations were analyzed for 
interrelations with various physicochemical properties of the study locations by 
performing a principal component analysis (PCA) using version 21 of the IBM SPSS 
software package (IBM, Armonk, New York, U.S.). Water and sediment quality 
parameters used in PCA were available by public record for the sampling location and 
time for 25 of the 40 samples analyzed in the present study. 
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3.3 Results and discussion 
3.3.1 Method performance 
Method detection limits (MDLs) for the various N-nitrosamines ranged from 0.1 
to 10.2 ng/g dw (Appendix B: Table 4). Method detection limits were determined based 
upon USEPA guidelines described in 40 CFR 136, Appendix B (USEPA 1984).  Process 
control samples and blanks showed no laboratory contamination. Method performance 
and analyte detection were further confirmed by performing matrix spike experiments in 
selected samples showing positive detections of N-nitrosamines (Appendix B: Fig. 18). 
Final, normalized recoveries of analytes determined with deuterated surrogates ranged 
from 78 to 88%. Absolute recoveries for all analytes ranged from 54 to 108% and were 
consistent with values previously observed for complex environmental matrices 
(Venkatesan et al. 2014). A complete list of absolute recoveries, relative recoveries and 
method detection limits for each screened N-nitrosamine is available in Appendix B: 
Table 4 of this document. Analysis of archived samples over a period of eight months did 
not show any significant degradation or formation of N-nitrosamines under the storage 
conditions chosen (see SI for more info). Concentrations and detection frequencies 
reported for NPYR and NDBA in sediments should be considered conservative, i.e., 
lower-bound estimates of the true value, because the concentrations were determined 
without labeled isotopes to correct for analyte losses and ion suppression during sample 
processing and analysis, respectively. Analysis precision expressed as relative percentage 
difference (RPD) was good at less than 20% (average) for NPYR and NDPhA, and 
slightly less favorable for NDBA at 38%. Similar RPD values (18 to 66%) have been 
reported in literature for organic and inorganic contaminants in sediments, and this high 
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value may be explained by the non-homogenous nature of wet sediment samples (Barber 
and Writer 1998, Gilmour et al. , Venkatesan et al. 2014). 
3.3.2 Occurrence of N-nitrosamines in U.S. freshwater sediments 
Out of the 40 freshwater sediment samples analyzed, 70% tested positive for at 
least one N-nitrosamine. Three of eight targeted N-nitrosamines were detected in 
freshwater sediments in three geographical regions of the United States (Fig. 9): NDBA, 
NPYR, and NDPhA. This is the first study to report the occurrence of the three 
aforementioned N-nitrosamines in freshwater sediment samples. The remaining smaller 
aliphatic N-nitrosamines (NDMA, NMEA, NDEA, NDPA and NPIP) were absent from 
all samples analyzed or present only at levels below the corresponding MDLs (Appendix 
B: Table 4). The most frequently detected N-nitrosamine was NDBA [58% detection 
frequency (DF)], with a concentration range of 0.2-3.3 ng/g dw, followed by NDPhA 
(50% DF) and NPYR (18% DF) with a concentration range of 0.2-4.7 ng/g dw and 3.4-
19.6 ng/g dw, respectively (Fig. 9).  
3.3.3 Potential sources of detected N-nitrosamines 
The higher detection frequency observed for NDBA and NDPhA may be 
explained in part by the relatively higher potential for hydrophobic sorption of these two 
N-nitrosamines (log KOW of 2.63 and 3.13, respectively). Similar partitioning properties 
of the corresponding secondary amines serving as precursors of these two N-nitrosamines 
(i.e., dibutylamine and diphenylamine featuring log KOW values of 2.83 and 3.50, 
respectively) also may have played a role; precursors accumulated in sediments may 
increase opportunities for in situ formation of the two N-nitrosamines detected. In 
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contrast to NDBA and NDPhA, NPYR has no hydrophobic sorption potential (log KOW = 
-0.19), yet it was still detected in 18% of sediment samples analyzed. In situ formation 
from unknown precursors is one potential explanation for NPYR occurrences in 
sediments. A number of research studies have reported detectable concentrations of 
aliphatic and aromatic amines (including dibutylamine, pyrrolidine, and diphenylamine) 
in effluent discharges, raw waters (rainwater and ground water), surface waters and both 
saltwater and freshwater sediment samples (Akyuz and Ata 2006, Sacher et al. 1997, 
Wang et al. 2011, Wang and Lee 1990). Amine-containing pharmaceuticals and personal 
care products (PPCPs) also have been found to increase the occurrence of aliphatic and 
aromatic amines near WWTP effluent discharge locations, and thus have been linked to 
N-nitrosamine DBP formation (Shen and Andrews 2011). It should also be noted that 
microbes, such as fecal streptococci, has been shown to produce N-nitrosamines in the 
presence of nitrites and secondary amines (Ayanaba et al. 1973, Collins-Thompson et al. 
1972, Okolie 2005). These conditions are typical in natural open water systems and could 
account for another potential pathway of N-nitrosamine sediment contamination. Since 
secondary amines have been detected in surface waters and have been shown to serve as 
precursors in the formation of stable N-nitrosamines (Mitch and Sedlak 2002, Padhye et 
al. 2011), in situ formation of N-nitrosamines in sediments of surface waters containing 
secondary amines is a plausible mechanism deserving future studies. 
Because of the variation of N-nitrosamine levels detected at different sample 
locations, it is reasonable to hypothesize that N-nitrosamine formation is not due to one 
factor alone, but a result of many different chemical reactions. For this reason, it is also 
important to consider the atmospheric photo-oxidation of amines as a potential loading 
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source. One study showed that NDMA and N-nitrodimethylamine can be produced 
through atmospheric photo-oxidation of N-methylformamide and N,N-
dimethylformamide (Bunkan et al. 2015). It is possible for these degradation products to 
sorb onto particulate matter and contribute to sediment contamination. 
Although at least one N-nitrosamine was detected in 70% of the sediment 
samples, the individual N-nitrosamines and concentrations varied across the different 
sediments. Diverse and distinct sources could be at play, including unique treatment 
processes used in WWTP near the studied locations, river sediment-water composition, 
and contribution from other non-point sources. With respect to the treatment processes of 
the studied locations, 88% of the sampled WWTPs which employed a chlorination and 
de-chlorination disinfection process (n = 8) tested positive for at least one N-nitrosamine 
in the neighboring sediment samples. However, detectable levels of N-nitrosamines also 
were found in 50% of sediment samples from areas near WWTPs utilizing UV 
disinfection (n = 4). Although UV radiation is known to effectively degrade N-
nitrosamines, irradiation with UV light also has been shown to result in the formation of 
NDMA in the presence of chlorinated dimethylamine and monochloramine (Soltermann 
et al. 2012). Therefore, both disinfection processes could potentially serve as a source to 
N-nitrosamine contamination in sediments. 
 A comparison of total detected N-nitrosamine concentrations between paired 
upstream and downstream sediment samples within 3,000 m from a WWTP showed 
neither appreciable differences (p = 0.42; 95% CI) nor any visual trends (Fig. 11). 
Additional reference sites (samples taken from distances greater than 3,000 m) also 
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showed varying levels of N-nitrosamine concentration. Determination of N-nitrosamine 
levels in the sediment sample local to the treated effluent discharge location of one 
WWTP showed no detectable concentrations of any of the three N-nitrosamines detected 
in other sediment. This observation and the detection of N-nitrosamines upstream of 
WWTPs suggest the existence of other, additional non-point sources of N-nitrosamines to 
sediments. For instance, urine has been shown to contain high levels of N-nitrosamines 
(NDMA, NPIP and NPYR) as well as ammonia (Mostafa et al. 1994, van Maanen et al. 
1996) and thus represents one potential source of both surface and groundwater N-
nitrosamine contamination (Ma et al. 2012). Urine may originate from human sources or 
wildlife. Discharge of untreated domestic wastewater at the study locations may have 
served as a source of N-nitrosamines in upstream sediments. The role of WWTPs in N-
nitrosamine formation is important to consider and could contribute to N-nitrosamine 
loading in sediments, but results obtained here suggest that these may not necessarily be 
the most important sources contributing to the N-nitrosamine levels discovered. 
Regardless, it is still important to consider WWTP’s as a source of N-nitrosamines in 
sediments due to the numerous reports of multiple N-nitrosamine detection in WWTP 
effluents (Krasner et al. 2009, Planas et al. 2008, Schreiber and Mitch 2006). Formation 
of N-nitrosamines in aquatic environments is a complex process that is still not yet fully 
understood and may vary in different environments due to differing environmental and 
anthropogenic loading factors. Sediment based microbial communities have been shown 
to induce degradation of NDMA precursors (which helps explain the lack of NDMA in 
our samples), but microbial presence and activity is highly dependent on water conditions 
(Woods and Dickenson 2016). Under appropriate conditions, it has been hypothesized 
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that sediments could be responsible for releasing NDMA precursors into water systems 
(Woods and Dickenson 2016). Despite a growing body of research findings on the 
formation and degradation of some N-nitrosamines such as NDMA, information on the 
occurrence and origin of other N-nitrosamine compounds is still limited.  Therefore, 
further research regarding the complex formation of these contaminants is necessary, 
including some of the N-nitrosamines reported on in this work. 
3.3.4 Principal component analysis of data relating to nitrosamine occurrences in 
sediments  
 
Fig. 10 - Principal component analysis of the N-nitrosamine levels and parameters of 
sediment and water quality from the corresponding sampling locations. The first two 
principal components accounted for 42% of total variance in the dataset. Highlighted 
circles represent clusters of parameters correlating with each other. OC – organic carbon 
fraction of sediments; Distance from the corresponding WWTP; concentrations of 
ammonia, nitrate + nitrite and chloride in surface water; pH of surface water; transition 
metals (Fe, Cu. Mn, Mo, Ni, V, Zn) concentration in surface water. 
A PCA was performed using obtained concentration data in conjunction with 
water and sediment quality parameters of the study locations for which secondary data 
sources were available (n = 25), i.e., water pH, distance of sampling site from WWTP 
(with upstream distance used as negative distance), organic carbon fraction (OC) of 
sediments, water concentration of ammonia, nitrate + nitrite, chloride and transition 
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metals – Fe, Cu, Mn, Zn, Ni, V, Mo (Fig. 10). The first two principal components 
explained the highest amount of variance in the dataset and combined accounted for 42% 
of the total observed variability. PCA determined that NDBA and NDPhA correlated 
positively with both bulk water pH and ammonia concentration (Fig. 10). Two different 
pathways of deposition or formation of N-nitrosamines in sediments may be envisioned 
based on the findings: a positive correlation of NPYR with OC suggests that its 
occurrence in sediments may be due to hydrophobic partitioning or electrostatic sorption 
following release of unidentified inputs that may include untreated wastewater; whereas 
hydrophobic interactions must be viewed as being a less likely occurrence pathway given 
the n-octanol-water partitioning coefficient of NPYR (Appendix B: Table 6), in 
conjunction with for example electrostatic interactions it may still be worth considering. 
Alternatively, organic carbon, which is well known to play a role in the formation of 
NDMA (Krasner et al. 2009, Kristiana et al. 2013), may have promoted the formation of 
NPYR in sediments through similar in situ reactions.  
 
Fig. 11 - Comparison of concentrations of the sum of N-nitrosamines detected in paired 
sediment samples obtained within a distance of 3,000 m upstream and downstream from 
WWTP discharge locations; shown are average total N-nitrosamine concentrations (Panel 
A) and data pairs for individual sampling locations (n = 10; Panel B). 
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 The effluent of WWTPs is known to contain detectable concentrations of N-
nitrosamines as well as precursors and promoters of N-nitrosamine formation, including 
chlorine, ammonia, and secondary amines (Chen et al. 2009, Gersberg et al. 1986, 
Krasner et al. 2009). Chlorine and ammonia can react to form chloramines, which have 
been found to produce significantly greater yields of N-nitrosamines than chlorine alone 
(Kristiana et al. 2013). In surface waters with high concentrations of ammonia, residual 
chlorine would be more readily transformed to chloramine, which in turn would account 
for a higher transformation of secondary amine precursors to N-nitrosamines. Also, 
degradation or formation of NDMA is known to be influenced by pH conditions (Xu et 
al. 2009), an important aspect to consider when interpreting the observed positive 
correlation of NDPhA and NDBA with both ammonia concentration and pH of the bulk 
water.  
Interestingly, the PCA determined that NPYR concentrations also correlate with 
bulk water iron content. Few studies have examined the role of transition metals in the 
formation of N-nitrosamines (Challis et al. 1978, Lunn and Sansone 1994, McCleverty 
1977, Shehad 1993). Based on the observed chemical relationship between 
[Fe(CN)5(NO)]
2−, ammonia, aliphatic amines and a high pH, it has been hypothesized 
that under similar conditions secondary amines could undergo transformation to metal-
bound N-nitrosamines (McCleverty 1977). Another study found a correlation between the 
rate of N-nitrosamine formation and the presence of metal salts (Challis et al. 1978). 
Reaction rates of NPIP increased substantially when metal salts (ferric nitrate and cupric 
chloride) were introduced to the system (Challis et al. 1978). Similarly, a patent focusing 
on the inhibition of N-nitrosamine formation suggests that some transition metals may 
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play a role in the formation of N-nitrosamines (Shehad 1993), although the pathway and 
mechanisms are not yet fully understood. Furthermore, absence of iron was found to 
inhibit cancerous growths known to be triggered by certain N-nitrosamines (Toyokuni 
1995), suggesting a potential role of iron in carcinogen formation and adverse effects. 
Some metal nitrosyl compounds have been found to also react with both primary and 
secondary amines, promoting N-nitrosamine formation (Lee et al. 2001); these reactions 
are typically coupled with high temperature and pressure conditions, and thus may not be 
applicable to aquatic environments. Nevertheless, the observed PCA correlation makes 
transition metals an important consideration in determining the possible pathways of N-
nitrosamine formation, with primary amines acting as chemical precursors in addition to 
secondary amines. Thus, the correlation between NPYR occurrence and sediment iron 
content is plausible, but more research is needed to substantiate or refute causal 
associations.  
3.3.5 Carcinogenic potential and aquatic toxicity of N-nitrosamines in sediment 
porewater 
 To understand the potential carcinogenic potential of the reported N-nitrosamines 
residing in sediments, cancer potency values for NDBA, NDPhA and NPYR were 
obtained from the California Office of Environmental Health Hazard Assessment 
(OEHHA). Inhalation/oral slope factors for the three reported N-nitrosamines are as 
follows: 9.0 μg/kg-day (NDPhA), 2.1 mg/kg-day (NPYR), and 11 mg/kg-day (NDBA) 
(OEHHA 2009). At face value, N-nitrosamines in freshwater sediments may not pose an 
immediate cancer risk to humans because there is no direct route of oral or respiratory 
exposure; however, N-nitrosamine levels in waters in contact with the contaminated 
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sediments have the potential to create an indirect route of oral exposure. Furthermore, 
these areas are commonly used for recreational water uses (e.g., camping, swimming), 
which may contribute to inadvertent human exposure to N-nitrosamines from either 
accidental or deliberate water ingestion. In order to further quantify the carcinogenic risk, 
the pore water N-nitrosamine concentrations were estimated from the sediment 
concentrations by using equation 3: 
𝐶𝑝𝑜𝑟𝑒 =
𝐶𝑠𝑒𝑑
𝐾𝑂𝐶𝑓𝑂𝐶
  Eq. 3 
KOC values were calculated using the equation: log KOC = 0.72 * log KOW + 0.49 
(Essington 2015). Mathematically, average sediment pore water concentrations were 
determined to be: 0.063 μg/L (NDPhA, 0.004-0.31 μg/L), 0.092 μg/L (NDBA, 0.022-0.51 
μg/L), and 201 μg/L (NPYR, 45.7-813.1 μg/L). When compared to the OEHHA data, it 
can be determined that these pore water levels alone do not exceed the given 
inhalation/oral exposure slope factors – but could still contribute to overall N-nitrosamine 
exposure. When compared to the California State Water Resource Control Board’s N-
nitrosamine notification limit of 10 ng/L (applicable to NDEA, NDMA and NDPA), it 
becomes clear that the carcinogenic potential of these sediment-based N-nitrosamines 
needs to be evaluated further. 
Also, the toxicological implications of N-nitrosamine occurrences in freshwater 
sediment deserve a brief discussion in this study. Presently available LC50 values for a 
number of aquatic species seem to span a wide range (330 mg/l for Gammarus limnaeus 
versus 1,365 mg/l for Dugesia dorotocephala), and are several orders of magnitude 
higher than the pore water concentrations reported here (Draper and Brewer 1979). These 
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LC50 values are significantly higher than reported concentrations in sediments or waters, 
and thus suggest no imminent threat to aquatic organisms (Brooks and Wright 2008, 
Draper and Brewer 1979, Jurado-Sánchez et al. 2010, Poste et al. 2014, Regulations 
1980). Certain chronic effects have been associated with NDMA and NDEA exposure, 
including hepatocellular carcinomas in rainbow trout (Oncorhynchus mykiss), antennal 
gland degradation and hyperplasia of tubular cells in crayfish (Procambarus clarkia), and 
adverse growth effects and DNA damage in multiple species of green algae (Brooks and 
Wright 2008). Severely toxic cellular and tissue responses have been shown in the 
Sheepshead Minnow (Cyprinodont variegatus) and the Japanese Rice Fish (Oryzias 
latipes) when subjected to contact with NDEA spiked waters (Hinton et al. 1988). Not all 
N-nitrosamines have been tested for their toxicity and for adverse mixture effects in 
aquatic ecosystems; and while they do not appear to pose a threat in terms of acute 
toxicity, chronic toxicity problems may be significant (Draper and Brewer 1979, Poste et 
al. 2014). 
3.3.6 Study limitations, data gaps, and research needs  
While providing important data on freshwater sediment quality, this study also 
featured a number of limitations. Data analysis was hampered by a lack of information on 
WWTP locations, lack of water quality quantification at certain test sites, unit operations 
employed, and treatment levels achieved for certain water quality parameters. Also, the 
number of nationwide sediment samples analyzed here was limited, rendering the 
representativeness of the study for the United States overall vulnerable to potential bias. 
The age of sediment samples analyzed in the present study varied between less than a few 
days to 5 years. To test for the stability of N-nitrosamines during storage at – 20oC, 
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freshly obtained sediment was analyzed repeatedly over eight months. Obtained data 
showed no appreciable differences in detectable concentrations of NDBA and NDPhA at 
the beginning and end of the experiment (8 months after sample collection), and the 
remaining six N-nitrosamines consistently showed non-detect values (<MDL) throughout 
the storage experiment (Appendix B: Fig. 19). Similar stability tests performed by our 
group in the past for sewage sludge samples using a methodology identical to that of the 
present study also had shown no significant differences in N-nitrosamine levels during 
prolonged storage (Venkatesan et al. 2014). Importantly, detection of NDBA, NPYR and 
NDPhA in freshly obtained sediments precludes in-storage generation of N-nitrosamines 
as a viable explanation of the contaminant occurrences reported here.  
Though PCA analysis of the dataset provided some important correlations 
observed between sediment/water quality parameters and N-nitrosamine levels, further 
research is needed to confirm the role of such parameters. The determination of the 
formation pathways and mechanism was beyond the scope of the present study, and thus 
formation and partition pathways discussed in this study should be viewed as only 
potential pathways but constitutes an important research need. Carcinogenic potential of 
N-nitrosamines discussed in this paper are estimates based on values from present 
literature available and represents another important gap in the understanding of N-
nitrosamines that needs to be filled. Since only one sample per sampling location was 
collected, a detailed analysis with respect to temporal and seasonal variability was not 
conducted. Future research on N-nitrosamine occurrence in aquatic environments would 
benefit from accounting for these variables. Furthermore, future research should focus on 
the environmental impacts of these N-nitrosamines in freshwater sediments and exposed 
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biota. Such work will be essential to further the currently limited understanding of the 
overall implications of the occurrence of these contaminants in U.S. aquatic 
environments. 
3.4 Conclusion 
This study constitutes the first report on the occurrence of three N-nitrosamines 
(NDBA, NPYR, and NDPhA) of a total of eight monitored for in freshwater sediments in 
three geographically distinct regions of the United States. Whereas the origin of this 
newly discovered contamination is yet uncertain, sharing this new knowledge with the 
research community is essential due to carcinogenic nature of these pollutants. 
The number of N-nitrosamines reported in this study accounts for less than 5% of 
all known N-nitrosamine compounds and hence future research should consider 
additional N-nitrosamine analytes of ecological and human health concern. Furthermore, 
methods to screen for both N-nitrosamine and nitramine contamination should be 
implemented when possible to better understand the origination and routes of formation 
of these contaminants. Future research also will help determine in greater detail how 
widespread the occurrence of N-nitrosamines in freshwater sediments is in U.S. regions 
not covered here and internationally, which routes of sediment contamination are 
important, and what preventive measures can and should be taken to limit source terms 
and to protect ecosystems and human populations alike. 
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TRANSITION 3 
 Substance abuse is a longstanding public health challenge worldwide and the 
ongoing opioid abuse crisis has had a particularly severe adverse impact on the U.S. 
population. Many strategies have been proposed to assist in managing the U.S. opioid 
crisis but could benefit from a technology which produces opioid-related health data in 
near-real time. Wastewater-based epidemiology (WBE) could be applied to U.S. 
populations to obtain near real-time opioid use data in a non-invasive and anonymous 
way but has seen little application within U.S. communities to track narcotic 
consumption. Smaller communities could see additional benefits from this technology as 
they are more limited in their resources and would benefit from stronger evidence-formed 
public health decision making. 
 In Chapter 4, a two-year longitudinal study identifying concentrations of five 
opioids (morphine, codeine, oxycodone, fentanyl, and heroin) in raw wastewater was 
conducted in two Midwestern cities of medium population size (25,000 to 250,000) that 
previously had reported high rates of opioid abuse. In year two sample screening was 
expanded to include the opioid metabolites: norcodeine, noroxycodone, norfentanyl, 
morphine-3-glucuronide, and 6-acetylmorphine. Samples (24-hour time weighted 
composites) were obtained once per month over a two-year sampling period and analyzed 
by LC-MS/MS. Opioid concentrations in raw wastewater were compared to wastewater 
flow and pharmacokinetic values to estimate approximate consumption values for the two 
cities. Estimated consumption was then compared across the two cities, and to U.S. and 
international consumption estimates obtained from related literature. 
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CHAPTER 4 
 
TRACKING OPIOID CONSUMPTION IN TWO UNITED STATES CITIES BY 
WASTEWATER-BASED URBAN METABOLISM METROLOGY 
ABSTRACT 
 Access to robust near-real time opioid use data is essential to the effective 
management of the U.S. opioid crisis. Current narcotic data collection methods are 
limited by time delay and would be complimented by a rapid data acquisition technique. 
Urban metabolism metrology using wastewater diagnostics potentially offers access to 
near real-time data on opioid consumption but thus far has seen little application in the 
United States. From 2015-2017, we analyzed monthly 24-hour time-weighted composites 
of municipal raw wastewater from two Midwestern U.S. cities using isotope dilution 
liquid chromatography tandem mass spectrometry. Opioid consumption rates estimated 
from wastewater analytics were similar compared to reported WBE-based estimates from 
New York and a nationwide U.S. survey but exceeded reported estimated consumption in 
Italy, London, Finland, Norway, Spain, Belgium, UK, Netherlands, Switzerland, and 
Denmark. Opioids were routinely detected in units of ng/L concentrations in effluent 
from City 1 and 2, respectively, including morphine (713 ± 38; 306 ± 29; detection 
frequency (DF): 100%), codeine (332 ± 37; 100 ± 27; DF: 93%), oxycodone (17.8 ± 1.1; 
78 ± 6; DF: 100%), fentanyl (1.7 ± 0.2; 1.0 ± 0.5; DF: 62%), and heroin (41 ± 16; 9 ± 11; 
DF: 81%). Opioid consumption rates estimated from wastewater analytics ranged 
between 9 (fentanyl) and 2,590 (morphine) mg/day/1,000 persons.  This long-term U.S. 
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screening study of opioids in wastewater was the first to identify detectable levels of the 
powerful synthetic opioid fentanyl in wastewater, and (2) the first U.S. study to identify 
opioid consumption trends of small cities within the midwestern United States. 
4.1 Introduction 
 The United States is in the midst of an unprecedented opioid epidemic that claims 
approximately 42,000 U.S. lives annually (Kounang 2017, Rudd 2016, Schuchat et al. 
2017) and challenges the development of economic and rapid methods for tracking drug 
consumption in real-time or near real-time. Opioids were responsible for 67% and 63% of 
all drug overdose fatalities in 2014 and 2015, with death rate increases from 12.3 to 16.3 
per 100,000 population being attributable to increased consumption of heroin (+21%) and 
the 50-times more powerful synthetic opioid, fentanyl (+72%) (Rudd 2016, Warner et al. 
2016). In the U.S., 10.3 million residents reported using prescription opioids for 
nonmedical purposes in 2014, and a nine-fold increase of young adults using heroin has 
been observed from 2002 to 2014 (Martins et al. 2017). Correlations between non-
medical opioid use and heroin use have also been observed (Compton et al. 2016). While 
exact percentages vary by study and city, studies cite that between 39% to 86% of heroin 
users admitted to nonmedical use of pharmaceutical opioids before beginning heroin use 
(Lankenau et al. 2012, Mateu-Gelabert et al. 2015, Peavy et al. 2012, Pollini et al. 2011, 
Siegal et al. 2003). Despite recent successful efforts by public health and medical 
professionals to curb opioid prescription rates (Dowell et al. 2016, Frieden and Houry 
2016, Schuchat et al. 2017), drug related overdose deaths have continued to increase in 
the United States (Katz 2017). 
67 
 
 With such widespread opioid use, obtaining relevant information related to opioid 
consumption is vital to developing effective substance abuse prevention strategies. 
Current data analysis involves a combination of population surveys, crime statistics, 
medical records and narcotic seizure data (Zuccato et al. 2008), but these methods are 
often costly, cumbersome, and may be subject to bias. Wastewater-based epidemiology 
(WBE) was first proposed in 2001 as a method for obtaining population health metrics 
(Daughton 2001). In 2005 it was tested as an alternative to current narcotic data 
collection methods of cocaine use (Zuccato et al. 2005), and since has experienced 
widespread use in Europe (Baker et al. 2014, Baz-Lomba et al. 2016, Gatidou et al. 2016, 
Kankaanpää et al. 2014, Lindberg et al. 2005, Postigo et al. 2011, Terzic et al. 2010, Van 
Nuijs et al. 2011, Vuori et al. 2014, Zuccato et al. 2008, Zuccato et al. 2005), Asia (Kim 
et al. 2015, Lai et al. 2013), Africa (Archer et al. 2018) and Australia (Lai et al. 2016, 
Tscharke et al. 2016) in order to obtain anonymous prescription and illicit narcotic 
consumption data in near-real time. The WBE approach has been further expanded under 
the umbrella of urban metabolism metrology (UMM), which studies multiple process 
flows within the natural and built water environment to obtain diagnostic information on 
activities, sustainability and the health statistics for a human population. Analysis of 
sample of flow-weighted composited sewage obtained from wastewater treatment plant 
(WWTP) may provide important epidemiological insights as usage prevalence statistics 
could theoretically be obtained for any commonly consumed product within a population 
(Dove 2006). The validity of this technique has been demonstrated through the 
comparison of wastewater epidemiological analysis of therapeutic drugs and known 
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amounts consumed by the population (Heberer and Feldmann 2005, Lindberg et al. 
2005).  
Compared to European and Asian countries, wastewater epidemiological analysis 
in the United States has seen limited use (Subedi and Kannan 2014). Studies which have 
examined U.S. wastewaters for drug use prevalence have primarily focused on US DEA 
schedule I and II narcotics (Banta‐Green et al. 2009, Gerrity et al. 2011, Subedi and 
Kannan 2014). Some U.S. based studies have screened wastewater for prescription and 
illicit parent opioids and/or metabolites, with positive detections of morphine (Heuett et 
al. 2015, Subedi and Kannan 2014), codeine (Heuett et al. 2015), oxycodone (Chiaia et 
al. 2008, Heuett et al. 2015), and heroin (Heuett et al. 2015) being recorded. Despite the 
recent drastic increase in fentanyl-related deaths (CDC and University 2017), U.S. studies 
on the occurrence in wastewater of fentanyl are thus far lacking. Furthermore, small U.S. 
communities have been significantly impacted by the opioid crisis due to additional 
circumstances which do not impact larger communities, such as: outdated substance 
abuse infrastructure, shortages in emergency medical technician (EMT) personnel, long 
travel times of the same, lack of regional coordination, lack of physicians administering 
programs on substance abuse and medication-assisted treatment, and various 
administrative barriers (Hancock et al. 2017). Some of these locations have also been 
identified as areas with strikingly high opioid prescription rates compared to the number 
of residents within the service area (Whitaker 2017). Therefore, the objective of the 
present study was to examine opioid abuse trends in two moderately sized (<200,000 
population) cities in the American Midwest, a U.S. region that has experienced the 
highest percentage increase of reported fentanyl abuse from 2014-2015 (CDC 2016). 
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Analytes investigated included morphine, morphine-3-glucuronide, codeine, norcodeine, 
oxycodone, noroxycodone, fentanyl, norfentanyl, heroin, and 6-acetylmorphine. The 
main objectives of the study were to: (i) obtain the first wastewater monitoring data for 
U.S. fentanyl use prevalence, (ii) to generate for participating municipalities wastewater-
based data on opioid use prevalence for informed decision making, and (iii) to benchmark 
estimated opioid consumption to other previously published wastewater epidemiological 
literature. 
4.2 Materials and Methods 
4.2.1 Study locations and wastewater sampling methods 
 Raw wastewater arriving at central treatment plants in two Midwestern U.S. cities 
was collected in 24-hour time-weighted composites using automated samplers by WWTP 
personnel from March 2015 to March 2017. The WWTP of City 1 serves an approximate 
130,000 residents, while that of City 2 serves an approximate 45,000 residents. The 
median age of residents was similar across both cities (City 1: 34.1 years; City 2: 37.1 
years), and age distribution also was similar across both cities (Appendix C: Table 7). 
The percentage of white residents (City 1: 57%; City 2: 86.9%) and African Americans 
(City 1: 34.5%; City 2: 2.7%) varied across cities, but all other racial demographics were 
similar. Unemployment rate (City 1: 8.3%; City 2: 3.7%) and per capita income per year 
(City 1: $14,500; City 2: $29,400) also varied between cities. Average household size, 
homeowner vacancy rate, and rental vacancy rate were also similar across both cities 
(USCB 2010). Both cities feature a sewer system designed to separate municipal 
wastewater from stormwater inputs. Both climate range and reported water use per 
resident were similar across both participating cities. Sampling occurred on one day per 
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month during the 24-month study period; the day of collection varied and was entirely at 
the discretion of sampling personnel. Samples were stored in polyethylene terephthalate 
(PET) bottles and shipped to Arizona State University in Styrofoam shipping containers 
containing either ice or dry ice. Upon receipt, samples were stored at -20°C until analysis. 
4.2.2 Target analytes 
 Five parent opioids and their respective metabolites were monitored in raw 
wastewater. The investigated opioids were morphine (MOR), its major metabolite 
morphine-3-glucuronide (M3G), codeine (COD), its major metabolite norcodeine 
(NCOD), oxycodone (OXY), its major metabolite noroxycodone (NOXY), fentanyl 
(FENT), its major metabolite norfentanyl (NFENT), heroin (HER), and its minor but 
exclusive metabolite 6-acetylmorphine (6-AM). High purity (>97%) standard solutions of 
the target compounds originated from Sigma Aldrich (Milwaukee, WI) and were 
prepared by Cerilliant (Round Rock, TX, USA) as solutions in methanol or acetonitrile. 
Five deuterated compounds, one for each of the parent opioid target compounds were 
also purchased from Cerilliant for use as internal standards for quantification, namely: 
heroin-d9 (HER-d9), morphine-d6 (MOR-d6), codeine-d6 (COD-d6), oxycodone-d3 (OXY-
d3), and fentanyl-d5 (FENT-d5).  
4.2.3 Isotope dilution liquid chromatography tandem mass spectrometry (ID-LC-
MS/MS) 
 Briefly, 200 mL of raw wastewater was loaded onto Oasis HLB 150 mg cartridges 
(Waters, Barcelona, Spain) at a rate of 1.5 mL/min to determine the analytes measured in 
positive ionization (PI) mode. Prior to extraction, all wastewater samples were spiked 
71 
 
with a standard mixture of the deuterated compounds at a concentration of 5 ng/mL for 
HER-d9, MOR-d6, COD-d6, OXY-d3, FENT-d5. After samples were loaded, cartridges 
were washed with water at a rate of 5 mL/min for five minutes and dried under a stream 
of nitrogen gas for 10 minutes. Slow, drip-wise elution of analytes from the solid phase 
extraction cartridges was accomplished using 4 mL of a 50:50 mixture of acetone and 
methanol containing 0.5% formic acid.  
 Mass spectrometric analyses were carried out on an API 4000 instrument 
(Applied Biosystems, Framingham, MA, USA), coupled to a Shimadzu Prominence 
HPLC (Shimadzu Scientific Instruments, Inc., Columbia, MD, USA) that was controlled 
by Analyst 1.5 software (Applied Biosystems, Framingham, MA, USA). 
Chromatographic separation was achieved with a Symmetry C18 3.5 µm by 6.4 mm by 75 
mm analytical column that was preceded by a guard column of the same material, both 
supplied by Waters (Massachusetts, USA), and a mobile phase consisting of gradient 
methanol/water with 0.2% formic acid at a 0.4 mL/min flow rate. Analytes were 
introduced into the mass spectrometer using an electrospray ionization probe operating in 
positive mode. Multiple reaction monitoring (MRM) was used for qualitative analysis 
(Appendix C: Table 8).  
4.2.4 Analyte concentrations in raw wastewater and mass loads 
Parent opioid compounds were selected as indicators of drug consumption in 
samples collected over the course of the sampling campaign, lasting from March 2015 to 
March 2017. Starting in June 2016, metabolite compound concentrations also were 
tracked as indicators of drug consumption until the end of the monitoring program in 
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March 2017. Potential loss of opioids and metabolites from wastewater during sample 
extraction was corrected for by using labeled internal standards and the isotope dilution 
method. Opioid mass loadings to the WWTP were calculated from concentration data for 
daily wastewater flows using equation 4: 
𝑀𝑎𝑠𝑠 𝐿𝑜𝑎𝑑 (
𝑚𝑔
𝑑𝑎𝑦
) = 𝑅𝑎𝑤 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
𝑛𝑔
𝐿
) ∗ 𝐹𝑙𝑜𝑤 (
𝐿
𝑑
) ∗ (
1 𝑚𝑔
1,000,000 𝑛𝑔
)          Eq. 4 
4.2.5 Estimation of mass and dose per-capita opioid consumption 
Estimates of drug consumption were obtained by normalizing the mass load of 
opioids to the population serviced by the WWTP and were subsequently subjected to a 
correction factor which accounts for metabolic excretion of the compounds and the molar 
mass ratio of the indicator compound to the parent opioid (Appendix C: Table 10). For 
mass and dose population normalized values, the following equations were used: 
𝑀. 𝐶. (
𝑚𝑔
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) = 𝑀. 𝐿. (
𝑚𝑔
𝑑𝑎𝑦
) ∗ (
1,000
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
) ∗ 𝐶. 𝐹.                            Eq. 5 
𝐷. 𝐶. (
𝑑𝑜𝑠𝑒
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) = 𝑀. 𝐶. (
𝑚𝑔
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) ∗ 𝐷𝑜𝑠𝑒 (
𝑑𝑜𝑠𝑒
𝑚𝑔
)                             Eq. 6 
Where M.C. refers to mass consumption, D.C. refers to dose consumption, M.L. refers to 
mass load, and C.F. refers to the analyte correction factor. Wastewater epidemiological 
data was then compared to opioid use statistics to estimate the number of opioid users. 
The number of estimated opioid abusers were then compared to national opioid use 
statistics. Per the National Drug Intelligence Center’s report on Heroin Consumption in 
the United States (NDIC 2000), average daily use of pure heroin mass was assumed to 
equal 50 mg/day per user. Prescription opioid mass use was obtained from Mayo Clinic 
prescription guidelines at an ingestion rate of two doses per day, equaling 60 mg/day for 
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morphine, 60 mg/day for codeine, and 20 mg/day for oxycodone (Mayo 2017). Since 
unknown exposure to fentanyl is thought to drive the increase in fentanyl use (CDC and 
University 2017) it is difficult to estimate the average dose a recreational user may 
receive. Therefore, fentanyl was omitted from this portion of the analysis. 
4.2.6 Overdose-death and black-market value estimates 
A ratio between opioid related overdose deaths and overdoses (Appendix C: 
Table 11) was computed from various state reported data (AZDHS 2017, CCPDAP 2017, 
MNDH 2017, OHA 2017, RIPO 2017, VDH 2017). The average of this ratio (5.35 
overdoses/death) was then compared to current data on national opioid overdose death 
rates (total 2015 opioid deaths: 33,091; total 2015 heroin deaths: 13,000; total 2015 
synthetic opioid deaths: 20,091) (CDC 2017) and U.S. opioid abuse prevalence (heroin: 
3.8 million (Martins et al. 2017); prescription opioids: 11.5 million (Thompson 2017)) to 
estimate the number of deaths and overdoses that may be attributable to the addicted 
population of the two test cities. From these numbers it was estimated that one thousand 
estimated daily heroin users account for 3.4 heroin overdose deaths and 18.3 heroin 
related overdoses. One thousand estimated daily synthetic opioid users account for 1.8 
synthetic opioid overdose deaths and 9.4 synthetic opioid related overdoses. The black-
market value of heroin was calculated by comparing the observed mass load of heroin to 
its street value (NBC 2017). Furthermore, the following assumptions were factored into 
every portion of the study analysis: (i) no sewage loss due to leaks or pipe degradation; 
(ii) no transformation or degradation within sewer lines; and (iii) no direct drug addition 
to the sewer system (Zuccato et al. 2008). In most cases, the major drug metabolite was 
selected as the consumption indicator – with the exception of the heroin metabolite 6-
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acetylmorphine, which is a minor but exclusive human metabolite of heroin (Postigo et 
al. 2011).  
4.2.7 Statistical analysis  
Statistical analysis of the data was performed with a combination of Microsoft 
Office suite products, Analyst 1.5 software (Applied Biosystems, Framingham, MA, 
USA), JMP Pro 12.1.0 (SAS, Phoenix, Arizona), and IBM SPSS 25 (IBM, Armonk, NY). 
Normality of the datasets was determined through two analyses run in IBM SPSS 25; (1) 
an analysis of skewness and kurtosis z-values, and (2) the Shapiro-Wilk test for 
normality. Following previously outlined wastewater epidemiological statistical testing 
(Brewer et al. 2016, Tscharke et al. 2016), two-tailed t-tests were used for comparison of 
parent-metabolite excretion rates, as well as opioid concentrations in raw wastewater 
between study locations.  
4.3 Results and discussion 
4.3.1 Method performance 
 Method detection limits (MDLs) for the various opioid parent compounds and 
metabolites ranged between 0.3 and 1.1 ng/L (Appendix C: Table 9, Appendix E), data 
that were in line with previous U.S. studies (Heuett et al. 2015, Subedi and Kannan 
2014). All MDLs were determined based on EPA guidelines described in 40 CFR 136, 
Appendix B (EPA 1986). Potential loss of opioids and metabolites from wastewater 
during sample extraction was corrected for by using labeled internal standards and the 
isotope dilution method. Metabolite loss was assumed to be similar to parent compound 
loss, and therefore loss was calculated from respective parent opioid internal standards. 
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Recoveries from matrix spike experiments for the various analytes averaged 114%. 
Analysis precision, expressed as relative percent difference (RPD) for non-blinded 
duplicates of composite wastewater samples averaged 30%.  
4.3.2 Concentrations of opioids and metabolites in raw wastewater 
 Opioid parent compounds were identified in pooled wastewater samples for each 
city once per month from March 2015 to April 2017 (Fig. 12, Appendix C: Table 12). 
Ratios of concentrations in raw wastewater of the parent drug and its metabolite 
compounds were observed to be similar across both cities (Appendix C: Fig. 20). 
Average concentrations in wastewater of heroin, fentanyl and their respective metabolites 
were not statistically different in either city (p=0.05), and the metabolites norfentanyl and 
6-acetylmorphine were both detected at a higher frequency than their respective parent 
compounds (Table 2). In both cities, concentrations of the fentanyl metabolite 
norfentanyl were significantly larger (2-times and 48-times) than the corresponding 
concentrations of parental fentanyl, a finding that potentially could be due to the 
previously observed rapid in vivo degradation and transformation following 
administration (Labroo et al. 1997). Average concentrations in raw wastewater of codeine 
(p<<0.001), oxycodone (p<<0.001), and their respective metabolites norcodeine 
(p=0.002) and noroxycodone (p=0.04) were all statistically different across cities with 
similar detection frequencies for both parent and metabolite compounds. Average 
concentrations of codeine were higher in City 1 compared to City 2, but interestingly 
average oxycodone concentrations in wastewater from City 2 were higher than those 
observed in City 1. 
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Fig. 12. Parent opioid concentrations determined in 24-hour time-weighted composite 
wastewater samples for the two cities over the sampling campaign from March 2015 to 
April 2017. Non-detects are represented by empty symbols within the graph. 
 
Morphine concentrations in City 1 were significantly higher (p<0.001) than those 
observed in City 2, but interestingly the metabolite compounds (p=0.644) did not follow 
this same trend. Morphine presence in wastewater can be attributed to consumption of 
morphine (Hasselström and Säwe 1993), consumption of heroin (Cone et al. 1993), 
consumption of codeine (Vree and Wissen 1992), or as result of narcotic disposal 
(Daughton and Ruhoy 2009). Further analyte degradation (Skopp et al. 2001) and 
metabolization in the sewer system is likely and may influence parent-metabolite ratios 
(O’Brien et al. 2017). The discrepancy between the morphine parent and metabolite 
concentrations in raw wastewater suggest that the morphine concentrations are influenced 
by one of the alternative sources of morphine occurrence in wastewater and may point to 
illicit drug use. 
 
77 
 
Table 2 - Detection frequency, average analyte concentrations in raw wastewater ± 
standard deviations (SD), and maximum concentrations per opioid consumption indicator 
of all sample concentrations. 
Consumption Indicator 
Frequency of 
Detection (%) 
Concentration (ng/L) 
Average + SD Max. 
Morphine 100 (n=45) 514 ± 268 1,304 
Morphine-3-glucuronide 90 (n=21) 7.3 ±6.6 26 
Codeine 93 (n=45) 218 ± 154 571 
Norcodeine 95 (n=21) 107 ± 90 397 
Oxycodone 100 (n=45) 47 ± 52 251 
Noroxycodone 100 (n=21) 88 ± 34 171 
Fentanyl 62 (n=45) 1 ± 0.9 4.4 
Norfentanyl 100 (n=21) 38 ± 49 198 
Heroin 81 (n=21) 27 ± 30 120 
6-Acetylmorphine 100 (n=21) 32 ± 28 115 
  
Most opioids show a relatively consistent concentration pattern when compared 
over the two-year period. An exception of this is the dataset obtained for City 2 codeine 
concentrations from March 2015 – January 2016 where concentrations varied from 260 
ng/L to below the method detection limit. This variation was not observed from June 
2016 to March 2017 for City 2, but this observation lacks a definitive explanation. 
Results of t-tests comparing analyte concentrations in raw wastewater were confirmed by 
applying t-tests on converted mass loads (Appendix C: Table 13). Converting analyte 
concentrations in raw wastewater (ng/L) to mass loads (g/day) provides additional insight 
into consumption within a sampling population and allows the data to be used for 
population normalization and additional modeling.  
4.3.3 Estimated opioid consumption 
Opioid consumption was estimated from opioid mass loads and determined to be 
stable throughout the sampling campaign for all opioids (Appendix C: Table 15) aside 
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from City 1’s oxycodone consumption which showed a statistically significant increase 
(565%, p-value: <0.01) from the March 2015 – Jan 2016 to the June 2016 – March 2017 
sampling periods. Per-capita opioid consumption masses were then compared to 
pharmacokinetic excretion correction factors (Labroo et al. 1997, Lafolie et al. 1996, 
Lalovic et al. 2006, Postigo et al. 2011) and dosage guidelines (Mayo 2017) for both 
parent and metabolite compounds in order to obtain dose-estimated use rates (Appendix 
C: Table 16). Analysis of the parent opioids suggests that morphine consumption is likely 
higher than codeine or oxycodone consumption within these two cities (Appendix C: 
Table 14). Estimated morphine consumption values were in-line with other U.S. 
estimates (range: 1,610-2,240 mg/day/1,000 persons) (Subedi and Kannan 2014) but 
higher than consumption estimates outside the United States (range: 13.8-310 
mg/day/1,000 persons) (Baker et al. 2014, Baz-Lomba et al. 2016, Tscharke et al. 2016, 
Vuori et al. 2014, Zuccato et al. 2008). Estimated morphine consumption from morphine-
3-glucuronide was lower than other U.S. estimates, but in line with studies conducted 
outside the U.S. This discrepancy likely points to the influence of codeine and heroin use 
on wastewater morphine concentrations (Cone et al. 1993, Cone et al. 1991b), and further 
solidifies the idea that a stable morphine metabolite would be preferable for morphine 
consumption estimations.  
79 
 
 
Fig. 13. Estimation consumption values for codeine, oxycodone and fentanyl derived 
from opioid parent compound analysis. Populations were estimated by population served 
by the wastewater treatment plants, and correction factors used are listed in Table 2. 
Codeine consumption estimated from parent codeine was 2-times higher in City 1 
compared to City 2, and oxycodone consumption estimated from parent oxycodone was 
nearly 8-times higher in City 2 compared to City 1. When compared to U.S. studies, 
oxycodone consumption estimates for City 1 (U.S. range: 8-170 mg/day/1,000 persons) 
(Chiaia et al. 2008) were in-line with other U.S. consumption estimates, but estimates for 
City 2 were significantly higher than reported values in other U.S. studies. When 
compared to international studies, oxycodone consumption estimates were higher across 
both cities (international range: 20-50.5 mg/day/1,000 persons), but codeine consumption 
estimates were in-line with international studies (international range: 164-927 
mg/day/1,000 persons) (Tscharke et al. 2016, Vuori et al. 2014). Using norcodeine for 
consumption estimation purposes resulted in higher codeine consumption estimations 
across both cities (approximately 8-times higher) compared to parent codeine, which 
resulted in U.S. consumption estimation exceeding international values. This observation 
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was not mirrored with the noroxycodone:oxycodone relationship, as both values provided 
similar results (relative percent difference: 53-60%).   
Heroin consumption estimates obtained from the metabolite 6-acetylmorphine 
were between 10 to 281 times higher than other estimated consumption values obtained 
from literature (range: 4.6-115 mg/day/1,000 population) (Heuett et al. 2015, Tscharke et 
al. 2016). This suggests that the scope of heroin abuse within these two midwestern cities 
may exceed both international and U.S. abuse rates. While comparison literature for U.S. 
fentanyl consumption is lacking, the estimated consumption unearthed by this analysis 
are still considerably higher than the average fentanyl consumption of 0.5 mg/day/1,000 
persons identified in Adelaide, South Australia (Tscharke et al. 2016).  While fentanyl 
concentrations were consistently the lowest of any analyte detected in this study, any 
detectable presence of synthetic fentanyl or its analogs should be considered significant 
due to the strength of the opioid (Donner et al. 1996), its prevalence in opioid-related 
fatalities (CDC and University 2017), and its ties to the illicit drug trade (CDC 2016). 
Furthermore, this study has provided the first U.S. wastewater concentrations for fentanyl 
and its metabolite norfentanyl – which is necessary for comparison purposes of future 
U.S. opioid-related wastewater epidemiological work. 
4.3.4 User count, estimated overdose-deaths, and monetary black-market contribution 
 The number of heroin addicts within the two study locations were estimated at 
3,400 (city 1) and 1,000 (city 2) persons. Considering the national average of 0.21% 
current habitual heroin users (SAMHSA 2013) these values are 1,135% and 982% higher 
than the calculated expectancy. These values were 61% and 41% higher than the national 
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average of lifetime heroin use of 1.6% (Martins et al. 2017). This suggests that current 
estimates of heroin use prevalence may be an underestimate of the true value. The 
number of codeine users were determined to be 3,600 (city 1) and 600 (city 2) persons. 
Oxycodone users were determined to be 800 (city 1) and 660 (city 2) persons. Number of 
morphine users estimated from parent morphine were determined to be 5,600 (city 1) and 
1,500 (city 2) persons but does not account for morphine occurrence due to heroin or 
codeine consumption.  
 The number of estimated heroin users were compared to state opioid overdose 
death data to estimate the number of expected heroin and prescription opioid overdoses. 
From this analysis 12 heroin attributable deaths, 62 attributable heroin overdoses, 18 
synthetic opioid attributable deaths, and 94 synthetic opioid attributable overdoses were 
estimated for City 1. City 2 was estimated to incur 4 heroin attributable deaths, 18 
attributable heroin overdoses, 5 synthetic opioid attributable deaths, and 26 synthetic 
opioid attributable overdoses. When compared to reported coroner data, the estimated 
attributable death counts of both cities were within 30% of the true number identifying a 
correlation between the statistics unearthed through this analysis and municipal data. A 
cost estimate for black-market heroin consumption was also attempted for the two cities, 
with the average street value of heroin estimated to be $240/gram (NBC 2017). This 
analysis resulted in annual black-market contributions of $1.14 million (city 1) and $990 
thousand (city 2) from heroin users. These estimates may be overly conservative, as a city 
with 100,000 individuals and a 0.21 addict rate could theoretically exceed an annual 
black-market contribution of 11.5 million USD from heroin alone. Cost estimations for 
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the remainder of the opioids were not attempted due to uncertainties with rates of medical 
vs. nonmedical use, and uncertainties in pharmaceutical vs. black market costs. 
4.3.5 Study Limitations 
 While narcotic use and trend data collection via wastewater monitoring has been 
shown a viable tool both domestically and internationally (Baker et al. 2012, Kankaanpää 
et al. 2014, Subedi and Kannan 2014), there are shortcomings which factor in a level of 
uncertainty within the analysis. The most robust data that can be obtained from 
wastewater monitoring are analyte concentrations in raw wastewater (mass per volume) 
and daily mass loads (mass per day).  These sources of data are not subject to significant 
error but also limit the knowledge that can be obtained from the dataset without further 
analysis. Previous literature has reported WBE data through usage statistics (in mass or 
doses per day per population) (Lai et al. 2013, Zuccato et al. 2008), monetary units (black 
market or overall economic impact) (Zuccato et al. 2011), and health statistics 
(attributable users, overdoses, or overdose deaths) (Terzic et al. 2010), but these analyses 
likely increase the associated error. Variations in individual narcotic mass usage 
(Harocopos et al. 2016, Warner et al. 2016), pharmacokinetic metabolization and narcotic 
excretion rates (Andes and Craig 2002, Cone et al. 1993, Jenkins et al. 1994, Schwartz 
2003), and the extent of in-sewer analyte degradation and/or metabolization (Postigo et 
al. 2011) can have a marked effect on estimating drug use statistics from WBE data. 
Analysis of specific narcotics with various limiting factors such as low urinary and fecal 
excretion profiles or rapid in/ex vivo degradation may provide additional challenges for 
the quantification of certain narcotics in wastewater.  
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 The use of time-weight samplers and the sampling frequency used in this study 
also constitutes limitations. The use of time-weighted sampling will not account for the 
diurnal wastewater flow patterns which could result in an underrepresentation of narcotic 
concentrations in raw wastewater. Due to budgetary constraints participating WWTP 
operators opted to sample for one 24-hour period per month. While this frequency of 
sampling can provide insights into long-term trends and baseline usage patterns obtaining 
more intricate trend analyses of the data (i.e. variation in weekly use trends) is not 
possible. An ideal study would sample for a set number of consecutive days throughout a 
longer timeframe to obtain data for both short and long-term drug use trends, and 
administration of self-reporting surveys for comparison purposes (Heuett et al. 2015, 
Moore et al. 2014). Large relative percent differences observed for some samples as well 
as increase in parent oxycodone observed for City 1 between the two sampling 
campaigns could have been impacted by errors in sample collection and processing, and 
possibly the hydrophobicity of the target analytes. While these factors contribute a level 
of uncertainty in this analysis data derived from these methods should still be considered 
a powerful analytical tool and considered alongside additional viable methods of data 
collection that are currently implemented within municipal communities. 
4.4 Conclusion 
 The results of this study indicate that the higher opioid consumption in the United 
States is reflected in the higher opioid analyte concentrations observed in U.S. 
wastewaters, which have produced some of the highest opioid consumption estimations 
presented in WBE literature. While many methods have been implemented to track U.S. 
opioid use (Cicero et al. 2015, Dart et al. 2015, Kolodny et al. 2015) the WBE process 
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can complement current procedure by providing an additional analysis tool capable of 
producing data in near-real time. It is likely that specific opioid use varies between these 
two cities despite similar population demographics. Because of this observation it is 
reasonable to assume that estimating drug use for a population by forecasting data 
obtained from national statistics or data obtained from another sampling location may not 
be sufficient. Implementing WBE monitoring within a community requires minimal 
adjustment to wastewater infrastructure but would result in pertinent information related 
to opioid use. This study also provides the first reported U.S. occurrence of fentanyl and 
its metabolite norfentanyl in wastewater in published literature. These analytes were 
found in higher concentration and more frequently than in international studies which is 
likely due to the known increase in U.S. fentanyl use (CDC 2016, CDC and University 
2017). Screening for fentanyl and its metabolites should be viewed as a mandatory 
practice in future U.S. WBE studies due to the association between fentanyl and the rise 
in opioid-related fatalities in the United States (Warner et al. 2016). WBE results could 
be further used to forecast opioid-related overdose and deaths attributable to a measurable 
concentration of drug analyte within wastewater. While the WBE process may be subject 
to some uncertainty the technology remains a valuable analytical tool to be used 
alongside current data acquisition approaches by providing location specific wastewater-
based epidemiological data in near real-time.  
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TRANSITION 4 
 The two communities studied in Chapter 4 were both identified with higher rates 
of estimated opioid consumption compared to previously published international 
literature, but specific opioid use varied between communities. While this observation 
could be attributed to the likely variation in drug consumption between communities it 
could have also been impacted by known limitations associated with WBE when working 
at the city scale. Some of these limitations, such as analyte degradation and 
transformation in-sewer, could theoretically be reduced through sampling methods which 
reduce the long sewage transit time from the originating source to the wastewater 
treatment plant. Sampling within the sewershed would likely produce the most robust 
data extractable from community wastewater analysis for a sub-population or location 
serviced by a municipal wastewater treatment system.  
 In Chapter 5, a targeted wastewater sampling campaign was conducted at 
southwestern U.S. university for the identification of twelve prescription and illicit drugs 
in wastewater: morphine, codeine, oxycodone, fentanyl, diacetylmorphine (heroin), 
methadone, buprenorphine, amphetamine, methylphenidate, alprazolam, 
benzoylmethylecgonine (cocaine), and methylenedioxymethamphetamine 
(MDMA/Ecstasy). Seven consecutive 24-hour flow-weighted composite wastewater 
samples were collected once per month. Data analysis was completed in the same method 
presented in Chapter 4, and estimated consumption values were compared to related U.S. 
and international literature, as well as four similar U.S. campus studies. Two-tailed t-tests 
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on mass load calculations were also completed to identify differences between weekday 
and weekend narcotic use. 
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CHAPTER 5 
 
APPLICATION OF WASTEWATER-BASED EPIDEMIOLOGY TRACKING 
NARCOTIC USE AT A SOUTHWESTERN U.S. UNIVERSITY 
ABSTRACT 
College-aged adults in the United States have been identified with the highest rates of 
drug abuse across all age categories but data collection for this age demographic relies 
heavily on self-reported surveys. Urban metabolism metrology using wastewater 
diagnostics potentially offers access to near real-time data on narcotic consumption but 
thus far has seen little application at U.S. universities. Furthermore, narcotic elimination 
half-lives which could have a marked effect on WBE results are often overlooked in the 
method development stages of WBE processes. From August 2017 to December 2017, 
seven consecutive 24-hour flow- or time-weighted composites of municipal raw 
wastewater were analyzed once per month from a Southwestern U.S. university using 
isotope dilution liquid chromatography tandem mass spectrometry. Estimated narcotic 
consumption (mg/day/1,000 persons) exceeded most U.S. and international WBE 
consumption estimates for the general population and were highest for cocaine (470 ± 
42), heroin (474 ± 32), amphetamine (302 ± 14) and methylphenidate (236 ± 28). Aside 
from attention deficit/hyperactivity disorder medication estimated narcotic consumption 
and analyte detection frequency exceeded previously reported values from related U.S. 
campus literature. This campus-based U.S. screening study of narcotic analytes in 
wastewater yielded (1) sporadic but detectable campus-wastewater concentrations for the 
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powerful synthetic opioid fentanyl, and (2) the first study to consider drug analyte 
elimination half-life within method development. 
5.1 Introduction 
 College-aged adults (ages 18-22) have historically been identified with the highest 
percentage of drug abuse compared to other age categories with 24-28% of respondents 
to a 2016 survey admitting to illicit drug use within the past 30 days (Schulenberg et al. 
2017). While 48% of high school respondents to the same survey reported trying at least 
one illicit drug in their lifetime prevalence of drug use has been shown to be higher for 
those in their 20s indicating that drug use initiation continues for many individuals 
throughout the ages of 18-29 (Schulenberg et al. 2017). Americans between the ages of 
15-24 have seen some of the lowest rates of overdose death (4-10 deaths per 100,000 
population) across all age categories from 2000-2016, but the subsequent age group (25-
34 years) has been identified with the highest number of drug overdose deaths in 2016 
(35+ deaths per 100,000 population) (Hedegaard et al. 2017). This observation may be 
partially explained through drug-related associative learning where drug seeking habits 
are sustained later in life while the subjective effects that initially encouraged the drug 
use diminish (Robbins and Everitt 1999). Continued neurological development in the 
early 20s (Giedd et al. 1999) coupled with changes in brain chemistry due to drug use 
(Squeglia et al. 2009) may have a marked effect on this demographic group. 
 Addressing substance abuse within college-aged adults should be viewed as a 
principal task – but understanding the scope of abuse within this age category is met with 
significant difficulty.  Current data analysis involves a combination of population 
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surveys, crime statistics, medical records and narcotic seizure data (Zuccato et al. 2008), 
but these analyses provide data on previous years and may not adequately capture the 
current state of drug use. The costly and cumbersome procedures may also induce 
unintentional bias into studies through misrepresentation in self-reporting surveys 
(Zuccato et al. 2008). First proposed in 2001 (Daughton 2001) wastewater-based 
epidemiology (WBE) has been shown as a viable alternative to current narcotic data 
collection methods (Zuccato et al. 2005), and has been applied worldwide to obtain 
narcotic abuse statistics in near-real time for varying population sizes (Kankaanpää et al. 
2014, Kim et al. 2015, Lai et al. 2013, Postigo et al. 2011). This idea has been further 
expanded under the umbrella of urban metabolism metrology (UMM), which examines 
multiple environmental matrices to estimated health statistics for a population or area of 
interest. Analysis of time- or flow-weighted composite wastewater treatment plant 
(WWTP) samples may provide a unique epidemiological insight as consumption statistics 
could theoretically be obtained for any commonly consumed product within a population 
(Dove 2006) if target analyte properties are favorable for WBE testing. Sampling for 
wastewater epidemiological analyses generally focus at the inlet point of the WWTP to 
obtain statistics related to the population served by the WWTP (Kankaanpää et al. 2014, 
Kim et al. 2015, Terzic et al. 2010), but the technique has also been applied to obtain 
similar information for smaller population sizes such as college campuses (Burgard et al. 
2013, Heuett et al. 2015, Moore et al. 2014) or prisons (Brewer et al. 2016, Postigo et al. 
2011).  
 Application of urban metabolism metrology has seen limited application in the 
United States (Subedi and Kannan 2014). To the authors’ knowledge four studies have 
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applied UMM technology at sampling points local to U.S. college campuses to obtain 
drug use statistics. Two of these studies were primarily interested in quantifying non-
medical ADHD prescription drug use (Burgard et al. 2013, Moore et al. 2014), while the 
latter two studies screened for a wider suite of illicit and prescription drugs including: 
amphetamines, opioids, cocainics, cannabinoids, and lysergics (Heuett et al. 2015, 
Panawennage et al. 2011). None of these studies screened for the potent synthetic opioid 
fentanyl, despite its known association with increasing overdose rates and fatalities from 
drug abuse (Rudd 2016). These studies typically focus on a single university and thus are 
limited in their generalizability due to the social, economic, and circumstantial factors 
that cause variation in drug use across different locations (Harocopos et al. 2016, Warner 
et al. 2016). Therefore the main objectives of the present study were to: (i) develop a 
demographic-targeted liquid chromatography-tandem mass spectrometry UMM method 
for the detection of 12 drugs of abuse including some of their known metabolites in a 
university setting, (ii) obtain the first wastewater monitoring data for prevalence of 
fentanyl use in a university setting where the contributing population is predominantly 
college-aged adults, and (iii) assess and quantify potential consumption of targeted 
prescriptions and illicit narcotics within the campus population. 
5.2 Materials and methods 
5.2.1 Study location and methods of wastewater sampling 
Seven (7) consecutive 24-hour flow-weighted wastewater samples were collected 
using automated samplers once per month from August 2017 to December 2017 from 
two sampling locations capturing 100% of campus-borne sewage. Sampling location 1 
accounted for approximately 95% of the total campus-borne wastewater while sampling 
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location 2 accounted for approximately 5% of the total flow. The sewershed contributing 
population for both locations ranged between approximately 15,000 to 60,000 persons 
depending on the day of sampling. Mean age (26.5 years) of the catchment population 
was estimated by comparing average age of the population from years with available age 
data (2004-2009). Of the student population, approximately 53.6% of students are male 
and 46.4% female. Furthermore, 81.8% of the student population are pursuing an 
undergraduate degree, and 18.2% of students are pursuing a graduate degree. 
Undergraduate ethnicity demographics were as follows: white: 50.5%; Hispanic/Latino: 
21.7%; international: 10.6%; Asian: 6.6%; African American: 4.3%; American Indian: 
1.3%. Graduate ethnicity demographics are as follows: white: 45.5%; Hispanic/Latino: 
10.9%; international: 30.8%; Asian: 4.9%; African American: 3.1%; American Indian: 
1.2%. Population demographics were provided by the participating university. The 
campus features a sewer system designed to separate municipal wastewater from 
stormwater inputs. Ambient temperatures throughout the study period ranged from 3.4-
42.8 ̊C. The average sewage travel distance within the study catchment was estimated to 
be 2,700 m. Sewage retention time in the catchment system was estimated to average 
about 50 minutes but could range between 10-110 minutes depending on travel distance 
and sewer flow conditions (Appendix D: Table 17). Sampling occurred one week per 
month during the five-month study period through a joint effort between the study 
researchers and municipality personnel. Samples were stored in polyethylene 
terephthalate (PET) bottles for transport and storage and immediately processed through 
solid phase extraction upon receipt by laboratory personnel. Remaining samples and 
concentrated sample extracts were stored at -20°C until analysis. 
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5.2.2 Target analytes 
 Ten parent prescriptions and illegal narcotics and nine (9) metabolites were 
monitored in raw wastewater collected from two sampling locations on university 
campus accounting for a majority of campus-borne wastewater. The investigated drugs 
were morphine’s major metabolite morphine-3-glucuronide (M3G), codeine (COD), its 
major metabolite norcodeine (NCOD), oxycodone (OXY), its major metabolite 
noroxycodone (NOXY), fentanyl (FENT), its major metabolite norfentanyl (NFENT), 
heroin (HER), its minor but exclusive metabolite 6-acetylmorphine (6-AM), methadone’s 
major metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 
buprenorphine (BUP), its metabolite norbuprenorphine (NBUP), amphetamine (AMP), 
methylphenidate (MPH), alprazolam (ALP), its metabolite α-OH-alprazolam (OH-ALP), 
cocaine (COC), its metabolite benzoylecgonine (BZE), and 3,4-methylenedioxy-
methamphetamine (MDMA). High purity (>97%) standard solutions of the target 
compounds originated from Sigma Aldrich (Milwaukee, WI) and were prepared by 
Cerilliant (Round Rock, TX, USA) as solutions in methanol or acetonitrile. 18 deuterated 
compounds, one for each of the parent opioid target compounds were also purchased 
from Cerilliant for use as internal standards (IS) for quantification, namely: heroin-d9 
(HER-d9), codeine-d6 (COD-d6), oxycodone-d3 (OXY-d3), fentanyl-d5 (FENT-d5), 
buprenorphine-d4 (BUP-d4), amphetamine-d6 (AMP-d6), methylphenidate-d9 (MPH-d9), 
alprazolam-d5 (ALP-d5), cocaine-d3 (COC-d3), 3,4-methylenedioxy-methamphetamine-d5 
(MDMA-d5), morphine-3-glucuronide-d3 (M3G-d3), noroxycodone-d3 (NOXY-d3), 
norcodeine-d3 (NCOD-d3), 6-acetylmorphine-d3 (6AM-d3), 2-ethylidene-1,5-dimethyl-
3,3-diphenylpyrrolidine-d3 (EDDP-d3), norbuprenorphine-d3 (NBUP-d3), α-OH-
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alprazolam-d5 (OH-ALP-d5), and benzoylecgonine-d8 (BZE- d8). Instrument analyte loss 
for norfentanyl was estimated from fentanyl-d5.   
5.2.3 Isotope dilution liquid chromatography tandem mass spectrometry (ID-LC-
MS/MS) 
 Briefly, 200 mL of raw wastewater was loaded onto Oasis HLB 150 mg cartridges 
(Waters, Barcelona, Spain) at a rate of 1.5 mL/min to determine the analytes measured in 
positive ionization (PI) mode. Prior to extraction, all wastewater samples were spiked 
with a standard mixture of the deuterated compounds at a concentration of 5 ng/mL for 
HER-d9, COD-d6, OXY-d3, FENT-d5, BUP-d4, AMP-d6, MPH-d9, ALP-d5, COC-d3, 
MDMA-d5, M3G-d3, NOXY-d3, NCOD-d3, 6AM-d3, EDDP-d3, NBUP-d3, OH-ALP-d5, 
and BZE-d8. After samples were loaded, cartridges were washed with D.I. water at a rate 
of 5 mL/min for five minutes and dried under a stream of nitrogen gas for 10 minutes. 
Slow, drip-wise elution of analytes from the solid phase extraction cartridges was 
accomplished using 4 mL of a 50:50 mixture of acetone and methanol containing 0.5% 
formic acid.  
 Mass spectrometric analyses were carried out on an API 4000 instrument 
(Applied Biosystems, Framingham, MA, USA), coupled to a Shimadzu Prominence 
HPLC (Shimadzu Scientific Instruments, Inc., Columbia, MD, USA) that was controlled 
by Analyst 1.5 software (Applied Biosystems, Framingham, MA, USA). 
Chromatographic separation was achieved with a Symmetry C18 3.5 µm by 6.4 mm by 
75 mm analytical column that was preceded by a guard column of the same material, both 
supplied by Waters (Massachusetts, USA), and a mobile phase consisting of gradient 
94 
 
methanol/water with 0.2% formic acid at a 0.4 mL/min flow rate. Analytes were 
introduced into the mass spectrometer using an electrospray ionization probe operating in 
positive mode. Multiple reaction monitoring (MRM) was used for qualitative analysis 
(Appendix D: Table 18). 
5.2.4 Analyte concentrations in raw wastewater and mass loads 
 Screened parent and metabolite narcotic compounds were all examined as 
potential indicators of drug consumption in samples collected over the course of the 
sampling campaign, lasting from August 2017 to December 2017. Potential loss of 
opioids and metabolites from wastewater during sample extraction was corrected for by 
using labeled internal standards and the isotope dilution method. Narcotic mass loadings 
within the study sewer catchment system were calculated from analyte concentrations in 
raw wastewater (in units of ng/mL) for daily wastewater flows provided by the city 
municipality using equation 7: 
𝑀𝑎𝑠𝑠 𝐿𝑜𝑎𝑑 (
𝑚𝑔
𝑑𝑎𝑦
) = 𝑅𝑎𝑤 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
𝑛𝑔
𝐿
) ∗ 𝐹𝑙𝑜𝑤 (
𝐿
𝑑
) ∗ (
1 𝑚𝑔
1,000,000 𝑛𝑔
)           Eq. 7 
5.2.5 Estimation of mass per-capita narcotic consumption 
Estimates of drug consumption were obtained by normalizing the mass load of 
narcotics to the estimated contributing population and were subsequently subjected to a 
correction factor which accounts for metabolic excretion of the compounds and the molar 
mass ratio of the indicator compound to the parent opioid (Appendix D: Table 18). 
Number of contributing individuals was estimated through wastewater flow, and 
concentrations of caffeine, paraxanthine, and nicotine in raw wastewater. Population 
estimates from wastewater flow were obtained using design standards outlined in the 
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Arizona Department of Environmental Quality – Water Pollution Control design manual 
through equation 8: 
𝐶. 𝐼. (𝑝𝑒𝑟𝑠𝑜𝑛𝑠) =
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐹𝑙𝑜𝑤
(80 𝐺𝑃𝑀)(𝐿.𝐶.)+(20 𝐺𝑃𝑀)(𝑂.𝐶.)
                                                                Eq. 8 
Where C.I. refers to the number of contributing individuals (in persons), L.C. refers the 
fraction of total population living on campus, and O.C. refers to the fraction of total 
population living off campus. Population estimates from analyte concentrations assumed 
5.1 mg/day/person for caffeine (FDA 2012, Gracia-Lor et al. 2017), 13.8 mg/day/person 
for paraxanthine (Gracia-Lor et al. 2017), 0.125 mg/day/smoker for nicotine (Hukkanen 
et al. 2005), and 14% smoking prevalence in the population (AZ-DHHS 2016). All 
estimated population values were within the expected population range for the catchment 
(15,000 to 60,000 persons). Mass population normalized values were calculated through 
equations 9 and 10: 
𝑀. 𝐶. (
𝑚𝑔
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) = 𝑀. 𝐿. (
𝑚𝑔
𝑑𝑎𝑦
) ∗ (
1,000
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
) ∗ 𝐶. 𝐹.                                       Eq. 9 
𝐷. 𝐶. (
𝑑𝑜𝑠𝑒
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) = 𝑀. 𝐶. (
𝑚𝑔
𝑑𝑎𝑦∗1,000 𝑝𝑒𝑟𝑠𝑜𝑛𝑠
) ∗ 𝐷𝑜𝑠𝑒 (
𝑑𝑜𝑠𝑒
𝑚𝑔
)                           Eq. 10 
Where M.C. refers to mass consumption, D.C. refers to dose consumption, M.L. refers to 
mass load, and C.F. refers to the analyte correction factor. Wastewater epidemiological 
data was compared to narcotic use statistics to estimate the number of users per narcotic 
of interest. Per the National Drug Intelligence Center’s report on Heroin Consumption in 
the United States (NDIC 2000), average daily use of pure heroin mass was assumed to 
equal 50 mg/day per user. Average cocaine (50 mg/dose) and MDMA (100 mg/dose) 
dose estimates were obtained from relevant human pharmacokinetic studies (Breiter et al. 
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1997, De La Torre et al. 2000). The remainder of prescription mass use was obtained 
from Mayo Clinic prescription guidelines, equaling 30 mg/dose for morphine, 30 
mg/dose for codeine, 10 mg/dose for oxycodone, 30 mg/dose for methadone, 30 mg/dose 
for amphetamine, 30 mg/dose for methylphenidate, and 2 mg/dose for alprazolam (Mayo 
2017). Due to the lack of detection of buprenorphine or its metabolite, these compounds 
were omitted from this portion of the analysis. Since unknown exposure to fentanyl is 
thought to drive the increase in fentanyl use (CDC and University 2017) it is difficult to 
estimate the average dose a recreational user may receive. Therefore, fentanyl was 
omitted from this portion of the analysis. 
5.2.6 Estimation of overdoses, overdose-deaths, and black-market value 
 Based upon the dose analysis, number of users per narcotic were estimated 
through the assumption that 1 user constitutes 2 doses per day. Overdose and overdose-
death analysis for heroin was computed in the same method detailed in chapter 4. The 
black-market value of heroin and cocaine was calculated by comparing the average mass 
of narcotic compound consumption to the “street value” (Kucher 2018, NBC 2017). 
Furthermore, the following assumptions were factored into every portion of the study 
analysis: (i) no sewage loss due to leaks or pipe degradation, (ii) no transformation or 
degradation within sewer lines, and (iii) no direct drug addition to the sewer system 
(Zuccato et al. 2008). 
5.2.7 Statistical analysis 
Statistical analysis of the data was performed with a combination of Microsoft 
Office suite products, Analyst 1.5 software (Applied Biosystems, Framingham, MA, 
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USA), JMP Pro 12.1.0 (SAS, Phoenix, Arizona), and IBM SPSS 25 (IBM, Armonk, NY). 
Normality of the datasets was determined through two analyses run in IBM SPSS 25; (1) 
an analysis of skewness and kurtosis z-values, and (2) the Shapiro-Wilk test for 
normality. Following previously outlined wastewater epidemiological statistical testing 
(Brewer et al. 2016, Tscharke et al. 2016), two-tailed t-tests were used for comparison of 
weekend vs. weekday mass load observations. 
5.3 Results and discussion 
5.3.1 Method performance 
 Method detection limits (MDLs) for the various narcotic parent and metabolite 
compounds ranged between 0.2 to 1.7 ng/L (Appendix D: Table 19, Appendix E), data 
that were in line with previous U.S. studies (Burgard et al. 2013, Heuett et al. 2015, 
Moore et al. 2014, Subedi and Kannan 2014). All MDLs were determined based on EPA 
guidelines described in 40 CFR 136, Appendix B (EPA 1986). Potential loss of narcotics 
and metabolites from wastewater during sample extraction was corrected for by using 
labeled internal standards and the isotope dilution method. Recoveries from matrix spike 
experiments for the various analytes averaged 110%. Analysis precision, expressed as 
relative percent difference (RPD) for non-blinded duplicates of composite wastewater 
samples averaged 7.4%.  
5.3.2 Concentrations of narcotics and metabolites in raw wastewater 
 Concentrations in raw wastewater (ng/mL) for all analytes of interest were 
identified for each sampling location seven consecutive days per month from August 
2017 to December 2017 (Fig. 14, Appendix D: Table 21, Table 22). Analyte 
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concentrations in raw wastewater for heroin, fentanyl, and norfentanyl were detected 
sporadically throughout the sampling campaign while the analytes buprenorphine and 
norbuprenorphine were not detected. The remainder of the analyte concentrations were 
frequently detected in raw wastewater (detection frequency (D.F.)=80%+) at both 
sampling locations with the exception of 6-acetylmorphine (D.F.=30%) and alpha-
hydroxyalprazolam (D.F.=33%) at one sampling location. The fentanyl and norfentanyl 
analytes were detected sporadically throughout the sampling campaign which may point 
to infrequent non-medical fentanyl consumption (CDC 2016, CDC and University 2017). 
No other narcotics considered in this analysis were identified with sporadic patterns 
within the catchment.  
 
Fig. 14 – Box plots of analyte concentrations identified in raw wastewater (ng/L) of all 
analytes detected during the August 2017-December 2017 sampling campaign.  
  Following normalization of the data by wastewater flow data was analyzed 
to determine weekly consumption trends and patterns (Fig. 15, Appendix D: Table 23). 
Data was log-transformed for normality and tested with 2 tailed t-tests to check for 
statistical differences in weekday and weekend narcotic use. Mass loads did not vary 
significantly between weekend and weekday use (p>0.05) for any of the screened opioids 
confirmed through both the parent and metabolite analyses. These findings are similar to 
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previously reported opioid use trends derived from WBE analysis (Kankaanpää et al. 
2014, Postigo et al. 2011, Zuccato et al. 2008). Weekday amphetamine mass loads were 
statistically higher (p<0.001) compared to weekend mass loads, but this trend was not 
observed for methylphenidate (p=0.303). These findings are supported by U.S. WBE 
literature which has identified a correlation between amphetamine (Adderall) use and 
times of high academic stress – for which the same relationship for methylphenidate 
(Ritalin) was not observed (Burgard et al. 2013, Moore et al. 2014).  Weekday 
alprazolam (Xanax) mass loads were statistically higher (p=0.005) than weekend mass 
loads but this same trend was not observed for the metabolite alpha-hydroxyalprazolam 
(p=0.747). Due to the high urinary excretion percentage of alpha-hydroxyalprazolam 
(Fraser et al. 1991) this discrepancy may be explained by in-sewer degradation and 
transformation (O’Brien et al. 2017, Thai et al. 2014). 
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Fig. 15 - Average drug residue mass loads per day and a comparison between weekend 
and weekday mass load occurrence for cocaine (COC), its metabolite benzoylecgonine 
(BZE), and MDMA. Error bars represent the standard error of all measured values for a 
specific day. Weekend comparison was done by a two-tailed t-test (α=0.05). Asterisks 
(**) denote a statistically significant difference between weekday and weekend mass 
loads. 
Weekend mass loads for the cocaine metabolite benzoylecgonine were 
statistically higher (p=0.006) compared to weekday mass loads which coincides with the 
higher observed rates of cocaine consumption on weekends (Kankaanpää et al. 2014, 
Tscharke et al. 2016, Zuccato et al. 2008). This same trend was not observed for parent 
cocaine within the sampling area (p=0.145). This discrepancy may be explained by the 
low excretion percentage of cocaine excreted as parent cocaine (Ambre et al. 1988) 
coupled with potential transformation and degradation in the sewer system. Previously 
reported concentrations of MDMA in raw wastewater have suggested higher weekend 
consumption (Kankaanpää et al. 2014, Tscharke et al. 2016) but our analysis did not 
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identify a statistically significant difference between weekday and weekend mass loads 
(p=0.204). This observation could be explained by the longer elimination half-life of 
MDMA (De La Torre et al. 2000, Torre et al. 2000) but is also likely impacted by 
metabolization rates and in-sewer degradation.  
While analyte concentrations in raw wastewater are necessary for further 
modeling of the data they provide little insight above an analysis of long-term trends. 
This point is demonstrated by comparing the amphetamine concentrations in raw 
wastewater at the two sampling locations. By comparing amphetamine concentrations in 
raw wastewater at sampling location 1 (average AMP = 574 ± 30) to sampling location 2 
(average AMP = 852 ± 66), one would assume the contributing population at the second 
sampling location has a higher usage of amphetamine than the first. When the data is 
normalized to the wastewater flow to obtain mass load values (mass/day), it becomes 
clear that first sampling location is responsible for most of amphetamine analytes 
entering the university sewer system – thus the aforementioned assumption would have 
been made in error. This demonstrates that comparisons of analyte concentrations in raw 
wastewater may not produce comparable results and exemplifies the necessity of 
normalization of analyte concentrations in raw wastewater to wastewater flow. 
5.3.3 Substance consumption estimates 
 Narcotic analyte mass loads were population normalized and corrected using the 
pharmacokinetic correction factors (Appendix D: Table 20) to provide narcotic 
consumption estimates. Population normalized and corrected data was then compared to 
dosage guidelines to obtain dose estimated consumption (Appendix D: Table 23). 
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Fig. 16 - Estimated campus population consumption of the following substances of 
potential abuse. Superscripts (a) denotes estimation from parent compound, (b) denotes 
estimation from metabolite compound, and (c) denotes estimation from both parent and 
metabolite compounds. 
  Estimated cocaine consumption (Fig. 16) was the highest of any of the 
screened metabolites and was similar to previously reported cocaine consumption 
estimates in U.S. WBE studies (range: 100-1,500 mg/day/1,000 persons) (Chiaia et al. 
2008, Subedi and Kannan 2014) and international WBE studies (range: 0.05-9,793 
mg/day/1,000 persons). The cocaine consumption reported here also exceeds previously 
reported values in other U.S. universities both in terms of detected mass and detection 
frequency (Heuett et al. 2015). Heroin consumption, constituting the 2nd highest 
consumption estimation within this study, also exceeded previously reported U.S. campus 
consumption estimates by over 10-fold (Heuett et al. 2015). Both attention 
deficit/hyperactivity disorder analytes exceeded both U.S. (Chiaia et al. 2008, Subedi and 
Kannan 2014) and international (Baker et al. 2014, Baz-Lomba et al. 2016, Tscharke et 
al. 2016, Vuori et al. 2014, Zuccato et al. 2008) mass consumption estimates but were in-
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line with similar studies identifying attention deficit/hyperactivity disorder stimulant use 
within the U.S. collegiate setting (Burgard et al. 2013, Heuett et al. 2015, Moore et al. 
2014, Panawennage et al. 2011). Average consumption estimates for the remainder of the 
analytes were similar to reported consumption U.S. estimates and higher than estimates 
presented in international literature except for morphine estimated from morphine-3-
glucuronide which was lower than U.S. estimates and in-line with values presented in 
international literature. It is possible that the instability of the metabolite morphine-3-
glucuronide (Skopp et al. 2001) coupled with the impact of in-sewer degradation 
contributed to the discrepancy in morphine consumption noted here. 
 The frequent detection of attention deficit/hyperactivity disorder medication 
analytes (D.F.=88%+) in this study was echoed by all WBE-based U.S. campus studies 
showing near ubiquitous amphetamine and methylphenidate detection (Burgard et al. 
2013, Heuett et al. 2015, Moore et al. 2014, Panawennage et al. 2011). This could suggest 
young adults within the collegiate setting may be more inclined to abuse attention 
deficit/hyperactivity disorder medication for recreational or educational purposes 
(McCabe et al. 2005, Teter et al. 2006) and non-medical ADHD stimulant use may not be 
limited to a single U.S. university or geographic location. Detection of the cocaine 
metabolite benzoylecgonine in this study (DF=100%) was also similar to previously 
reported U.S. campus literature (DF=97-100%) (Heuett et al. 2015, Panawennage et al. 
2011). The remainder of the narcotic analytes were detected at a much higher frequency 
at this location compared to reported values from other U.S. campus studies. The heroin 
metabolite 6-acetylmorphine was detected infrequently within U.S. campus literature 
(DF=0-1%) which screened for the compound compared to the relatively high detection 
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frequency presented in this study (Appendix D: Table 21, Table 22). This higher 
detection frequency was similar for morphine, codeine, MDMA, oxycodone, and EDDP. 
This suggests that variation in narcotic use among different campus populations could be 
analyzed in near-real time through WBE analysis. Furthermore no U.S. campus studies 
have identified concentrations of fentanyl, alprazolam, or their metabolites within 
campus-borne wastewater which were identified in this study. The lack of detectable 
fentanyl and norfentanyl within the Southwestern university wastewater samples suggests 
that medical use of fentanyl at this location is low and any detection of either compound 
could point towards non-medical fentanyl use. The chemical data also does not provide 
any information regarding substance abuse control measures that may have been 
implemented on the campus.  
5.3.4 Drug user count, estimated overdose-deaths, and estimated black-market value 
 An estimation of the number of narcotic users, presented in units of users/1,000 
persons resulted in values between 0.15 ± 0.05 (MDMA) to 14.9 ± 0.6 (alprazolam) 
(Appendix D: Table 23), with notable values observed for oxycodone (4 ± 0.26), heroin 
(7.9 ± 0.6), amphetamine (5.1 ± 0.2), methylphenidate (3.9 ± 0.47), alprazolam (14.9 ± 
0.6), and cocaine (4.9 ± 0.4). The number of calculated heroin users exceeded the 
national average of 0.21% by four-fold (SAMHSA 2013) but was under the national 
average lifetime heroin use of 1.6% (Martins et al. 2017). While heroin use is usually 
higher in young adults (Cerdá et al. 2015, SAMHSA 2013) compared to other age 
demographics the high estimated percentage of heroin users (1%) could have been 
impacted by the low excretion percentage (1.6%) used for 6-acetylmorphine calculations. 
If the higher-bound excretion percentage of 5% (Labroo et al. 1997) is used the resulting 
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number of estimated heroin users decreases by 68% and puts the estimation in-line with 
national averages. This identifies the importance of the pharmacokinetic and excretion 
rates within WBE approaches; metabolization of heroin to 6-acetylmorphine may be 
greater in younger adults compared to older populations which could account for the high 
user estimate. Samples collected for this study were subjected to much shorter sewage 
retention times compared to studies which sample at the WWTP inlet point theoretically 
reducing analyte degradation within the wastewater. This may have resulted in higher 
concentrations than what would have been observed if the wastewater had been subjected 
to a longer transit time. Estimated overdose and overdose-deaths due to heroin were 
estimated from 6-acetylmorphine concentrations. This resulted in 6 ± 0.5 expected heroin 
overdoses and 1.1 ± 0.1 expected heroin overdose-deaths for the campus population 
during the 2017 year. Overdose and overdose-deaths for other substances were not 
attempted due to unavailability of pertinent information.  
 An estimated black market monetary contribution for the 2017 year was also 
calculated for the narcotics cocaine and heroin. Assuming a price per gram of $240 for 
heroin (NBC 2017) and $33.8 for cocaine (Kucher 2018) the estimated black-market 
value of heroin was $1.6 million and the estimated black-market value of cocaine was 
$230 thousand. These estimates only account for street-value of the narcotics and do not 
constitute the economic impact of use of these drugs, which is likely much higher due to 
the additional strain drug use causes on communities due to crime rates, hospitalization, 
child abuse and neglect, and increased risk of HIV transmission (Hoffman and Goldfrank 
1990). 
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5.3.5 Impact of elimination half-life 
 Following ingestion of a narcotic parent compounds and metabolites are retained 
within the body and excreted over time. This excretion, generally expressed as the 
narcotic elimination half-life, is governed by the average dose of drug, the route of 
administration, duration of use, rate of metabolism, and the chemical properties of the 
analyte (Cary 2006). Consideration of the elimination half-life in WBE method 
development offers an opportunity to refine analysis techniques and improve the value of 
data collected. The drug analytes used in this study were identified with elimination half-
lives ranging from 0.6 to 39.5 hours (Appendix D: Table 24)  (Ambre et al. 1988, Chan et 
al. 1983, Cone et al. 1991a, Cone et al. 1991b, DeVane et al. 1991, Greenhill et al. 2003, 
Hasselstrom et al. 1990, Kirvela et al. 1996, Kuhlman Jr et al. 1996, Olkkola et al. 1999, 
Schepers et al. 2003, Torre et al. 2000, Wolff et al. 1997), which could impact the 
presented results. The elimination half-life of 6-acetymorphine (0.6 hours) results in 
99.9% body elimination of the compound within a 24-hour period, thus any detectable 
presence of 6-acetylmorphine can be reasonably attributed to heroin consumption within 
the 24-hour sampling period. The long elimination half-life of EDDP (39.5 hours) results 
in an excretion period exceeding 16 days from a single dose of methadone making 
estimations on daily consumption difficult. 
 Considering elimination half-lives within method development should be looked 
at as a necessary step in wastewater-based epidemiological approaches and analytes with 
specific elimination half-lives should be chosen to compliment the study design. If 
sampling occurs frequently analytes with lower elimination half-lives should be chosen 
so that day-to-day variance in consumption estimates can be easily identified. If sampling 
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occurs infrequently analytes with longer elimination half-lives should be used to increase 
the chance that a target analyte will be identified within the sample. Within this study 
41% of the analytes were estimated to have 99.9% narcotic elimination within a 24-hour 
period and 47% of analytes were estimated to have 99.9% narcotic elimination between 
2-4 days. Only two of the analytes were identified with 99.9% narcotic elimination 
exceeding 7 days. Due to the frequent sampling of this study it is more advantageous to 
select analytes with lower elimination half-lives if possible.  
 Factoring in elimination half-lives prior to population normalization could 
account for the variation in narcotic excretion but is met with significant limitation. 
Accounting for the long elimination half-life of EDDP (16.5 days) would require 17 days 
of continuous sampling to obtain corrected consumption for a single day. This is an 
obvious increase in time and cost to the researcher and may not constitute additional cost 
of such an analysis. Back-calculation becomes less cumbersome when considering 
analytes with shorter elimination half-lives but application to this study resulted in 
statistically insignificant changes to the individual mass loads and no change to the trends 
observed in the non-corrected dataset.  
5.3.6 Study limitations 
 Analyte concentrations in raw wastewater and narcotic mass loads can be 
considered the most robust data that can be collected from WBE procedures as error 
mostly stems from deviance in sample collection, preparation, analyte loss, population 
variance, and instrument error. This error can be quantified through sample replication 
and use of proper controls. Narcotic consumption estimates may provide a more tangible 
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analysis of WBE data but also factor error into the analysis. Variation in narcotic use 
across the population (Harocopos et al. 2016, Lankenau et al. 2012), prevalence of 
specific narcotic abuse within a specific region (Harocopos et al. 2016, Warner et al. 
2016), uncertainties in pharmacokinetic metabolization and excretion rates (Andes and 
Craig 2002, Jenkins et al. 1994, Schwartz 2003), uncertainties in the contributing 
population count (Been et al. 2014, Rico et al. 2017), and the extent of in-sewer narcotic 
degradation and/or biotic transformation (Postigo et al. 2011) can skew results by orders 
of magnitude. Analysis of specific narcotics with various limiting factors such as low 
urinary and fecal excretion profiles or rapid in/ex vivo degradation may provide 
additional challenges for the quantification of certain narcotics in wastewater. 
Furthermore, large relative percentage differences observed for some samples during the 
sampling campaign could be explained in-part by errors in sample collection, preparation, 
and analysis procedures, as well as the hydrophobicity of target analytes. The lack of 
detection of buprenorphine and its metabolite norbuprenorphine in any campus samples 
is likely due to method sensitivity for the compounds but could also reflect local 
prescribing practices for opioid withdrawal medication. 
 There are several factors which would have strengthened this analysis and should 
be considered in future WBE studies. The pharmacokinetic percentages used in this 
analysis were obtained for a normalized age range but the average age of the population 
within the study catchment is likely lower. This could lead to discrepancies in actual 
metabolization of the compounds which would be reflected in the estimated consumption 
data. The analytes used for population estimations suffer from the same limitations as the 
narcotic analytes and could also have impacted the population normalized results. The 
109 
 
addition population estimation from wastewater flow also suffers from the incorporated 
design safety factor in the flow values used and possible incorrect stormwater tie-in. 
While this study sampled more routinely (seven consecutive days per month for 5 
months) than previous campus-related WBE projects daily sampling would have been 
ideal and may have identified trends of fentanyl and norfentanyl in wastewater which 
could have passed through the catchment unobserved. Expanding the analytical method 
to include more types of drug analytes or using methods which can identify classes of 
narcotics could provide additional insight into the scope of narcotic abuse on this campus. 
Inclusion of a self-reporting drug use survey would have also provided a comparison 
metric for the WBE data. 
5.4 Conclusions 
 Except for ADHD medication, the concentrations and detection frequencies of the 
narcotics examined in this study exceeded values presented in previously published 
campus-related literature. Estimated consumption values varied by narcotic compared to 
U.S. estimations but were predominantly higher than international estimations from city-
based WBE literature. These findings correlate with the observed higher drug 
consumption of college-aged young adults (Schulenberg et al. 2017) and may suggest 
that variations in drug use could be tracked and compared between geographically 
distinct U.S. regions through WBE analysis. The first sporadic detection of fentanyl and 
its metabolite in U.S. campus wastewater may also point to illicit non-medical 
consumption within the university population (CDC 2016, CDC and University 2017). 
Certain design factors such as reducing the sewage retention time and consideration of 
elimination half-life in analyte selection were chosen to improve the study design. This 
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could account for the high concentrations observed for some narcotic analytes but further 
examination into the degradation and metabolization of target analytes across different 
demographic representations is necessary to understand this observation. These results 
have demonstrated that implementation of WBE in the collegiate setting can provide 
useful temporal information pertaining to the use of a wide array of narcotics in near-real 
time and should be adopted by institutes which have a vested interest in the well-being of 
a collegiate population. 
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CHAPTER 6 
 
RESEARCH IMPLICATIONS AND RECOMMENDATIONS 
 This work has shown that chemical data available from environmental matrices 
can potentially provide insight into health or related trends for a specific community but 
is still subject to many uncertainties and variants in data analysis which can cause often 
overlooked discrepancies between sampling locations and/or studies. Variations in 
sampling method, duration and frequency of sampling, metabolization and/or excretion 
rates used, and variation in population-normalization procedures can all induce 
unintended bias into the analyses. Despite these disadvantages application UMM can still 
provide relatively precise analyte concentrations and mass loads in municipal wastewater 
which can be used as a complimentary source of data to be considered alongside other 
viable methods of community health data collection. Furthermore, the technology has 
primarily been applied to drug analytes to provide hard-metrics on drug consumption – 
but this technology has seldom been applied to gauge other metrics related to human 
health and wellness.  
 Known concentrations of N-nitrosamines in matrices commonly related to human 
exposure were inventoried in Chapter 2, including: food, water, tobacco products, 
alcoholic beverages, and personal care products. Average daily total N-nitrosamine 
exposure in the U.S. in units of ng/d is estimated at 25,000 ± 4,950 and identified with 
6,000 ± 2,950 attributable lifetime cancer cases per one million U.S. residents. 
Approximately 92% of total daily N-nitrosamine exposure can be reduced through 
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deliberate choices in lifestyle and diet, but some sources of unavoidable exposure exist. 
In Chapter 3, 40 freshwater sediments collected near 14 U.S. wastewater treatment plants 
were analyzed by LC-MS/MS to identify N-nitrosamine contamination. Three N-
nitrosamines (NDBA, NDPhA, and NPYR) were detected for the first time in freshwater 
sediments with a 70% detection frequency across the entirety of the study. N-Nitrosamine 
occurrences up- and downstream of WWTPs were statistically indistinguishable (p 
>0.05) – which led us to reject one of our initial hypotheses. The results from these two 
studies suggest that N-nitrosamine contamination may be prevalent within environmental 
matrices within to the urban water system which could provide challenges in application 
of UMM to track the prevalence of human N-nitrosamine exposure within the built 
environment.  
 Concentrations of parent and metabolite opioid compounds were screened for in 
24-hour composite raw wastewater samples collected from two small midwestern cities 
in Chapter 4. Consumption estimates within the two small communities was for the most 
part similar compared to other parts of the U.S. but exceeds use in cities outside of the 
U.S. for most opioids. Despite similar demographic characteristics of the two regions, 
prevalence of specific opioid use varied between the two regions – calling into question 
the validity of forecasting national drug statistics onto a smaller population demographic. 
In Chapter 5, the WBE approach was applied to a campus population where samples 
were obtained along the sewer line to capture 100% of campus-borne wastewater and 
minimize analyte degradation within the sewer system. All analytes aside from 
buprenorphine and its metabolite were detected at least once during the sampling 
campaign but estimated narcotic consumption and analyte detection frequency exceeded 
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previous reported values from related U.S. campus literature. The results presented in 
Chapters 4 and 5 suggest that the variation in narcotic consumption between similar 
communities could be tracked through WBE approaches which could provide valuable 
insight for evidence-based public health decision making. The sensitive method detection 
limits developed for the LC-MS/MS analysis also allowed for the detection of fentanyl 
and its metabolite in all the sampling locations, which could yield clues into the 
prevalence of non-medical fentanyl consumption within the United States. Focusing on 
potent opioids responsible for the drastic increase of drug-induced overdose deaths, like 
fentanyl and its analogs, could have a large positive impact on the current U.S. opioid 
crisis – and thus would benefit from frequent and widespread wastewater monitoring. 
 To summarize, two parameters of UMM (freshwater sediments and wastewater) 
have been examined and results suggest that (i) N-nitrosamine exposure from the 
ingestion pathway due to food consumption (6.7 ± 0.8 ng/g) constitutes an important role 
in exposure which can be mitigated to some extent through deliberate diet and lifestyle 
choices; (ii) N-nitrosamine contamination (NDBA: 0.2-3.3 ng/g dw; NDPhA: 0.2-4.7 
ng/g dw; NPYR; 3.4-19.6 ng/g dw) is prevalent (DF=70%) in freshwater sediments; (iii) 
upstream and downstream N-nitrosamine sediment contamination were not statistically 
different (p=0.42); (iv) estimated opioid consumption varied between similar 
communities, was in-line with previous U.S. consumption estimates, but exceeded 
estimates provided in international literature, and (v) narcotic consumption in the 
southwestern U.S. university was higher, and more frequently detected compared to 
similar WBE studies focusing on sampling at college campuses. 
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6.1 Considerations for further development of WBE analysis methods 
 Wastewater-based epidemiology has experienced significant worldwide 
implementation, especially within the European Union (Kankaanpää et al. 2014, Vuori et 
al. 2014, Zuccato et al. 2005) even though it is still a developing technology. While city-
specific WBE data provides valuable information for internal validation and trend 
analyses, discrepancies in method development and analytical approaches can propagate 
error into the results (Fig. 17) (Thai et al. 2014). These discrepancies could be partially 
addressed if WBE researchers approach data analysis using standardized metabolite 
excretion rates, degradation rates, analyte elimination half-lives, population estimators, 
correction factors, and target analytes used for the estimation of narcotic consumption. 
While error will still propagate within analyses it would likely be relatively similar across 
studies and could strengthen trend observations between unrelated study locations. 
Furthermore, if the study catchment primarily consists of individuals from a specific sub-
demographic (i.e. college-aged young adults) average population metabolization and 
excretion parameters used in the data analysis may need to be reevaluated.  
 
Fig. 17 - Uncertainty in various steps of WBE data modeling and estimations. 
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One assumption that is echoed through many WBE papers is the assumption of no 
analyte degradation in-sewer (Postigo et al. 2011, Zuccato et al. 2008), but papers which 
have examined analyte degradation rates note up to 90% degradation (O’Brien et al. 
2017, Thai et al. 2014) under sewershed conditions. The frequent use of the negligible 
degradation assumption has likely contributed to the underestimation of narcotic abuse in 
some study regions, thus sewer degradation rates should be considered in the WBE 
approach.  The frequency of sampling is also an important consideration in the analyte 
selection phase of method development. Analytes with short elimination half-lives 
compliment frequent sampling, as these analytes point to the recent ingestion of a 
narcotic. If possible, short elimination half-life analytes should not be used in sporadic 
sampling campaigns as there is a high chance that an analyte mass will pass through the 
catchment system unnoticed. Consequently, analytes with longer elimination half-lives 
will excrete slowly over time – and should be coupled with infrequent sampling as there 
is a high chance for analyte capture but less dissectible information regarding day-to-day 
consumption trends of the narcotic. 
6.2 Application of wastewater-based epidemiology to N-nitrosamine exposure 
 Before WBE can be applied to the N-nitrosamine class of carcinogens it is 
important to understand at what rate humans are exposed to these chemicals, how they 
are degraded, formed, and metabolized in vivo (Lundberg et al. 2004), and how they 
impact matrices that are integral to urban water systems. These carcinogens are not 
knowingly ingested by individuals but instead are a result of unintentional exposure 
through ingestion, inhalation and dermal sorption. This provides a unique limitation 
because it becomes difficult to identify sources of N-nitrosamines wastewater occurrence 
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through N-nitrosamine congener analysis. It may be advantageous to identify N-
nitrosamine metabolites in wastewater as these may provide a more accurate 
representation of human exposure. Literature related to the human metabolism of N-
nitrosamines is limited (Carmella et al. 1993, Kozlovich et al. 2015), and studies that 
have examined human metabolism of N-nitroso compounds suggest a high variability 
between individuals (Camus et al. 1993). It would also be necessary to identify any 
potential additional routes of formation for these metabolites within the microbial 
communities encountered in sewer pipe biofilms.  
 Application of the WBE process to monitor N-nitrosamines and respective 
metabolites would result in a novel method of tracking carcinogen exposure within our 
communities. Estimated exposure concentrations founded in chemical data (in units of 
mass/day/person) could be calculated for a specific community and benchmarked against 
the theoretical exposure concentrations identified in Chapter 2. N-Nitrosamines WBE 
analysis could also provide an additional metric for smoking prevalence by monitoring 
tobacco-specific N-nitrosamines and their respective metabolites (Ma et al. 2017). As 
regulations and maximum contamination limits regarding the N-nitroso class are 
developed it will become important to understand if the imposed regulatory limits are 
sufficient. While testing for N-nitrosamine contamination at the drinking water treatment 
plant (DWTP) is necessary, concentrations reported here may not accurately reflect 
exposure levels due to the observed N-nitrosamine formation in water distribution 
systems after treatment discharge (Zhao et al. 2006). By sampling both at the DWTP 
discharge point and the WWTP inlet, we can understand if (i) drinking water is in 
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accordance with regulations, and (ii) if those regulations have any impact on exposure 
levels within the service community. 
6.3 Widespread spatial and temporal WBE testing 
  Evidence-formed public health decision making is vital to addressing public 
health crises effectively, but this process is only effective if key players have a 
comprehensive understanding of the health crisis. The nature of the opioid epidemic 
makes this a difficult task as prevalence of opioid abuse can vary substantially between 
two similar regions, made evident in chapters 4 and 5. Targeted substance abuse 
programs have been implemented as tools to reduce addiction prevalence through 
education and intervention (Botvin et al. 1984, Jalilian et al. 2015, Walsh 2015) but the 
efficacy of these programs is subject to debate (West and O’Neal 2004). Some programs, 
such as needle exchanges (Lurie et al. 1993), have also been proposed as methods to 
reduce substance abuse or lessen some of the externalities associated with drug addiction, 
such as HIV transmission (Hurley et al. 1997) or overdose-death rates (Maxwell et al. 
2006). Implementation of WBE approaches provides researchers and health officials with 
an analytical tool to monitor drug analyte concentrations in wastewater within a specific 
region and could be employed to provide near real-time information regarding the 
efficacy of implemented substance abuse programs. WBE also has the potential to be 
applied to screen for viral DNA (Bofill-Mas et al. 2006, Tamaki et al. 2012) and could be 
implemented to determine estimated rates of HIV prevalence before and after 
implementation of a needle-exchange program, although this would likely require long-
term monitoring as reduction in HIV prevalence would not be an immediate response. 
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 While WBE has traditionally been applied to gauge drug addiction, the 
technology has widespread potential application. As previously mentioned, health 
parameters such as carcinogenic exposure, prevalence of viral or bacterial infection 
within a community, prevalence of smoking and alcohol use, stress profiles of a 
community, and prevalence of antibiotic resistance all constitute potential applications of 
the WBE technology. In fact, if an event results in the deposition of a target analyte 
within the urban water environment it is likely that we can track that parameter through 
WBE analysis – which is perhaps the largest benefit of this technology. Between 70-90% 
of U.S. residents are serviced by a municipal wastewater treatment system (Westerhoff et 
al. 2015) so WBE analyses can be applied for most U.S. populations without any major 
infrastructure changes. These factors favor the widespread implementation of WBE 
testing across the United States, and data obtained from this practice will continue to 
improve as the technology continues to develop.  
6.4 Recommendations for future research 
 While wastewater analysis can provide researchers with an understanding of 
health trends within a specific area, further development in the field is necessary to 
improve the validity and accuracy of the results obtained. Standardization of WBE 
method development, sampling, and analysis procedures is necessary to provide more 
uniform results across unrelated study locations. This includes (i) the development of 
standard target analytes, (ii) further understanding of the percentage and variation of 
analyte metabolization and excretion rates across the general population and sub-
demographics, (iii) the development of robust population estimator compounds, (iv) use 
of frequent sampling as opposed to infrequent sampling, and (v) development of robust 
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analyte in-sewer degradation and/or transformation rates. Widespread application of 
WBE in the United States will also provide additional necessary benchmarks for narcotic 
abuse and identify areas where intervention is mandatory – thus constituting a necessary 
area of continued research. Perhaps more important is the expansion of the wastewater 
analysis approach to health parameters outside drug abuse, as it represents a small 
percentage of the total volume of information that can be derived from wastewater 
analyses. Expansion of the WBE process will likely require additional information 
regarding the in vivo occurrence, metabolization, and excretion of target analytes – but it 
is possible pertinent information already exists within literature. 
 The UMM analyses conducted in this dissertation represent a small subset of the 
potential information that can be derived from routine wastewater analysis. While WBE 
has traditionally been applied to track drug consumption within a community, the process 
could be applied to better understand population consumption habits (Baker et al. 2014, 
Kim et al. 2015), general wellness of a community (Fattore et al. 2016, Rousis et al. 
2017), prevalence of personal care product use (Gao et al. 2016), and approximate 
carcinogen exposure (Lai et al. 2017). Expanding matrix analysis outside of wastewater 
could provide additional insight into some of these population health and wellness 
parameters. Benefits of UMM will only increase as the technology continues to develop 
and it is likely that the technology will experience wider implementation in the future, so 
continued development of UMM analytical methods should be viewed as incumbent for 
researchers involved in UMM and WBE analyses. Regardless, the UMM analyses 
conducted in this dissertation have shown that variation of analyte concentrations in raw 
wastewater can be identified through wastewater analysis and should be implemented in 
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conjunction with currently viable methods of public health data collection across the 
United States. 
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Table 3 - Existing regulations involving N-nitrosamine congener contamination within 
water sources. 
Regulatory Country 
or State 
Enacted 
Law 
Water 
Type 
Contaminant 
(Maximum Limit) 
Source 
United States Federal 
Government 
Contaminant 
Candidate 
List 
Drinking 
NDMA (no limit) 
CCL 4, 
2016 
NDEA (no limit) 
NDPA (no limit) 
NDPhA (no limit) 
NPYR (no limit) 
California (U.S. State) 
Action 
Level 
Drinking 
NDMA (2 ng/L) EPA, 
2011 Public 
Health Goal NDMA (3 ng/L) 
Massachusetts (U.S. 
State) 
Regulatory 
Limit Drinking NDMA (10 ng/L) 
EPA, 
2015 
Arizona (U.S. State) 
Regulatory 
Limit 
Discharge 
NDMA (1 ng/L) 
AZDEQ, 
2015 
NDPA (5 ng/L) 
NDPhA (7,100 
ng/L) 
Canada 
Maximum 
Limit Drinking NDMA (40 ng/L) 
Selin, 
2011 
Germany 
Maximum 
Limit 
Any 
Waters NDMA (10 ng/L) 
Selin, 
2011 
United Kingdom 
Maximum 
Limit 
Drinking 
NDMA (10 ng/L) UKDWI, 
2001 Emergency 
Action NDMA (200 ng/L) 
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Quality Assurance and Quality Control 
Calibration accuracy was verified for each batch using a calibration standard 
solution with labeled and native analytes. Retention times of native and labeled 
compounds in the sample had to be within ±12 s (0.2 min) of the respective 
retention time established during the previous calibration. Multiple lab blanks 
were analyzed for each batch to check for laboratory contamination. A duplicate 
sample was analyzed for every five samples in a batch to evaluate analysis 
precision. Precision between samples and duplicates was expressed as relative 
percentage difference (RPD), which was calculated using the following 
expression: 
RPD[%] =  
|Csample − Cduplicate| ∗ 100
Csample + Cduplicate
2
 
where Sample and Cduplicate are the concentrations detected in the original sample 
and in its duplicate, respectively. Matrix spikes were performed for selected 
samples to confirm analyte presence in the sample and to evaluate recovery rates 
for analytes without deuterated labeled analogues.  The stability of N-
nitrosamines under storage conditions was tested for freshly collected samples by 
frequent analysis over a period of eight months.  Testing of these samples 
revealed no discernable degradation or formation of N-nitrosamines under the 
aforementioned storage conditions. 
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N-Nitrosamine Analysis. All glassware used in the experiments were baked at 550 oC, 
caps were acid washed using 10% HCl and thoroughly rinsed with ultrapure water prior 
to use to prevent contamination. About 6 g wet weight (ww) of sediment was weighed in 
amber glass (40 mL) vials, spiked with 250 ng each of deuterated surrogates and 
extracted using DCM (2 mL per g of sediments) as described for sludge elsewhere 
(Venkatesan et al. 2014).  The extract was concentrated to near dryness under a gentle 
stream of nitrogen gas, reconstituted with 2 mL methanol and then sonicated for 15 
minutes. The extract was then centrifuged at 440 G for 5 minutes, and 0.75 mL of the 
resulting supernatant was diluted 1+1 (v/v) with water prior to analysis by liquid 
chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) in 
positive ionization mode.  
 
The tandem mass spectrometer (API 4000 instrument; Applied Biosystems, Framingham, 
MA, USA) used was coupled to a Shimadzu Prominence HPLC (Shimadzu Scientific 
Instruments, Inc., Columbia, MD, USA) for sample introduction and compound 
separation. Separation of analytes was carried out on an XBridge BEH C8 column, (130 
Å, 3.5 μm, 4.6 x 150 mm; Waters, Milford, USA). The mobile phase consisted of solvent 
A (10 mM ammonium acetate with 0.01% acetic acid) and solvent B (100% methanol) 
flowing at a rate of 400 μL/min with a total runtime of 16 minutes. The solvent gradient 
program consisted of 50% of solvent B for 2 min, followed by an increase from 50% to 
90% over 11 min, and holding at 90% for 3 min, before returning back to 50% of solvent 
B over 0.1 min, followed by a 2-min equilibration period prior to injection of the next 
sample aliquot (100 μL volume). Analytes were introduced into the mass spectrometer 
using an electrospray ionization probe in positive mode. Multiple reaction monitoring 
(MRM) was used for qualitative analysis. Optimized conditions for the ionization and 
fragmentation of the analytes and QA/QC protocol are included as supporting 
information (see supporting information Table S-1). Wet weight concentrations obtained 
from the analysis were converted to dry weight (dw) concentrations using the solid 
content of the analyzed sediments. All concentrations are reported as ng/g dw.
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Fig. 18 - LC-MS/MS chromatograms of standards, sample extracts and matrix spike 
samples of three detected N-nitrosamines. The number next to the peak represents the 
retention time of the analyte in minutes. 
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Fig. 19 - Stability test for the analyzed N-nitrosamines in fresh sediments during storage 
at –20C analyzed over a period of eight months. Concentrations were normalized to the 
average initial concentration detected in freshly collected sediment (Month 1). Half the 
corresponding MDL value was used for non-detects (NDMA, NMEA, NDEA, NDPA 
and NPIP).  NDBA and NDPhA were present in native sediment and did not show 
appreciable changes in concentration during prolonged storage. 
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Table 4 - Method performance and concentrations of N-nitrosamines in freshwater 
sediments 
Compound Recovery 
(%) 
MDL 
(ng/g 
dw) 
Sediment 
concentration 
avg. (min, max)  
(ng/g dw)c 
RPD 
(%) 
Detection 
frequency 
(%) 
Absolute Relative 
N-nitrosodimethylamine (NDMA) 54 ± 21 87 ± 2 10.2 <MDL (10.2) - - 
N-nitrosomethylethylamine 
(NMEA)a 
63 ± 34b - 1.7 <MDL (1.7) - - 
N-nitrosodiethylamine (NDEA)a 60 ± 28b - 3.9 <MDL (3.9) - - 
N-nitrosodi-n-propylamine 
(NDPA) 
64 ± 23 78 ± 8 1.7 <MDL (1.7) - - 
N-nitrosodibutylamine (NDBA)a 64 ± 17b - 0.1 0.7 (0.2, 3.3) 38 ± 
25 
58 
N-nitrosopyrrolidine (NPYR)a 108 ± 39b - 3.5 8.7 (3.4, 20) 18 ± 
16 
18 
N-nitrosopiperidine (NPIP) 78 ± 18 80 ± 17 3.6 <MDL (3.6) - - 
N-nitrosodiphenylamine 
(NDPhA) 
59 ± 14 82 ± 31 0.1 1.4 (0.2, 4.7) 11 ± 9 50 
aConcentrations of analytes lacking stable-isotope labeled analogues are not recovery corrected. bAbsolute 
recoveries of these analytes were determined from matrix spike studies. cDry weight concentrations were calculated 
from wet weight concentrations using the solids content of the biosolids samples. “<MDL” represent not-
applicable/non-detects. MDL: method detection limit. RPD: relative percentage difference. 
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Table 5 - LC-ESI-MS/MS parameters for analysis of N-nitrosamines 
MS/MS parameter 
Ion source Positive electrospray ionization 
Collision Gas  6 
Curtain Gas 50 
Ion source Gas 1 80 
Ion Source Gas 2 70 
Ion Spray Voltage 4500 V 
Source Gas 
Temperature 
700 oC 
 
Analyte Parent 
ion 
(m/z) 
Product 
ion 
(m/z) 
Declustering 
potential 
(V) 
Exit 
Potential 
(V) 
Collision 
Energy 
(V) 
Collision 
Cell Exit 
Potential 
(V) 
Retention 
Time (min) 
NDMA 75 43 51 10 25 2 5.34 
NMEA 89 61 51 10 17 10 5.86 
NDEA 103 75 51 10 17 12 6.65 
NDPAa 131 
131 
89 
43 
51 10 17 8 8.82 
NDBAa 159 
159 
103 
57 
56 10 17 8 11.18 
NPYR 101 55 61 10 23 8 5.64 
NPIPa 115 
115 
69 
41 
61 10 23 12 6.73 
NDPhAa 199 
199 
169 
168 
56 10 17 8 11.16 
Deuterated isotopes 
NDMA-d6 81 46 51 10 25 2 5.35 
NDPA-d14 145 50 51 10 17 8 8.76 
NPIP-d10 125 78 61 10 23 12 6.70 
NDPhA-d6 205 175 56 10 17 8 11.11 
aTwo different transitions were used for these analytes for quantification and 
identification  
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Table 6 - n-Octanol-water partitioning coefficient of N-nitrosamines (source: SciFinder). 
Compound Log Kow 
N-nitrosodimethylamine (NDMA) -0.5 
N-nitrosomethylethylamine (NMEA) 0.01 
N-nitrosodiethylamine (NDEA) 0.51 
N-nitroso-di-n-propylamine (NDPA) 1.54 
N-nitrosodibutylamine (NDBA) 2.56 
N-nitrosopyrrolidine (NPYR) -0.1 
N-nitrosopiperidine (NPIP) 0.44 
N-nitrosodiphenylamine (NDPhA) 3.13 
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Table 7 - Demographic information for City 1 and City 2, obtained from the U.S. Census 
Bureau 2010 American fact finder statistics. 
  City 1 City 2 
Median Age 34.1 37.1 
Under 18 (%) 27.7 27.6 
18-29 (%) 12.4 12.8 
30-64 (%) 46.3 45.2 
65+ (%) 13.6 14.4 
% White 57 86.9 
% African American 34.5 2.7 
% Asian 0.4 5.6 
% Other/Mixed 8.1 4.8 
% Hispanic or Latino (any 
race) 8.2 5.8 
Average Household Size 2.53 2.43 
Homeowner Vacancy Rate 2.8 2.9 
Rental Vacancy Rate 10.6 14.2 
Unemployment Rate (%) 8.3 3.7 
Per Capita Income 14,500 29,400 
 
 
Table 8 - Optimized conditions for the ionization and fragmentation of the opioid parent 
and metabolite analytes screened for in this method. 
Opioid 
Type 
Consumption 
Indicator 
Precursor 
ion (m/z) 
Product 
ion 1 (m/z) CE(1) 
Product 
ion 2 (m/z) CE(2) 
Morphine 
Morphine 268.054 151.9 81 164.9 57 
Morphine-3-
Glucuronide 462.184 268 45 164.9 83 
Codeine 
Codeine 300.153 151.9 89 164.8 57 
Norcodeine 268.084 152.1 79 164.9 57 
Oxycodon
e 
Oxycodone 316.029 240.8 41 297.9 27 
Noroxycodone 302.117 284 25 187 35 
Fentanyl 
Fentanyl 337.1 188.1 33 105.1 51 
Norfentanyl 223.144 84 25 55 59 
Heroin 
Heroin 370.018 164.8 67 58 59 
6-Acetylmorphine 328.162 165 51 210.9 37 
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Table 9 - Method detection limits for opioid analytes. 
Analyte Method Detection Limit (ng/L) 
Morphine 0.9 
Morphine-3-
Glucuronide 0.2 
Oxycodone 0.2 
Noroxycodone 0.3 
Codeine 1.4 
Norcodeine 0.8 
Heroin 0.3 
6-Acetylmorphine 0.3 
Fentanyl 0.3 
Norfentanyl 0.2 
 
Table 10 - Opioid narcotics, respective consumption indicator compounds, excretion rate 
of respective consumption indicators, correction factors used for each consumption 
indicator, and average prescribed oral dose per opioid per Mayo Clinic doctor guidelines. 
Drug Consumption Indicator 
Excretion Rate 
(%) 
Correction 
Factor 
Average 
Dose  
(mg) 
Morphine 
Morphine 10 10.0 
30 
Morphine-3-Glucuronide 75 0.8 
Codeine 
Codeine 57.5 1.7 
30 
Norcodeine 3.77 27.8 
Oxycodone 
Oxycodone 8.9 11.2 
10 
Noroxycodone 22.1 4.7 
Fentanyl 
Fentanyl 6 16.7 
0.1 
Norfentanyl 91.08 1.6 
Heroin 
Heroin n/a n/a 
30 
6-Acetylmorphine 1.3 86.8 
 
Table 11 - State overdose, overdose-deaths, and ratio information. 
State Overdose Death Ratio Notes 
Arizona 3920 538 7.29  
Virginia 8710 803 10.85  
Rhode Island  1499 335 4.47  
Minnesota 2074 395 5.25  
Oregon 9.6 6.829 1.41 *Pop Normalized Values 
Colorado 22.3 7.8 2.86 *Pop Normalized Values 
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Table 12 - Average ± standard error, minimum, and maximum raw wastewater analyte 
concentrations across the two cities. 
City 1 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in ng/L 
Morphine 713 ± 38 379 1,310 
Oxycodone 17.8 ± 1.1 3 43 
Codeine 322 ± 37 191 571 
Fentanyl 1.7 ± 0.2 <MDL 3.6 
Heroin 41 ± 16 <MDL 120 
Morphine-3-
Glucuronide 7.0 ± 2.5 
<MDL 26.1 
Noroxycodone 73 ± 5 61 96 
Norcodeine 162 ± 27 15 397 
Norfentanyl 30 ± 2 12 136 
6-Acetylmorphine 43 ± 15 13 136 
        
City 2 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in ng/L 
Morphine 306 ± 29 159 750 
Oxycodone 78 ± 6 22 251 
Codeine 100 ± 27 <MDL 453 
Fentanyl 1.0 ± 0.5 <MDL 4.4 
Heroin 19 ± 11 <MDL 28 
Morphine-3-
Glucuronide 7.6 ± 1.8 
<MDL 23.8 
Noroxycodone 105 ± 7 47 171 
Norcodeine 47 ± 8 <MDL 103 
Norfentanyl 48 ± 2 11 198 
6-Acetylmorphine 21 ± 3 7 35 
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Table 13 - Average ± standard error, minimum, and maximum analyte daily mass 
loading across the two cities. 
City 1 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in mg/day 
Morphine 30,000 ± 1,600 15,332 60,296 
Oxycodone 850 ± 51 161 2,249 
Codeine 15,800 ± 1,800 8,520 26,273 
Fentanyl 80 ± 9 <MDL 162 
Heroin 910 ± 335 <MDL 5,152 
Morphine-3-
Glucuronide 350 ± 109 
<MDL 1,360 
Noroxycodone 3,470 ± 230 2,923 4,754 
Norcodeine 7,680 ± 1,320 794 19,647 
Norfentanyl 1,450 ± 80 569 7,097 
6-Acetylmorphine 1,950 ± 640 665 4,915 
        
City 2 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in mg/day 
Morphine 8,690 ± 790 4,287 29,718 
Oxycodone 2,185 ± 170 578 7,305 
Codeine 2,648 ± 600 <MDL 10,303 
Fentanyl 24 ± 9 <MDL 89 
Heroin 156 ± 92 <MDL 730 
Morphine-3-
Glucuronide 200 ± 44 
<MDL 630 
Noroxycodone 2,770 ± 176 1,244 5,240 
Norcodeine 1,230 ± 190 <MDL 2,713 
Norfentanyl 1,270 ± 60 290 5,240 
6-Acetylmorphine 560 ± 75 190 929 
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Table 14 - Average ± standard error, minimum, and maximum analyte population 
normalized mass load consumption across the two cities. 
City 1 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in mg/day/1,000 population 
Morphine 2,590 ± 157 1,170 4,603 
Oxycodone 72 ± 12 14 192 
Codeine 204 ± 13 111 341 
Fentanyl 10 ± 1.2 4 21 
Morphine-3-
Glucuronide 
26 ± 8 <MDL 103.8 
Noroxycodone 124 ± 6 105 171 
Norcodeine 1,630 ± 284 169 4,169 
Norfentanyl 18 ± 7 7 87 
6-Acetylmorphine 1,294 ± 296 441 3,257 
        
City 2 
Analyte 
Average 
Concentration 
Minimum 
Concentration 
Maximum 
Concentration 
all concentration in mg/day/1,000 population 
Morphine 1,970 ± 255 974 6,754 
Oxycodone 556 ± 89 147 1,859 
Codeine 102 ± 21 0.9 398 
Fentanyl 9 ± 2.7 0.9 34 
Morphine-3-
Glucuronide 
3.8 ± 1 <MDL 11.5 
Noroxycodone 300 ± 35 128 487 
Norcodeine 790 ± 180 <MDL 1,726 
Norfentanyl 47 ± 18 10 191 
6-Acetylmorphine 1,127 ± 163 404 1,844 
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Table 15 - Analyte concentration changes across the study period for City 1 and City 2. 
City 1 
Analyte Increase/Decrease Percent P-Value 
Morphine Decrease 1.9% 0.875 
Oxycodone Increase 565% <0.01 
Codeine Decrease 13.50% 0.258 
Fentanyl Decrease 22.10% 0.307 
        
City 2 
Analyte Increase/Decrease Percent P-Value 
Morphine Decrease 25.80% 0.244 
Oxycodone Increase 39.10% 0.303 
Codeine Decrease 33.30% 0.327 
Fentanyl n/a n/a n/a 
 
 
Table 16 - Dose-estimated usage for City 1 and City 2. 
City 1 
Analyte 
Parent Compound 
Estimation 
Metabolite Compound 
Estimation 
Percent 
Difference 
all concentration in dose/day/1,000 population 
Morphine 86 (range: 39-153) 1 (range: 0-3) 195.4% 
Oxycodone 7 (range: 1-19) 12 (range: 10-17) 52.6% 
Codeine 5 (range: 4-11) 54 (range: 6-139) 166.1% 
Fentanyl 102 (range: 37-207) 177 (range: 70-867) 53.8% 
Heroin n/a 43 (range: 15-109) n/a 
        
City 2 
Analyte 
Parent Compound 
Estimation 
Metabolite Compound 
Estimation 
Percent 
Difference 
all concentration in dose/day/1,000 population 
Morphine 66 (range: 32-225) n/a n/a 
Oxycodone 56 (range: 15-186) 30 (range: 13-49) 60.5% 
Codeine 3 (range: 0-13) 26 (range: 0-58) 158.6% 
Fentanyl 91 (range: 9-339) 475 (range: 104-1,905) 135.7% 
Heroin n/a 38 (range: 13-61) n/a 
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Fig. 20 - Comparison of raw wastewater parent opioid and opioid metabolite 
concentrations during the 2016-2017 sampling period. Error bars represent calculated 
standard error. 
 
 
Fig. 21 - Total daily wastewater loading and estimation consumption values for the suite 
of opioids derived from opioid metabolite analysis. Populations were estimated by 
population served by the wastewater treatment plants, and correction factors used are 
listed in Table S2. 
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Table 17 - Sewer length and approximate sewage retention time (SRT) information. 
  Location 1 Location 2 Location 3 Longest Distance 
Max (ft) 4528 5808 1624 9951 
Min (ft) 1341 2882 1519 6764 
Average (ft) 3463.375 4572.4 1571.5 8886.375 
Minimum Velocity (ft/s) 1.5 1.5 1.5 1.5 
Average Velocity (ft/s) 3 3 3 3 
Maximum Velocity (ft/s) 10.7 10.7 10.7 10.7 
Max Time (min) 50.3 64.5 18.0 110.6 
Min Time (min) 2.1 4.5 2.4 10.5 
Average Time (min) 19.2 25.4 8.7 49.4 
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Table 18 - Optimized conditions for the ionization and fragmentation of the opioid parent 
and metabolite analytes screened for in this method. 
Opioid Type 
Consumption 
Indicator 
Precursor 
ion (m/z) 
Product 
ion 1 (m/z) 
CE(1) 
Product 
ion 2 (m/z) 
CE(2) 
Morphine Morphine 268.054 151.9 81 164.9 57 
 
Morphine-3-
Glucuronide 
462.184 268 45 164.9 83 
Codeine Codeine 300.153 151.9 89 164.8 57 
 Norcodeine 268.084 152.1 79 164.9 57 
Oxycodone Oxycodone 316.029 240.8 41 297.9 27 
 Noroxycodone 302.117 284 25 187 35 
Fentanyl Fentanyl 337.1 188.1 33 105.1 51 
 Norfentanyl 223.144 84 25 55 59 
Heroin Heroin 370.018 164.8 67 58 59 
 6-Acetylmorphine 328.162 165 51 210.9 37 
Methadone EDDP 278.192 234.1 43 186 49 
Buprenorphine Buprenorphine 468.281 396.1 55 414.3 47 
 
Norbuprenorphine 414.328 101.1 57 115.1 125 
Amphetamine Amphetamine 136.039 91 23 119 35 
Methylphenidate Methylphenidate 234.2 84 35 56.1 40 
Alprazolam Alprazolam 309.105 281 39 205 59 
 
alpha-
hydroxyalprazolam 
325.112 215.9 55 205 61 
Cocaine Cocaine 304.117 182 29 104.9 45 
 Benzoylecgonine 290.103 168 29 105 45 
MDMA MDMA 194.098 162.8 19 105 35 
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Table 19 – Method detection limits for narcotic analytes. 
Analyte Method Detection Limit (ng/L) 
Morphine 0.9 
Morphine-3-Glucuronide 0.2 
Oxycodone 0.2 
Noroxycodone 0.3 
Codeine 1.4 
Norcodeine 0.8 
Heroin 0.3 
6-Acetylmorphine 0.3 
Fentanyl 0.3 
Norfentanyl 0.2 
EDDP 1.7 
Buprenorphine 140 
Norbuprenorphine 120 
Amphetamine 0.9 
Methylphenidate 0.3 
Alprazolam 0.5 
Alpha-hydroxyalprazolam 0.2 
Cocaine 0.6 
Benzoylecgonine 0.7 
MDMA 0.5 
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Table 20 - Screened narcotics, respective consumption indicator compounds, excretion 
rate of respective consumption indicators, correction factors used for each consumption 
indicator, and average prescribed oral dose per opioid per Mayo Clinic doctor guidelines. 
Drug 
Consumption 
Indicator 
Excretion 
Rate 
(%) 
Molar 
Mass 
Ratio 
Correction 
Factor 
Average 
Dose  
(mg) 
Morphine Morphine 10 1 10.0 
30 
 
Morphine-3-
Glucuronide 
75 0.62 0.8 
Codeine Codeine 57.5 1 1.7 
30 
 Norcodeine 3.77 1.05 27.8 
Oxycodone Oxycodone 8.9 1 11.2 
10 
 Noroxycodone 22.1 1.05 4.7 
Fentanyl Fentanyl 6 1 16.7 
0.1 
 Norfentanyl 91.08 1.45 1.6 
Heroin Heroin n/a n/a n/a 
30 
 6-Acetylmorphine 1.3 1.13 86.8 
Methadone EDDP 23 1.12 4.9 30 
Amphetamine Amphetamine 30 1 3.3 30 
Methylphenidate Methylphenidate 1.5 1 66.7 30 
Alprazolam Alprazolam 20 1 5.0 
2 
 
Alpha-OH-
Alprazolam n/a n/a 
n/a 
Cocaine Cocaine n/a n/a n/a 
50 
 Benzoylecgonine 45 1.05 2.3 
MDMA MDMA 65 1 1.5 100 
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Table 21 – Sampling location 1 narcotic analyte sample extract concentration average ± 
standard deviation, minimum and maximum concentrations observed, and detection 
frequency. 
Analyte 
Average ± 
Standard 
Deviation 
Minimum 
Concentration 
Maximum 
Concentration 
Detection 
Frequency 
  (ng/mL) (%) 
Oxycodone 2.4 ± 0.1 1.6 3.9 100 
Codeine 3.1 ± 0.2  1.5 7.1 100 
Heroin 0.07 ± 0.04 <MDL 1.2 7 
Fentanyl N.D. <MDL <MDL 0 
Morphine-3-
Glucuronide 7.7 ± 1.3 <MDL 44.6 98 
Noroxycodone 2.4 ± 0.3 <MDL 9.5 95 
Norcodeine 0.37 ± 0.03 0.14 0.73 100 
6-Acetylmorphine 1.7 ± 0.1 0.8 3.6 100 
Norfentanyl 0.13 ± 0.09 <MDL 3.74 7 
EDDP 5.4 ± 0.4 2 15 100 
Amphetamine 28.7 ± 1.5 13.3 50 100 
Methylphenidate 1.0 ± 0.1 <MDL 3.8 90 
Alprazolam 3.6 ± 0.1 1.4 5.6 100 
alpha-OH-
Alprazolam 0.48 ± 0.03 0.07 0.96 100 
Cocaine 15.2 ± 1 5.8 35.9 100 
Benzoylecgonine 59.8 ± 3.2 29 104.4 100 
MDMA 5.7 ± 1.8 0.6 67.9 100 
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Table 22 – Sampling location 2 narcotic analyte sample extract concentration average ± 
standard deviation, minimum and maximum concentrations observed, and detection 
frequency. 
Analyte 
Average ± 
Standard 
Deviation 
Minimum 
Concentration 
Maximum 
Concentration 
Detection 
Frequency 
  (ng/mL) (%) 
Oxycodone 1.3 ± 0.1 0.4 3 100 
Codeine 2.8 ± 0.5 0.4 15.3 100 
Heroin N.D. <MDL <MDL 0 
Fentanyl 0.05 ± 0.03 <MDL 1.05 5 
Morphine-3-
Glucuronide 2.2 ± 0.5 <MDL 9.9 50 
Noroxycodone 4.3 ± 0.3 2.3 10.2 100 
Norcodeine 0.37 ± 0.03 0.14 0.73 100 
6-Acetylmorphine 0.34 ± 0.15 <MDL 5.2 30 
Norfentanyl N.D. <MDL <MDL 0 
EDDP 0.80 ± 0.15 <MDL 4.6 85 
Amphetamine 42.6 ± 3.3  6.7 87.6 100 
Methylphenidate 0.77 ± 0.11 <MDL 2.68 88 
Alprazolam 4.8 ± 0.2 2.5 7 100 
alpha-OH-
Alprazolam 0.21 ± 0.03 <MDL 0.52 33 
Cocaine 2.0 ± 0.2 0.2 6 100 
Benzoylecgonine 17.1 ± 2.2 0.5 61.7 100 
MDMA 3.0 ± 0.9  0.2 26.7 100 
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Table 23 - Average estimated consumption, dose consumption, and estimated number of 
users within the university study area. 
Analyte 
Estimated 
Consumption 
Dose 
Consumption 
Estimated 
Number of Users 
 
(mg/day/1,000 
persons) 
(dose/day/1,000 
persons) 
(Users/1,000 
persons) 
Morphine  18 ± 2.8 0.6 ± 0.1 0.3 ± 0.5 
Oxycodone 80 ± 6 8 ± 0.5 4 ± 0.26 
Codeine 26 ± 2 0.85 ± 0.06 0.43 ± 0.03 
Heroin 474 ± 32 15.8 ± 1.1 7.9 ± 0.55 
Fentanyl N.D. N.D. N.D. 
Methadone 86 ± 10 2.9 ± 0.3 1.5 ± 0.15 
Amphetamine 302 ± 14 10.1 ± 0.4 5.1 ± 0.2 
Methylphenidate 236 ± 28 7.8 ± 0.95 3.9 ± 0.47 
Alprazolam 60 ± 2 29.7 ± 1.2 14.9 ± 0.6 
Cocaine 470 ± 42 9.4 ± 0.8 4.9 ± 0.4 
MDMA 30 ± 12 0.3 ± 0.1 0.15 ± 0.05 
 
 
 
 
 
 
 
 
 
 
171 
 
Table 24 - Analyte elimination half-lives. 
Analyte Classification 
Elimination Half-Life 
(hours) 
Morphine 2-day 4.2 
Morphine-3-
Glucuronide 2-day 4.2 
Codeine 24-hour 2.3 
Norcodeine 24-hour 2.3 
Oxycodone 24-hour 2.3 
Noroxycodone 24-hour 2.3 
6-Acetylmorphine 24-hour 0.6 
Norfentanyl 3-day 9.4 
EDDP 7+ day 39.5 
Buprenorphine 24-hour 3.21 
Norbuprenorphine 7+ day 35.56 
Amphetamine 3-day 8 
Methylphenidate 24-hour 2 
Alprazolam 4-day 12 
Cocaine 2-day 5.1 
Benzoylecgonine 2-day 5.1 
MDMA 3-day 8.5 
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Fig. 22 – Uncorrected sample extract concentrations (ng/mL) of all analytes detected 
during the August 2017-December 2017 sampling campaign. MOR: morphine; OXY: 
oxycodone; COD: codeine; HER: heroin; FENT: fentanyl; M3G: morphine-3-
glucuronide; NOXY: noroxycodone; NCOD: norcodeine; 6-AM: 6-acetylmorphine; 
NFENT: norfentanyl; EDDP: 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; AMP: 
amphetamine; MPH: methylphenidate; ALP: alprazolam; OH-ALP: alpha-hydroxy-
alprazolam; COC: cocaine; BZE: benzoylecgonine; MDMA: 3,4-
Methylenedioxymethamphetamine; METH: methamphetamine. Non-detects are 
represented by an asterisk (*). 
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Fig. 23 - Average drug residue mass loads per day and a comparison between weekend 
and weekday mass load opioid occurrence for morphine-3-glucuronide (M3G), 
oxycodone (OXY), noroxycodone (NOXY), codeine (COD), norcodeine (NCOD), 6-
acetylmorphine (6-AM), and EDDP. Error bars represent the standard error of all 
measured values for a specific day. Weekend comparison was done by a two-tailed t-test 
(α=0.05). Asterisks (**) denote a statistically significant difference between weekday and 
weekend mass loads. 
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Fig. 24 - Average drug residue mass loads per day and a comparison between weekend 
and weekday mass load prescription occurrence for alprazolam (ALP), alpha- 
hydroxyalprazolam (OH-ALP), methylphenidate (MPH), and amphetamine (AMP). Error 
bars represent the standard error of all measured values for a specific day. Weekend 
comparison was done by a two-tailed t-test (α=0.05). Asterisks (**) denote a statistically 
significant difference between weekday and weekend mass loads. 
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APPENDIX E 
NARCOTIC ANALYTE CHROMATOGRAMS FOR CHAPTERS 4 AND 5 
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Fig. 25 – Total Ion Count Chromatograms for Morphine: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
 
Fig. 26 - Total Ion Count Chromatograms for Morphine-3-Glucuronide: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
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Fig. 27 - Total Ion Count Chromatograms for Codeine: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
 
Fig. 28 - Total Ion Count Chromatograms for Norcodeine: Standard, Raw Wastewater, 
and the Deionized Water Blank. 
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Fig. 29 - Total Ion Count Chromatograms for Oxycodone: Standard, Raw Wastewater, 
and the Deionized Water Blank. 
 
Fig. 30 - Total Ion Count Chromatograms for Noroxycodone: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
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Fig. 31 - Total Ion Count Chromatograms for Fentanyl: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
 
Fig. 32 - Total Ion Count Chromatograms for Norfentanyl: Standard, Raw Wastewater, 
and the Deionized Water Blank. 
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Fig. 33 - Total Ion Count Chromatograms for Heroin: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
 
Fig. 34 - Total Ion Count Chromatograms for 6-Acetylmorphine: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
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Fig. 35 - Total Ion Count Chromatograms for EDDP: Standard, Raw Wastewater, and the 
Deionized Water Blank. 
 
Fig. 36 - Total Ion Count Chromatograms for Buprenorphine: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
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Fig. 37 - Total Ion Count Chromatograms for Norbuprenorphine: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
 
Fig. 38 - Total Ion Count Chromatograms for Amphetamine: Standard, Raw Wastewater, 
and the Deionized Water Blank. 
 
183 
 
 
Fig. 39 - Total Ion Count Chromatograms for Methylphenidate: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
 
Fig. 40 - Total Ion Count Chromatograms for Alprazolam: Standard, Raw Wastewater, 
and the Deionized Water Blank. 
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Fig. 41 - Total Ion Count Chromatograms for Alpha-Hydroxyalprazolam: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
 
Fig. 42 - Total Ion Count Chromatograms for Cocaine: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
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Fig. 43 - Total Ion Count Chromatograms for Benzoylecgonine: Standard, Raw 
Wastewater, and the Deionized Water Blank. 
 
Fig. 44 - Total Ion Count Chromatograms for MDMA: Standard, Raw Wastewater, and 
the Deionized Water Blank. 
